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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these
recommendations along with other considerations such as feasibility and 
means of implementation in developing regulatory standards.
It is intended to present successive reports as research and
epidemiologic studies are completed and as sampling and analytical methods 
are developed. Criteria and standards will be reviewed periodically to 
ensure continuing protection of the worker.
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constructive comments by the Review Consultants on Ethylene Dibromide, by 
the ad hoc committees of the Society for Occupational and Environmental
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O'Connor, H.D., NIOSH consultant in occupational medicine. The NIOSH 
recommendations for standards are not necessarily a consensus of all the 
consultants and professional societies that reviewed this criteria document 
on ethylene dibromide. A list of Review Consultants appears on page vi.
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The Division of Criteria Documentation and Standards Development, National 
Institute for Occupational Safety and Health, had primary responsibility 
for development of the criteria and recommended standard for ethylene 
dibromide. Gamil Debbas, Ph.D., was the criteria manager for the major 
development of the document and Jerry LR Chandler, Ph.D., served as 
criteria manager during the latter stages. SRI International developed 
the basic information for consideration by NIOSH staff and consultants 
under contract No. CDC-99-74-31.
The Division review of this document was provided by Douglas L. Smith, 
Ph.D. (Chairman), J. Henry Wills, Ph.D., Paul E. Caplan, with Harry B. 
Plotnick, Ph.D. (Division of Biomedical and Behavioral Sciences), Robert 
A. Rinsky, (Division of Surveillance, Hazard Evaluations, and Field 
Studies), and Clara H. Williams, Ph.D.
The views expressed and conclusions reached in this document, together with 
the recommendations for a standard, are those of NIOSH, after review of the 
evidence and consideration of the comments of reviewers. These views and 
conclusions are not necessarily those of the consultants, other federal 
agencies, and professional societies that reviewed the document, or of the 
contractor.
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I. RECOMMENDATIONS FOR AN ETHYLENE DIBROMIDE STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to ethylene dibromide in the workplace be 
controlled by adherence to the following sections. The standard is
designed to protect the health and provide for the safety of employees for 
up to a 10-hour workday, 40-hour workweek, over a working lifetime. 
Compliance with all sections of the standard should prevent adverse effects 
of ethylene dibromide on the health of employees and provide for their 
safety. Techniques recommended in the standard are valid, reproducible, 
and available to industry and government agencies. Sufficient technology 
exists to permit compliance with the recommended standard. Although NIOSH 
considers the workplace environmental limit to be a safe level based on 
current information, the employer should regard it as the upper boundary of 
exposure and make every effort to maintain the exposure as low as is 
technically feasible. The criteria and standard will be subject to review 
and revision as necessary.
The possible health effects of employees chronically exposed to 
ethylene dibromide may include the induction of cancers, malformations and 
heritable changes in offspring, and sterility. Ethylene dibromide may also 
cause adverse effects to the liver, kidneys, heart, and other internal 
organs and systems. Direct contact of the skin with ethylene dibromide may 
induce chemical burns as well as systemic effects, and ingestion of 
ethylene dibromide may damage internal organ systems, or even be fatal. 
The alkylation of cellular constituents, including the genetic material, 
deoxyribonucleic acid (DNA), is the most plausible molecular basis for the
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induction of adverse effects after exposure to ethylene dibromide.
These criteria and the recommended standard apply to occupational 
exposure of workers to the brominated hydrocarbon BrCH2CH2Br, hereinafter 
referred to as "ethylene dibromide." Synonyms for ethylene dibromide 
include ethylene bromide, dibromoethane, sym-dibromoethane, 1,2- 
dibromoethane, glycol dibromide, and EDB. The major uses of ethylene 
dibromide are as an additive to leaded gasoline and as a component of 
fumigants.
"Occupational exposure to ethylene dibromide" is defined as work in 
any establishment where ethylene dibromide is manufactured, blended, 
stored, used, handled, or otherwise present. The "action level" is defined 
as one-half of the recommended workplace exposure concentration designated 
as a ceiling limit for ethylene dibromide. Exposure to airborne ethylene 
dibromide at concentrations less than the action level, as determined in 
accordance with Section 8, will not require adherence to Sections 2, 3, 
4(a), or 8(c,d). If exposure to other chemicals also occurs, the employer 
shall comply with any applicable standard for the other chemicals.
Section 1 - Environmental (Workplace Air)
(a) Concentration
The employer shall control workplace concentrations of ethylene 
dibromide so that no employee is exposed in his workplace to concentrations 
greater than 1.0 mg/cu m (0.13 ppm) as a ceiling limit, as determined by a 
sampling period of 15 minutes.
2
(b) Sampling and Analysis
Procedures for the collection and analysis of workroom air samples 
for compliance with the standard shall be as provided in Appendices I and 
II, or by any methods shown to be at least equivalent in precision,
sensitivity, and accuracy to the methods specified.
Section 2 - Medical
Medical surveillance shall be made available to employees as outlined
below:
(a) Comprehensive preplacement and annual medical examinations
unless a more frequent schedule is indicated by professional medical
judgment based on such factors as emergencies, variations in work periods, 
and the preexisting health status of the individual worker.
(b) These examinations shall include at least:
(1) Comprehensive or interim medical and work histories,
with special emphasis directed to disorders of the heart, liver, kidneys, 
and nervous system.
(2) A comprehensive physical examination, with particular 
emphasis given to cardiovascular, pulmonary, neurologic, hepatic, and renal 
systems, and to the skin.
(3) An evaluation of the employee's physical ability to
safely wear a negative or positive pressure respirator.
(c) Employees shall be counseled by the physician to ensure that
each employee is aware that ethylene dibromide has been shown to induce in
experimental animals adverse effects in reproductive processes, including
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abnormalities in offspring, mutations, and stomach cancer following direct 
administration. The relevancy of these findings in animals to male or 
female employees has not yet been established. They do indicate, however, 
that both employers and employees should do everything possible to minimize 
exposures to ethylene dibromide. If a physician becomes aware of any 
adverse effects on the reproductive system, or cancers in individuals who 
have been exposed to ethylene dibromide, or any abnormal babies born to 
parents either or both of whom have been exposed to ethylene dibromide, 
such information should be forwarded to the Director, National Institute 
for Occupational Safety and Health, as promptly as possible.
(d) Medical attention shall be provided promptly to all employees 
suspected of being exposed to ethylene dibromide vapor at or above the 
action level or to liquid ethylene dibromide. A 48-hour medical 
observation period for delayed systemic or dermal effects is recommended.
(e) Examinations of current employees shall be performed as soon 
as practicable after the promulgation of a standard based on these 
recommendations.
(f) The employer shall maintain medical records for all persons 
exposed to ethylene dibromide at or above the action level. All medical 
records, including information on required medical examinations and 
supporting documents, shall be kept for at least 30 years after the 
termination of the individual's employment.
(g) The medical representatives of the Secretary of Health, 
Education, and Welfare, of the Secretary of Labor, of the employee or 
former employee, and of the employer shall have access to these medical 
records.
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Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in 
the predominant language of non-English-reading workers. Illiterate 
workers and workers reading languages other than those used on labels and 
posted signs shall receive information regarding hazardous areas and shall 
be informed of the instructions printed on labels and signs.
(a) Labeling
The following warning label shall be affixed in a readily visible 
location on ethylene dibromide processing or other equipment and on 




BREATHING VAPOR MAY BE HAZARDOUS TO HEALTH 
CAN BE FATAL IF SWALLOWED 
HARMFUL IF ABSORBED THROUGH SKIN 
CAUSES SEVERE IRRITATION OF SKIN AND EYES
Avoid breathing vapor.
Avoid contact with skin or eyes.
Use only with adequate ventilation.
Keep containers closed when not in use.
Wash thoroughly before eating, drinking, smoking, or using toilet.
First aid: If inhaled, remove to fresh air. Give artificial
respiration if needed. Give oxygen if breathing is impaired. 
Call a physician.
In case of contact, immediately flush eyes or skin with water
for at least 15 minutes. Call a physician.
If swallowed, induce vomiting immediately if patient is
conscious. Call a physician.
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(b) Posting




HARMFUL IF INHALED 
CAN BE FATAL IF SWALLOWED
HIGHLY IRRITATING TO SKIN AND EYES 
HARMFUL IF ABSORBED THROUGH SKIN
Section 4 - Personal Protective Equipment and Clothing 
Ca) Respiratory Protection
Cl) Engineering controls shall be used wherever needed to
keep airborne ethylene dibromide concentrations below the recommended 
occupational exposure limit. Compliance with this limit may be achieved by 
the use of respirators under the following conditions only:
(A) During the time necessary to install or test the 
required engineering controls.
(B) For nonroutine operations, such as emergency 
maintenance or repair activities.
(C) During emergencies when air concentrations of 
ethylene dibromide may exceed the recommended occupational exposure limit.
C2) When a respirator is permitted by paragraph (a)(1) of
this section, it shall be selected and used pursuant to the following 
requirements:
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(A) The employer shall ensure that no employee is
exposed to ethylene dibromide because of improper respirator selection, 
fit, use, or maintenance.
(B) The employer shall establish and enforce a
respirator program meeting the requirements of 29 CFR 1910.134 as amended.
(C) The employer shall provide respirators in 
accordance with Table 1-1 and shall ensure that the employee uses the 
respirator provided when necessary.
(D) Respiratory protective devices described in
Table 1-1 shall be those approved under the provisions of 30 CFR 11.
(E) Respirators specified for use in higher
concentrations of ethylene dibromide may be used in atmospheres of lower
concentrations.
(F) The employer shall ensure that chemical
cartridges are not used with ethylene dibromide except for evacuation or 
escape because of the poor warning properties of ethylene dibromide at the 
recommended occupational exposure limit.
(G) The employer shall ensure that respirators are
adequately cleaned and maintained, and that employees are instructed and 
drilled, at least annually, in the proper use and testing for leakage of 
respirators assigned to them.
(H) Respirators shall be easily accessible and
employees shall be informed of their location.
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TABLE 1-1
RESPIRATOR SELECTION GUIDE FOR ETHYLENE DIBROMIDE
Respirator Type Approved 
Concentration under Provisions of 30 CFR 11
Less than or 
equal to 
10 mg/cu m
Less than or 
equal to 
50 mg/cu m




2,000 mg/cu m 
or entry into 
area of unknown 
concentration
Supplied-air respirator with half-mask 
facepiece operated in demand (positive 
pressure) mode
(1) Supplied-air respirator with full 
facepiece, helmet, or hood
(2) Self-contained breathing appara­
tus with full facepiece
Type C supplied-air respirator with 
full facepiece operated in pressure- 
demand or other positive pressure mode 
or with full facepiece, hood, or hel­
met operated in continuous-flow mode
(1) Self-contained breathing appara­
tus with full facepiece operated in 
pressure-demand or other positive 
pressure mode
(2) Combination respirator that in­
cludes Type C supplied-air respirator 
with full facepiece operated in pres- 
sure-demand or other positive pressure 
or continuous-flow mode and auxiliary 
self-contained breathing apparatus op­
erated in pressure-demand or positive 
pressure mode
(3) Supplied-air suits may be neces­
sary
(b) Eye Protection
Eye protective devices shall be provided by the employer and used by 
each employee where contact of ethylene dibromide with the eyes is likely. 
Chemical safety goggles or plastic face shields (8-inch minimum) with 
goggles made completely of ethylene dibromide-resistant materials shall be 
used. Selection, use, and maintenance of eye protective devices shall be 
in accordance with 29 CFR 1910.133.
(c) Protective Clothing
Protective clothing shall be resistant to the penetration and to the 
chemical action of ethylene dibromide. Additional protection, including 
gloves, bib-type aprons, boots, and overshoes, shall be provided for, and 
worn by, each employee while in any operation that may cause direct contact 
with liquid ethylene dibromide. Supplied-air hoods or suits resistant to 
penetration by ethylene dibromide shall be worn when entering confined 
spaces, such as pits or storage tanks. In situations where heat stress is 
likely to occur, supplied-air suits, preferably cooled, are recommended. 
The employer shall ensure that all personal protective clothing is 
inspected regularly for defects and is maintained in a clean and 
satisfactory condition by the employee.
Section 5 - Informing Employees of Hazards from Ethylene Dibromide
(a) All new and present employees working where occupational
exposure to ethylene dibromide may occur shall be informed orally and in 
writing of the hazards, relevant signs and symptoms of exposure, 
appropriate emergency procedures, and proper conditions and precautions 
concerning safe use and handling of ethylene dibromide. First-aid
procedures shall be included. This information shall be readily available 
to all employees involved in the manufacture, use, transport, or storage of 
ethylene dibromide and shall be posted in prominent positions within the 
workplace.
(b) All employees involved with the manufacture, use, transport, 
or storage of ethylene dibromide shall be informed that ethylene dibromide 
has been reported to induce cancer in experimental animals after repeated 
oral intubation.
(c) Employers shall institute a continuing education program to 
ensure that all employees have current knowledge of job hazards, 
maintenance procedures, cleanup methods, emergency procedures, and 
evacuation procedures. This program should include at least:
Emergency procedures and drills.
Instruction in handling spills and leaks.
Decontamination procedures.
Location and use of firefighting equipment.
First-aid procedures, equipment location, and use.
Rescue procedures.
Confined space entry procedures.
Inadequacy of odor as a means of detection.
Records of such training should be kept for inspection by authorized 
personnel as required. This program shall be held for all employees with 
occupational exposure to ethylene dibromide at intervals not greater than 
quarterly, or whenever there is a process change.
(d) Information as required shall be recorded on the "Material 
Safety Data Sheet" shown in Appendix III, or on a similar form approved by 
the Occupational Safety and Health Administration, US Department of Labor.
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Section 6 - Work Practices
(a) Emergency Procedures
For all work areas where emergencies may occur, the employer shall 
take all necessary steps to ensure that employees are instructed in and 
follow the procedures specified below and any others appropriate to the 
specific operation or process.
(1) Procedures shall include at least prearranged plans
for :
(A) Immediate evacuation, transportation, and 
medical assistance for affected employees; this procedure should include 
alerting medical treatment facilities of the impending arrival of affected 
employees.
(B) Designation of medical receiving facilities and 
names of physicians trained in ethylene dibromide emergency procedures.
(C) Reentry into areas where ethylene dibromide 
leaks or spills have occurred for cleanup, decontamination, or maintenance 
purposes.
(2) Evacuation alarm systems shall be provided by the
employer.
(3) Personal protective equipment and clothing as specified 
in Section 4 shall be used by trained personnel essential to emergency 
operations.
(4) Nonessential employees shall be evacuated from
hazardous areas during emergencies. Perimeters of these areas shall be 
delineated, posted, and secured. The employees in adjacent areas shall be 
trained in evacuation procedures if these work areas become involved.
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C5) Only personnel trained in the emergency procedures and
protected against the attendant hazards shall shut off sources of ethylene 
dibromide, clean up spills, control and repair leaks, and fight fires in 
ethylene dibromide areas.
(6) Firefighting procedures shall be established for areas 
where flammable materials are used with ethylene dibromide. Chemical foam, 
carbon dioxide, or dry chemicals shall be used for fighting fires in areas 
where ethylene dibromide is present. Proper protective respirators and 
clothing shall be worn by all personnel in the hazard area until 
concentrations of airborne ethylene dibromide have been demonstrated by 
monitoring to be below the recommended occupational exposure limit.
(7) Showers, eyewash fountains, and washroom facilities 
shall be provided and so located as to be readily accessible to workers in 
all areas where skin or eye contact with liquid ethylene dibromide is 
likely. If liquid ethylene dibromide is splashed on the clothing or skin, 
contaminated clothing shall be promptly removed and the skin washed 
thoroughly with soap and water for at least 15 minutes. If liquid ethylene 
dibromide gets into the eyes, they shall be irrigated immediately with 
copious quantities of running water for at least 15 minutes.
(8) Medical attention shall be provided promptly for any 
affected worker. Such exposures shall be reported to the immediate 
supervisor by the affected worker or by a fellow employee.
(b) Control of Airborne Ethylene Dibromide
(1) Suitable engineering controls designed to limit
exposure to ethylene dibromide to that prescribed in Section 1(a) shall be 
used. The use of completely enclosed processes is the recommended method
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of control for ethylene dibromide. Local exhaust ventilation may also be 
effective, used alone or in combination with process enclosure. When a 
local exhaust ventilation system is used, it shall be designed to prevent 
the accumulation or recirculation of ventilation control or process air in 
the workroom, to maintain ethylene dibromide concentrations below the limit 
of the recommended standard, and to remove ethylene dibromide from the 
breathing zones of employees. Exhaust systems discharging into outside air 
must conform with applicable local, state, and federal air pollution 
regulations. Ventilation systems shall be subjected to regular preventive 
maintenance and cleaning to ensure effectiveness, which shall be verified 
by periodic airflow measurements at least every 3 months. Measurements of 
system efficiency shall also be made immediately by personnel properly 
attired in specified protective equipment when any change in production, 
process, or control might result in increased concentrations of airborne 
ethylene dibromide. Tempered makeup air shall be provided to work areas in 
which exhaust ventilation is operating.
(2) Forced-draft ventilation systems shall be equipped with 
remote manual controls and shall be designed to turn off automatically in 
the event of a fire in the work area.
(c) Handling of Ethylene Dibromide and General Work Practices
Cl) Written operating instructions and emergency medical
procedures shall be formulated and posted where ethylene dibromide is
handled or used.
C2) Prompt medical attention shall be provided if there is
known or suspected exposure to ethylene dibromide, whether or not symptoms
are present.
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C3) The employer shall ensure that safety showers, eyewash
fountains, and other emergency equipment is in proper working order through 
regularly scheduled inspections performed by qualified maintenance 
personnel.
(4) Ethylene dibromide operating systems shall be inspected 
daily for signs of leaks by personnel attired in specified protective 
equipment. All equipment including valves, fittings, and connections shall 
be checked for tightness and good working order. All newly made 
connections shall be checked for leaks immediately after ethylene dibromide 
is introduced by trained personnel attired in prescribed personal 
protective equipment.
(5) If there is a leak, the leak shall be corrected 
immediately. Work shall resume normally only after necessary repair or 
replacement has been completed, the area has been ventilated, and the 
concentration of ethylene dibromide has been determined by monitoring to be 
below the recommended occupational exposure limit.
(6) Transportation and use of ethylene dibromide shall 
comply with all applicable local, state, and federal regulations. Where 
ethylene dibromide is used as a fumigant, strict adherence to the pesticide 
container label requirements for application and personal protection shall 
be followed. Additional standards for pesticide use by agricultural 
workers can be found in 40 CFR 170.
(7) When ethylene dibromide containers are being moved, or 
when they are not in use and are disconnected, valve protection covers 
shall be in place. Containers shall be moved only with the proper
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equipment and shall be secured to prevent dropping or loss of control while 
moving.
(8) Process valves and pumps shall be readily accessible 
and should not be located in pits and congested areas.
(9) Containers and systems shall be handled and opened with
care. Approved protective equipment as specified in Section 4 shall be 
worn while opening, connecting, and disconnecting ethylene dibromide 
containers and systems. Adequate ventilation shall be available to prevent 
exposure to ethylene dibromide when opening containers and systems.
(10) Personnel shall work in teams when ethylene dibromide 
is first admitted to a system, while repairing leaks, or when entering a 
confined or enclosed space.
(11) Any odor of ethylene dibromide shall be reported to a
responsible authority and an alarm sounded immediately.
(d) Work Areas
(1) Ethylene Dibromide Hazard Areas
A hazard area shall be considered as any space workers may 
enter that has physical characteristics and sources of ethylene dibromide 
that could result in air concentrations exceeding the recommended limit. 
Exits shall be plainly marked and shall open outward. Emergency exit doors 
shall be conveniently located and shall open into areas which will remain 
free of contamination in an emergency. At least two separate means of exit 
shall be provided from each room or building in which ethylene dibromide is 
stored, handled, or used in quantities that could create a hazard.
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(2) Confined or Enclosed Spaces
Entry into confined spaces, such as tanks, pits, process 
vessels, tank cars, sewers, or tunnels, where there may be limited egress 
shall be controlled by a permit system. Permits shall be signed by an 
authorized employer representative certifying that preventive and 
protective measures have been followed.
Confined spaces which have contained ethylene dibromide shall 
be thoroughly ventilated to ensure an adequate supply of oxygen, tested for 
ethylene dibromide and other contaminants, and inspected for compliance 
with these requirements prior to each entry. Adequate ventilation shall be 
maintained while workers are in the space. Leakage of ethylene dibromide 
into the confined space while work is in progress shall be prevented by 
disconnecting and blanking the ethylene dibromide supply lines. An 
individual entering confined spaces shall be furnished with appropriate 
personal protective equipment and protected by a lifeline harness tended by 
another worker outside the space, who shall also be equipped for entry with 
approved personal protective equipment and who has contact with a third 
party. Communication (visual, voice, signal line, telephone, radio, or 
other suitable means) shall be maintained by the standby person with the 
employee inside the confined or enclosed space. A third employee, equipped 
to proceed to the aid of the other two if necessary, shall have general 
surveillance of their activities.
(e) Storage
(1) Storage facilities shall be designed to contain spills
completely within a surrounding dike and to prevent contamination of 
workroom air.
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(2) Storage of ethylene dibromlde in the same area as
reactive metals, such as aluminum or magnesium, or as liquid ammonia shall 
be prohibited.
(3) Ethylene dibromide shall be stored in tightly closed
containers in a well-ventilated area away from excessive heat and sunlight.
C4) Storage containers shall be periodically inspected for
leakage.
(5) Ventilation switches and emergency respiratory
equipment shall be located outside storage areas in readily accessible 
locations which will be free of ethylene dibromide in an emergency.
(f) Spills, Leaks, and Waste Disposal
(1) If ethylene dibromide leaks or is spilled, the following 
steps shall be taken:
(A) Evacuate all nonessential personnel from the
area.
(B) Adequately ventilate the area of the spill or
leak to prevent accumulation of the vapor.
(C) If in liquid form, collect spilled material for
reclamation or absorb in vermiculite, dry sand, earth, or similar 
nonreactive material.
(D) If in solid form, collect spilled material in 
the most convenient and safe manner for reclamation or for disposal.
(2) Personnel entering the spill or leak area shall be 
furnished with appropriate personal protective equipment. All other 
personnel shall be excluded from the area.
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(3) All wastes and residues containing ethylene dibromide 
shall be collected in ethylene dibromide-resistant containers and 
incinerated or buried in such a manner that no ethylene dibromide or toxic 
decomposition products are released to the environment.
Section 7 - Sanitation Practices
(a) Plant sanitation shall meet the requirements of 29 CFR 
1910.141.
(b) Appropriate locker rooms shall be available for changing into
required protective clothing in accordance with 29 CFR 1910.141(e). 
Clothing contaminated with liquid ethylene dibromide shall be immediately 
removed and placed in a closed container in a well-ventilated area for 
later disposal or decontamination. Employers shall require personnel who 
work with ethylene dibromide to shower before leaving the workplace at the 
end of a workday.
(c) Employers shall ensure that employees who handle ethylene
dibromide wash their hands thoroughly with soap and water before eating, 
smoking, or using toilet facilities.
(d) The storage, dispensing, preparation, and consumption of food,
beverages, or tobacco shall be prohibited in ethylene dibromide work areas.
(e) The employer shall ensure that personnel who launder and clean
clothing or equipment contaminated with ethylene dibromide are provided 
adequate personal protective equipment to prevent exposure and shall ensure 
that these employees are aware of the potential hazards of exposure to 
ethylene dibromide.
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Section 8 - Monitoring and Recordkeeping Requirements
(a) Industrial hygiene surveys shall be made in any workplace 
where ethylene dibromide is handled, processed, or stored. Records of 
these surveys, including the basis for concluding that environmental 
concentrations are below the recommended limit or below the action level, 
shall be maintained. Surveys shall be repeated every month or whenever a 
process change is made.
(b) Where exposure concentrations have not been determined, they
shall be determined as soon as practicable after the promulgation of a
standard based on these recommendations.
(c) Requirements set forth below apply to work areas in which the 
concentration of ethylene dibromide has been determined to be at or above 
the action level.
(1) An adequate number of samples shall be collected
monthly in accordance with Appendix I for the evaluation of the work 
environment with respect to the occupational exposure of the employees.
(2) Environmental samples shall be taken when a new process
is installed or process changes are made which may cause an increase in 
environmental concentrations. Significantly increased production, 
relocation of existing operations, interruption of normal maintenance
schedules, or other functions which may increase ethylene dibromide
concentrations shall require resampling and analysis.
(3) In all monitoring, samples shall be collected in
accordance with the provisions prescribed in Section 1(b).
(4) The minimum number of representative exposure 
determinations for an operation or process shall be based on variations in
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exposures and production schedules and in accordance with the provisions 
prescribed in Section 1(b).
(5) If initial, periodic, or special evaluations indicate 
that the recommended limit is exceeded, corrective engineering or other 
control measures shall be immediately instituted to ensure the safety of 
employees until a concentration below the recommended occupational exposure 
limit is achieved. In such cases, sampling of each operation and work 
location shall be conducted at least weekly until two consecutive employee 
exposure measurements, taken at least 1 week apart, reveal that the
employee is not exposed to ethylene dibromide above the recommended 
occupational exposure limit. Employers shall notify in writing, within 5 
days, every employee who is found to be exposed to ethylene dibromide above 
the recommended environmental limit.
(d) Employers or their successors shall maintain records which 
shall include sampling and analytical methods, types of respiratory
protection used, concentrations found, and information concerning exposure 
of employees to ethylene dibromide. Each employee shall have access to
data on the employee's own environmental exposures. Pertinent records of 
occupational accidents and environmental exposures within the workplace 
shall be kept for at least 30 years after the worker's employment has
ended. Records of occupational exposures applicable to an employee should
be included in that employee's medical records. The medical 
representatives of the Secretary of Health, Education, and Welfare, of the 
Secretary of Labor, of the employee or former employee, and of the employer 
shall have access to all such records.
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II. INTRODUCTION
This report presents the criteria and the recommended standard which 
were prepared to meet the need for preventing disease or injury arising 
from exposure to ethylene dibromide. The criteria document fulfills the 
responsibility of the Secretary of Health, Education, and Welfare under 
Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, has formalized a 
system for the development of criteria upon which standards can be 
established to protect the health and provide for the safety of employees 
exposed to hazardous chemical and physical agents. Any criteria and 
recommended standard should enable management and labor to develop better 
engineering controls and more healthful work practices. Simple compliance 
with the recommended standard should not be used as a final goal.
These criteria for a standard for ethylene dibromide are part of a 
continuing series of documents developed by NIOSH. The recommended 
standard applies to the processing, manufacture, use of, or other 
occupational exposure to ethylene dibromide as applicable under the 
Occupational Safety and Health Act of 1970. The standard was not designed 
for the population-at-large, and any extrapolation beyond occupational 
exposures is not warranted. It is intended to (1) protect against the
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development of short- and long-term adverse effects on health from ethylene 
dibromide exposure, C2) protect against local effects on the skin, (3) be 
measurable by techniques that are valid, reproducible, and available to 
industry and government agencies, and (4) be attainable with existing 
technology.
The development of the criteria for the recommended standard for 
occupational exposure to ethylene dibromide has demonstrated a need for 
further research in the following areas: (1) epidemiologic studies of
employees exposed to ethylene dibromide, (2) animal studies designed to 
determine the cumulative effects from dermal contact and inhalation of 
ethylene dibromide, (3) studies on the mutagenic effects of ethylene 
dibromide in mammals, and (4) animal studies to investigate the
carcinogenic and reproductive effects from ethylene dibromide by dermal 
absorption and inhalation.
Adherence to the recommended standard for occupational exposure to 
ethylene dibromide is intended to minimize the potentials for the induction 
of sterility, carcinogenesis, mutagenesis, or teratogenesis in employees
and their offspring from exposure to ethylene dibromide in the workplace.
Adherence to the recommended standard is also intended to minimize the
hazards from skin penetration and irritation associated with exposure to 
liquid ethylene dibromide and the delayed and insidious long-term systemic 
effects resulting from exposure to bath liquid and vaporous ethylene 
dibromide.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Ethylene dlbromide, also known as 1,2-dibromoethane and ethylene 
bromide, is a clear, colorless, heavy liquid at room temperature with a 
distinctive odor described as "characteristic, mildly sweet" [1]. The 
minimum concentrations of ethylene dibromide in air reported to be 
detectable by odor range from 10 ppm (77 mg/cu m) [2] to 25 ppm (192.5 
mg/cu m) [3]. Selected chemical and physical properties of ethylene 
dibromide are listed in Table XII-1 [1,3,4].
Ethylene dibromide is a reactive molecule which may form covalent 
bonds under biologic conditions [5,6]. Because of the two replaceable 
bromine atoms, ethylene dibromide is considered to be a bifunctional 
alkylating agent that is capable of introducing cross-links into biologic 
materials [6]. It tends to react with nucleophilic organic compounds [7] 
more readily with those that are relatively easily polarized, such as those 
containing sulfhydryl or amino groups, than with those that are less 
readily polarized, such as acids and ketones.
The half-life of ethylene dibromide in water at 20 C and at a pH of 7 
is about 14 years [7]. Although the biologic half-life of ethylene 
dibromide in humans is unknown, the presence of large numbers of 
nucleophiles in biologic tissue suggests that the half-life would be 
considerably shorter than that in water. The approximate biologic half- 
life of ethylene dibromide after intravenous (iv) injection in rats was 
less than 2 hours, and in chicks, it was less than 12 hours [8]. An 
approximate biologic half-life of 14C-labeled ethylene dibromide in mice 
and in guinea pigs can be estimated from the data presented by Edwards et
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al [9] and Plotnick and Conner [10] as less than 48 hours. This indicates 
that either spontaneous reactions with nucleophiles, enzymatically 
catalyzed degradative reactions, or efficient excretory mechanisms 
predominate in biologic systems.
Alkyl bromides, such as ethylene dibromide, readily react with 
thiols, amines, alcohols, and other nucleophilic biochemical constituents 
[11-13] . The initial monoalkylation product between ethylene dibromide and 
substrate heteroatoms, such as nitrogen, oxygen, or sulfur, is a "half­
mustard" (a thiane) reagent which may spontaneously cyclize under biologic 
conditions to form a strained three-membered ring. This highly reactive 
intermediate product may then undergo a second alkylation reaction with 
cellular constituents. When both alkylation reactions occur with cellular 
DNA, the covalent cross-links between the DNA strands may prevent the 
normal separation of the strands during DNA synthesis and subsequent cell 
division [11,13]. Thus, such bifunctional alkylating agents as ethylene 
dibromide tend to possess a considerably greater biologic activity than 
monofunctional agents of the same primary reactivities [11].
The covalent reaction of ethylene dibromide with biologic materials 
may alter the chemical behavior and physical characteristics of the 
cellular constituents so as to prevent the altered molecules from 
functioning normally in physiologic processes. The formation of stable 
reaction products may account, in part, for the subsequent deleterious 
effects observed in biologic systems exposed to ethylene dibromide. The 
alkylation by foreign chemicals of the biologic materials controlling 
cellular metabolism is the most plausible basis for the induction of 
genetic and neoplastic alterations after the exposure of biologic
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populations to alkylating agents. When the risk of induction of adverse 
biologic changes, such as mutation and neoplasia, increase as a cumulative 
function of the total dosage, then the observation of measurable effects 
may not be possible until after long periods of exposure to low 
concentrations of the inducing agent [7,14].
Extent of Exposure
Ethylene dibromide-manufacturing processes are based on the 
bromination of ethylene [1]. Natural bromide-containing brines are treated 
with chlorine to release elemental bromine through anionic replacement. 
The reaction between gaseous ethylene and liquid bromine (which may contain 
traces of chlorine) yields a mixture of ethylene dibromide and reaction 
side-products, including very small amounts of vinyl bromide, ethyl 
bromide, and ethyl chlorobromide [15]. If the reaction temperatures and 
pressures are carefully controlled, the purity of the ethylene dibromide 
can approach 99.95% [15]. Ethylene dibromide can also be produced by the 
hydrobromination of acetylene [2], although this process is of little 
commercial value today.
In 1921, the antiknock properties of tetraalkyl lead compounds in the 
internal combustion engine were discovered [16]. To prevent the deposition 
of lead on the cylinder walls, a substance capable of reacting with the 
lead to aid its removal from the engine was needed. Ethylene dibromide was 
found to be such a substance and has been used since then in leaded 
gasoline as a lead scavenger.
The US production of ethylene dibromide increased from an estimated 
64 million pounds in 1940 to over 331 million pounds in 1973 [17]. This
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fivefold increase can be related to the increased consumption of gasoline 
containing ethylene dibromide as an additive, which has always been its 
largest use [1]. About 85% of the ethylene dibromide produced during the 
last few years has been used as a constituent of antiknock mixtures 
containing tetraethyl lead [17,18]. Other applications (about 15%) include 
use as a fumigant-insecticide or nematocide, as a synthetic intermediate, 
and as a specialty solvent for resins, gums, and waxes [18]. Ethylene 
dibromide has previously been used as a gauge fluid, in fire extinguishers, 
and as an industrial solvent [2,19]; however, these applications are now 
limited or nonexistent. Although over 100 pesticides registered with the 
Environmental Protection Agency contain ethylene dibromide [19,20], the 
compound is not available as an over-the-counter product [18].
The production of ethylene dibromide is the largest single use of 
bromine, and, as such, the locations of manufacturing plants have usually 
been near the major sources of bromine [1]. Until 1961, the major source 
of bromine for ethylene dibromide manufacture was seawater; since 1961, the 
major source of bromine has been underground brine deposits, and the 
manufacturing of ethylene dibromide has been redistributed to be near these 
natural bromide brine wells in Michigan and Arkansas [1]. A number of 
other occupations in which a potential for ethylene dibromide exposure 
exists are listed in Table XII-2 [21].
NIOSH estimates that approximately 9,000 employees (manufacturing, 
formulating, fumigating) are potentially exposed to ethylene dibromide in 
the workplace. If one includes gasoline station attendants, this figure 
becomes much larger (about 660,000).
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Historical Reports
One of the first instances of ethylene dibromide intoxication was 
described by Marmetschke [22] in 1910. This case history described the 
accidental use of ethylene dibromide instead of ethyl bromide as an 
anesthetic or narcotic agent. Although this report is historical rather 
than clinical, it is one of the few relating to human exposure which give 
the amount of ethylene dibromide administered to each patient and the 
clinical symptoms resulting from the exposures. Thus, this report will be 
discussed in detail in Effects on Humans.
Another early case of occupational exposure to ethylene dibromide, 
which will also be discussed in Effects on Humans, was described in 1928 by 
Kochmann [23].
Effects on Humans
In 1910, Marmetschke [22] wrote about a case of ethylene dibromide 
poisoning that occurred as the result of the mistaken administration of 
ethylene dibromide to a patient instead of ethyl bromide. A woman was 
administered the contents of a 70-g bottle of ethylene dibromide in 
aliquots of about 10 ml (22.0 g) through a gauze mask without producing the 
expected anesthesia. She coughed constantly during the administration and 
was dizzy at the completion of the application. She began to vomit and 
continued vomiting throughout the night. The patient complained of a 
burning sensation in her chest and of inability to sleep. During the 
night, she had diarrhea, and the next day she became dizzy again after 
exertion. She became very restless and nervous and complained of having 
trouble in breathing. She continued to complain of thirst, abdominal pain,
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and a burning sensation in her chest. The next day, she had uterine 
hemorrhaging, and died approximately 44 hours after she received the 
ethylene dibromide.
The results of the autopsy showed that the skin was a very pale blue 
and that the vessels of the skin were filled with blood [22], The body 
cavities contained a clear reddish liquid. Examination of the internal 
organs showed advanced stages of parenchymatous degeneration of the heart, 
liver, and kidneys. Signs of upper respiratory tract irritation and 
extensive surface hemorrhage were found, in addition to swelling of the 
pulmonary lymphatic glands. Several hemorrhages were also noted in blood 
vessels of the mediastinum. Microscopic examination showed fatty 
degeneration of the cardiac musculature and of the liver cells. 
Marmetschke [22] concluded that the woman became ill from inhalation of 
ethylene dibromide, which produced general weakness, nausea, vomiting, 
diarrhea, chest pains, coughing, shortness of breath, cardiac 
insufficiency, and hemorrhagic diathesis with bleeding from the uterus.
In 1928, Kochmann [23] described a case history of an employee 
exposed repeatedly to ethylene dibromide vapor in the course of his work in 
the production of the chemical. The employee was exposed at an unknown 
concentration of what was described as a foul-smelling, pungent vapor for 
only short periods. He was suffering from an irritation of the conjunctiva 
with external swelling of the lower lids and swelling of the glands under 
the chin and in the angle of the jaw. He was disturbed and seemed pale and 
fatigued.
The employee returned to his work shortly thereafter, but soon became 
ill again [23]. This time, he suffered from conjunctivitis, pharyngeal and
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bronchial irritation, severe loss of appetite, headaches, and depression. 
His condition improved rapidly on cessation of work and resumption of 
treatment. The concentration of airborne ethylene dibromide at which he 
was exposed was not stated.
In 1938, Pflesser [24] reported that a seaman aboard a destroyer 
accidentally spilled some gauge fluid in his boots. This fluid contained 
55 parts of ethylene dibromide, 30 parts of tetrachloroethane, 15 parts of 
paraffin oil, and a trace of Sudan Red B. He continued working without 
emptying or removing his boots. During the following night, burning pain 
developed in both feet, and, the next morning, his feet were reddened, 
extremely painful, and blistered between the toes. The attending physician 
observed that the feet were inflamed and very sensitive to pressure, but
that no vascular disturbances or neurogenic lesions were evident. With
extensive treatment, complete healing occurred after 14 days.
Pflesser [24] subjected eight human volunteers and himself to the 
gauge fluid and to each of the components separately to determine their 
effects on the skin. One milliliter of the gauge fluid was placed on the 
hands of the volunteers and rubbed between the hands for about 1 minute. 
Two hours later, the hands were washed with soap and water. None of the 
subjects developed any symptoms of adverse effects on the day of the test 
or later. Pflesser observed that, after rubbing the fluid between the 
hands for 1 minute, the liquid could no longer be seen on the skin, and he 
concluded that it had been absorbed or had evaporated.
In an additional experiment [24], the same volunteers rubbed 1 ml of 
the gauge fluid into the skin of the right forearm for 1 minute. Again,
washing with soap and water was done after 2 hours. No symptoms of
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irritation were seen immediately after the exposure or later.
In a third experiment [24], the same volunteers were subjected to 1 
ml of the gauge fluid on a cotton swab that was placed on the left forearm 
and covered; exposure time was 2 hours. After a few minutes, all eight 
subjects noted a sensation of heat at the application site, sometimes 
complaining of a pronounced burning of the skin. At the end of the 2-hour 
exposure, a strong reddening of the skin had appeared at the application 
site in all cases, and, in one case, pinhead-sized blisters had developed. 
During the next 12 hours, a severe burning pain developed in addition to 
small blisters which merged into large ones. The blisters initially 
contained a clear, amber-yellow, thick liquid, but the liquid had a 
pronounced tendency to coagulate because of its high protein content. The 
area immediately surrounding the application site was edematous and 
swollen, and, in some cases, the swelling extended from the fingertips to 
the upper arm. In one case, the axillary lymph nodes were moderately 
swollen and painful. Even with topical cod liver oil treatment, the skin 
did not grow back until 13-17 days after exposure, and surface scars 
persisted for at least 4 months. Pflesser [24] stated that all subjects 
felt severely ill during the first days following exposure. In two 
subjects, dermatitis, consisting of severe swelling and reddening of the 
skin accompanied by intensive itching, persisted in the area of the 
application for several weeks.
To determine which component of the gauge fluid was responsible for 
the adverse effects on the skin, Pflesser [24] subjected the same eight 
subjects and himself to each of the individual components. The results of 
the tests with the paraffin oil, Sudan Red B, and tetrachlorethane were
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negative. During the 1-hour exposure to 0.5 ml of tetrachlorethane, 
several individuals noted a slight sensation of heat at the application 
site, but no symptoms similar to those for the gauge fluid were 
subsequently noted. All volunteers rubbed 0.5 ml (1.1 g) of ethylene 
dibromide into the skin of the forearm for 1 minute and washed with soap 
and water 30 minutes later. All subjects developed swelling and reddening 
of the exposed area, as well as itching, during the 24 hours immediately 
after exposure. The symptoms subsided without supportive treatment within
2-3 days.
In an additional experiment [24], the subjects received 0.5 ml (1.1 
g) of ethylene dibromide applied to the skin on a swab, the swab and the 
application site being covered for 10 minutes. The swab was then removed 
and the area was washed with soap and water. A sensation of heat or slight 
burning was noticed during the exposure; and, during the next 24 hours a 
painful reddening and swelling of the skin developed. However, no 
blistering was noticed in any of the subjects. The injuries disappeared in
3-5 days without leaving visible traces.
In a subsequent experiment [24], this procedure was repeated except 
that the application site was covered for 30 minutes. After this exposure 
period, the swab was removed and the area was washed with soap and water. 
During the 30-minute exposure, the subjects reported the customary heat or 
burning sensation at the application site. After exposure, a very painful 
inflammation of the skin occurred, including reddening, swelling, and 
blistering, within 15-20 hours. The damaged skin grew back after 7-13 days 
of supportive treatment. The author experienced such a strong burning pain 
in his skin immediately after application that increased so rapidly that
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the swab containing the ethylene dibromide had to be removed after 3 
minutes. The pain and reddening of the skin subsided, but then increased 
again after a few hours until a blister the size of a crab apple had formed
at the application site after 18 hours. Very strong pain was associated
with the blister. When the blister was opened, Pflesser collected 21 ml of 
a clear exudate, which coagulated soon afterward, and over 245 ml of fluid 
within the first 3 days after application. In addition, the author stated 
that when the blister appeared on the right arm, all places that had
previously been exposed to ethylene dibromide or to the gauge fluid on both 
the left and right arms began swelling, reddening, and itching. A 
moderately strong, painful glandular swelling occurred in the left armpit 
(opposite the arm of the application site). Pflesser also reported that 
only a slight edema had occurred surrounding the application site after the 
1st day, but that, on the 2nd day, an extensive edema of the entire right 
forearm and right hand suddenly developed. During these first few days
after exposure, there was a pronounced feeling of illness and a slight
temperature increase in addition to the physical manifestations at the 
exposure site. Healing of the damaged skin was complete after 17 days of 
zinc-sulfur ointment supportive treatment, leaving only a surface scar.
From this series of experiments, Pflesser [24] concluded that
ethylene dibromide was the component of the gauge fluid that was
responsible for the swelling, reddening, and blistering of the skin of the 
seaman on the destroyer. He also concluded that the effects and their
intensities depended on the duration of exposure to the skin, and that 
covering the application site to prevent evaporation greatly increased the 
extent of damage from exposure. Pflesser concluded that ethylene dibromide
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was absorbed through the skin, causing tissue death, general inflammation, 
and plasma exudation. He further postulated that ethylene dibromide 
possessed a sensitization potential, citing the symptoms that appeared at 
previous application sites after his own exposure for 3 minutes to 0.5 ml 
of ethylene dibromide as proof of the assumption.
In 1960, Olmstead [25] reported the death of a 43-year-old woman who 
was hospitalized 48 hours after ingesting 4.5 ml, or approximately 140
mg/kg, of ethylene dibromide in capsular form. She vomited almost
immediately after swallowing the capsules; vomiting recurred periodically 
during the next 48 hours. Twenty-four hours after ingestion, watery
diarrhea was first noted and recurred frequently. About 12 hours later,
the patient noted a decrease in the volume and a darkening of the urine.
She was completely anuric by the time of hospitalization. She had
tachypnea and marked agitation after ingesting the capsules. At the time 
of hospitalization, the patient complained of abdominal pain, nausea, 
vomiting, and diarrhea. Physical examination showed normal temperature and 
blood pressure. Her appearance was that of an acutely agitated,
disheveled, very ill person. Her pulse was thready, respiration was
increased, and systolic murmurs and sinus tachycardia were present. The 
lungs were clear and the results of abdominal, rectal, and neurologic 
examinations were normal.
The patient did not improve even after supportive treatment [25]. 
Her pulse became weaker and more sporadic, and she died 54 hours after the 
ingestion of the ethylene dibromide. An autopsy, 3 hours after death, 
disclosed no excess fluid in any of the body cavities, that all organ 
weights were normal, and that there were no gross abnormalities in the
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heart. The surface texture of the liver was more friable than normal and 
it was studded with small, bright yellow areas; the usual structure was 
destroyed. The kidneys were intensely congested, particularly in the
medullary area. The lungs were moderately congested and had some edema. A 
diffuse reddening of the gastric mucosa and of the small and large 
intestines was noted, but without associated evidence of necrosis or 
ulceration. Microscopic examination showed centrilobular necrosis of the
liver, with masses of red blood cells in the sinusoids and scattered yellow
pigment, but remarkably little inflammation. Also noted was damage in the
proximal tubular epithelium of the kidney with focal vascular congestion, 
but this damage was local and not widespread. From the results of the 
autopsy, Olmstead [25] concluded that ingestion of ethylene dibromide 
resulted primarily in changes in the liver and kidneys. The hepatic 
lesions were characterized by massive necrosis with minimal cell 
inflammation, whereas the kidney lesions displayed patchy and local 
necrosis. He further concluded that these changes paralleled those found 
in various animals after oral administration of ethylene dibromide.
Epidemiologic Studies
In 1977, Ott et al [26] submitted to NIOSH the results of a 
preliminary epidemiologic study on the mortality experience of 161 chemical 
company employees at two ethylene dibromide manufacturing sites. Plant A 
was opened in 1926 and was closed in 1976; Plant B began operation in 1942 
and closed in 1969. Plant A continuously produced ethylene dibromide 
during its 50-year operation. Employees were potentially exposed over this 
period, either during the manufacture of ethylene dibromide or indirectly
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through the production of other chemicals, to approximately 25 substances 
including bromine, benzene, substituted phenols, vinyl bromide, carbon 
tetrachloride, and numerous other halogenated hydrocarbons. Industrial 
hygiene estimates of ethylene dibromide exposure for the plant A reactor 
and still operators included in the study group were based on area and 
personal sampling in 1950, 1952, 1971-1972, and 1975. Plant B operations 
consisted of the batch production and distillation of ethylene dibromide. 
Both functions in Plant B were performed in the same building until the 
early 1960's when the batch reactors were replaced by continuous ones. No 
industrial hygiene surveys were conducted with respect to plant operations 
at Plant B. Exposures in Plant B were estimated to be primarily to 
ethylene dibromide, bromine, ethylene, sulfur dioxide, and chlorine. In 
addition to the ethylene dibromide operators, lead burners in Plant B may 
have been exposed to ethylene dibromide, since they could have spent up to 
90% of their time in the ethylene dibromide production area repairing glass 
and lead lines.
In Plant A, 18 breathing zone samples taken in 1950 ranged from 1.0 
to 7.4 ppm for reactor operators and from 2.2 to 10.6 ppm for still 
operators [26]. In 1952, area samples between the stills ranged from 19 to 
24 ppm and up to 31 ppm on warm days. Breathing zone determinations taken 
while filling drums ranged up to 13.4 ppm and, after a spill, up to 71 ppm. 
Extensive monitoring during 1971-1972 using continuous infrared 
soectrophotometry indicated TWA concentrations of 2.0 ppm (range 0.4-38 
ppm) for the reactor operators and 3.5 ppm (range 0-23 ppm) for the still 
operators before a shed was fixed. The still operator exposures were 
consistently higher than those of the reactor operators. The 1975 sampling
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indicated that reactor operators were exposed to concentrations ranging 
from 1.8 to as high as 96 ppm, with an 8-hour TWA concentration of 5 ppm 
for 22 samples. The authors stated that occasional excursions to 
concentrations beyond 75 ppm were suspected, based on symptomatology. Past 
records indicated that employees sensed a strong odor and reported 
respiratory irritation at about 75 ppm of ethylene dibromide. 
Gastrointestinal discomfort and vomiting were probably induced by short 
exposures to ethylene dibromide at 100-200 ppm for up to 1 hour, or by 
lower exposures over longer periods of time. Between 1954 and 1970, three 
episodes of acute exposure with respiratory or gastrointestinal involvement 
were reported by individuals in the study.
Employees were identified for this study by reviewing annual census 
lists and selecting all reactor and still operators from both plants, and 
foremen and lead burners from Plant B [26]. In Plant A, all individuals 
who had left the company prior to 1950 were not included in the study 
because of the difficulty of conducting followups on individuals from their 
social security numbers. Expected deaths were calculated from observed 
mortality rates for US white males, by 5-year groups, for the years 1942- 
1971. Five employees working with arsenicals in addition to ethylene 
dibromide were analyzed separately because of prior indications that 
arsenical employees were at an increased risk of developing respiratory 
malignancies. All of the arsenical-exposed employees were located in Plant 
A. Interestingly, three deaths have occurred among these five employees as 
compared with 0.6 expected deaths, and two of the three deaths were due to 
respiratory cancer.
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By January 1976, deaths had occurred in 15 of 57 Plant A workers and 
in 20 of 99 Plant B workers [26]. In Plant B workers, no increase in 
malignancy was noted (total malignant neoplasms: 1 observed, 3.8 expected)
and deaths from all causes were not elevated over expected deaths and were 
not clustered in any cause. The one death was attributed to pancreatic 
cancer (foreman, 18.7 years of exposure); another death was listed as 
arteriosclerotic heart disease with metastatic lymph node cancer (operator, 
26 months of exposure). A total of eight deaths occurred due to malignant 
neoplasms, which included a father and son who both died of stomach cancer. 
This highly unusual occurrence indicates that a heritable family trait may 
have been a contributing factor in these two cases.
In Plant A workers, increased malignancies and respiratory deaths 
were observed. Total malignant neoplasms: 5 observed, 2.2 expected
(P<0.072); malignant neoplasms, digestive system: 2 observed, 0.7 expected
(P<0.157): all other malignant neoplasms: 3 observed, 0.9 expected
(P<0.063); influenza and pneumonia: 2 observed, 0.3 expected (P<0.037).
The levels of significance were calculated using a Poisson distribution.
An examination of mortality in relation to duration of exposure and 
interval since the first exposure for Plants A and B combined indicated no 
statistically significant increase in deaths; however, an increase in total 
deaths was observed in the subgroup categorized as 15-24 years since the 
first exposure (18 observed, 12.2 expected) as well as the total deaths 
from malignancies in this same category (4 observed, 2.2 expected). This 
increase, although not statistically significant, seems to have been most 
apparent in employees having 6 or more years' exposure in ethylene
dibromide operations (total deaths: 6 observed, 3.5 expected; total
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malignancies: 3 observed, 0.7 expected).
Ott et al [26] recognized the difficulty in the interpretation of 
these data due to limitations in the size of the study group (161 
employees) and the variety of toxic agents to which individuals may have 
been exposed. Nevertheless, they noted that an indication of increased 
mortality may exist in the population (Plant A) with presumably higher 
ethylene dibromide exposure. Investigation of the deaths from nonmalignant 
respiratory disease indicated no apparent influence from exposure to 
ethylene dibromide.
The findings reported from this study group were equivocal because of 
the small population size, the exclusion of employees who were not 
routinely exposed to ethylene dibromide but probably had occasional 
exposures, and the lack of comparative data on employees in Plants A and B 
who did not work with ethylene dibromide yet had exposures to the numerous 
other chemical agents used.
Animal Toxicity
(a) General
In 1927, Thomas and Yant [27] investigated the toxic effects of 
ethylene dibromide vapor on guinea pigs . Three groups of three guinea pigs 
each were subjected to ethylene dibromide vapor at concentrations of 0.8, 
0.4, or 0.2% (61,600, 30,800, or 15,400 mg/cu m) for 30, 60, or 150
minutes, respectively. The animals were observed for external appearance 
while being exposed; both macroscopic and microscopic examinations were 
performed after death. All the guinea pigs died within 6-18 hours after 
the exposure at each concentration. Evidence of nasal irritation and a
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generalized weakened condition were noted during exposure; external 
appearance was normal for all nine animals when examined at autopsy. 
Macroscopic and microscopic examinations of the internal organs showed a 
pronounced granular degeneration of the parenchymal tissue of the kidneys 
and smaller amounts of damage in the pancreas, spleen, heart, liver, and 
adrenals. In addition, the authors observed that ethylene dibromide 
exposure produced swelling and a generalized interstitial edematous 
degeneration of the endothelial lining of the abdominal vascular system 
that was not described further.
Thomas and Yant [27] noted that commercial and purified ethylene 
dibromide applied to the shaved abdomens of three groups of two rats each 
over a 2-cm square area killed all of the animals within 6-18 hours at 
doses of 0.25, 0.50, or 1.00 ml (0.55, 1.1, or 2.2 g)/animal. No attempt 
was made to determine the minimum lethal dose. The application site showed 
marked hyperemia of the small cutaneous blood vessels, and the abdominal 
muscles became contracted and remained tense. By 20 minutes, the reflexes 
became weak and the animals were scarcely able to stand. A slight, 
temporary increase in activity was noted during the next 10 minutes, but 
the general appearance remained that of great weakness. Macroscopic and 
microscopic examinations of tissues were similar to those in guinea pigs 
after vapor inhalation. The only difference observed between the two 
routes of exposure concerned the spleen: gross examination of the guinea
pigs exposed to the vapor of airborne ethylene dibromide revealed that 
spleens were pale and edematous, whereas spleens of the dermally exposed 
rats were highly congested and edematous. No microscopic characterization 
of these differences was given.
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In 1928, Lucas [28] published the results of an experiment in which 
two adult rabbits inhaled ethylene dibromide vapor in quantities sufficient 
to produce light or deep anesthesia (concentrations not reported). Very 
light anesthesia was maintained in one rabbit by inhalation of ethylene 
dibromide for about 10 minutes. The rabbit vocalized during exposure, 
presumably responding to the irritating effects of ethylene dibromide. 
Respiration became extremely rapid during exposure and there was 
considerable phonation. The mucous membranes of the mouth were a peculiar 
"old rose" color after recovery from the anesthesia. This may have been 
due to a combination of vascular congestion and cyanosis. Death occurred 
within 18 hours, and, at autopsy, the liver was enlarged and mottled. 
Microscopic examination of the liver showed slight-to-moderate diffuse 
fatty changes, which tended to be more marked in the portal regions.
Another rabbit deeply anesthetized by inhalation of ethylene 
dibromide for about 12 minutes exhibited signs of marked irritation from 
the gas, considerable phonation, rapid breathing progressing as the 
anesthesia continued, and snuffling in its breathing after recovery from 
the anesthesia [28]. Death occurred within 15 hours. Autopsy showed the 
lungs to be enlarged and filled with a frothy exudate. About 10 ml of 
fluid was found in the pleural cavity. The liver was swollen and markedly 
congested. Lucas postulated that these results may have been caused by the 
decomposition of ethylene dibromide to hydrogen bromide and that local high 
concentrations of this material would be sufficient to bring about the 
observed changes.
In 1928, Kochmann [23] subjected rabbits and cats to ethylene 
dibromide vapor to determine the toxic effects of repeated exposures. An
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unspecified number of cats and rabbits was exposed to ethylene dibromide at 
an aerosol concentration of approximately 0.01% (770 mg/cu m) for 30
minutes each day. The author stated that the actual concentration was 
somewhat lower, because the fine fog was partially condensed and the 
substance did not pass into the vapor state completely. The survival 
period for rabbits varied from 4 to 22 days and for cats, it lasted 
approximately 10 days. Kochmann reported that the same effects were 
observed in all experiments. In cats, there was a reddening of the nasal 
mucosa and frequent sneezing after the first exposure. Two exposures 
later, the animals developed agitation, locomotor impairment, and excessive 
salivation. The next day, the animals began to tremble while in the cage, 
tears began forming, and the nasal mucosa was strongly reddened. After 11 
exposures, the survivors were very weak and maintained a reclining posture, 
and strong trembling was observed, especially in the extremities. These 
conditions persisted until death occurred. There was a general weight loss 
during the exposures. Autopsy showed that the body cavities contained a 
clear, yellowish liquid. The lungs contained dark red discolorations and 
were judged by the author to be partially nonfunctional. The spleen was 
slightly enlarged and the kidneys were swollen and yellow colored. 
Kochmann diagnosed the condition of the cats after exposure to ethylene 
dibromide as follows: rhinitis, conjunctivitis, ascites, pleural effusion,
pneumonia in the left superior lobe of the lung, and incipient fatty 
degeneration of the liver and possibly degeneration of the tubules of the 
kidneys. Similar adverse signs of intoxication, including rhinitis, 
conjunctivitis, anorexia, and loss of weight, appeared in rabbits. 
Autopsies of the rabbits showed that the small intestine contained an
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excessive amount of liquid, that the colon contained blood, and that the 
liver and kidneys were hyperemic.
In an additional experiment, the animals inhaled ethylene dibromide 
at a concentration of 0.01% (770 mg/cu m) once for 30 minutes, and the 
author [23] noted that there was a reduction in appetite, a corresponding 
loss of weight, a distinctly reduced hemoglobin content in the blood, and a 
slow recovery to the pretreatment conditions of the test animals.
Kochmann [231 exposed an unspecified number of cats and rabbits to 
ethylene dibromide at concentrations of 0.005 or 0.007% (385 or 538
mg/cu m, respectively) for 4 hours every 2nd day until death occurred or 
the experiment was terminated. The cats exposed to 538 mg/cu m (70 ppm) 
lost weight, developed general trembling, agitation and spasms in the rear 
legs, and died after 14 days. Autopsies showed a yellowish discoloration 
of the liver parenchyma but no other remarkable abnormalities. The rabbit 
exposed to 538 mg/cu m (70 ppm) lost weight during the experiment but was 
alive after 40 days. No other signs of toxic effects were reported by the 
author. Another rabbit exposed to 385 mg/cu m (50 ppm) died after 7 days. 
The results of the autopsy showed slight amounts of serous liquid in the 
body cavities and a swelling of the intestines, but other organs appeared 
to be normal.
Kochmann [23] concluded that the results of the animal experiments 
agreed substantially with the effects described by and observed in humans, 
as presented in the Effects on Humans. He concluded that, even when 
ethylene dibromide was inhaled in concentrations as low as 385 mg/cu m (50 
ppm), it would cause local irritation, absorptive metabolic interference, 
and possible deterioration of the parenchymatous tissues of organs through
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long-term exposures. Kochmann indicated that death was probably from 
injury to the circulatory system, especially to the heart and vessels, and 
to the secondary paralysis caused by damage to the nervous system. Because 
of the imprecise measurements of the concentrations in this study, it is 
difficult to draw quantitative conclusions as to a dose-effect 
relationship. Data show that ethylene dibromide at concentrations as low 
as 385 mg/cu m (50 ppm) may produce death and pronounced systemic injuries 
in mammals when inhaled repeatedly for up to 4 hours daily.
In 1929, Glaser and Frisch [29] published the results of an 
experiment with a group of guinea pigs to determine the effects of repeated 
exposure to ethylene dibromide vapor. The guinea pigs, weighing 
approximately 650 g, were exposed to ethylene dibromide at measured 
concentrations of 19.6, 24.6, 8.0, 29.0, 25.5, and 16.5 mg/liter (19,600, 
24,600, 8,000, 29,000, 25,500, and 16,500 mg/cu m, respectively) for 15- 
minute periods on 6 consecutive days. The authors noted that nose rubbing 
and muscular spasms of the diaphragm occurred during the exposures, but 
disappeared immediately after the guinea pigs were removed from the 
exposure chamber. Paralysis of the rear extremities occurred 24 hours 
after the sixth exposure, but it had partially disappeared after 5 
additional days and was completely gone after another 8 days. The authors 
concluded that the adverse effects, such as paralysis of the extremities 
and spasms of the diaphragm, appeared at a lower concentration and in a 
much shorter time than did the adverse effects in a concurrent experiment 
with methyl bromide. They also concluded that the signs of toxicity 
remained longer than those observed from methyl bromide.
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In 1929, Kistler and Luckhardt [30] reported the effects on 
respiration, muscle reflexes, and blood pressure in dogs exposed to 
ethylene dibromide by inhalation, ingestion, and injection. Dogs, 
anesthetized with sodium barbital, were sequentially injected iv with 0.2-
1.0 ml (0.44-2.2 g) of ethylene dibromide for a total of 5.5 ml (12 g). 
Marked decreases in respiratory rate, blood pressure, and muscle reflexes 
resulted. Ethylene dibromide at 0.3 ml (0.66 g) injected iv caused 
cessation of respiration which was "momentary" or lasted as long as 40 
seconds in the dogs tested. The cessation was followed by panting and a 
gradual return to almost normal breathing rate. The same dose produced a 
75% decrease in blood pressure, the fall being immediate and sharp. The 
blood pressure gradually returned toward normal in a period of 2-12 
minutes; but, in some cases, it remained 30% below normal. Ethylene 
dibromide at doses of 0.1-0.3 ml (0.22-0.66 g) injected iv caused a 
profound and rapid depression of the knee jerk reflex, which never returned 
to normal after the exposure.
The effects on dogs exposed to 1.0-10.0 ml (2.2-22.0 g) of ethylene 
dibromide vaporized from an ether bottle were essentially the same as those 
caused by the iv injections, differing only slightly in the extent of the
decreases [30]. The recovery times were described as being prolonged
because of the longer exposure times, but complete experimental details
were not given.
The investigators [30] found that each unanesthetized dog receiving 
oral doses of 0.0625, 0.125, 0.250, or 0.55 ml/kg (approximately 135, 270,
540, or 1,200 mg/kg, respectively) of ethylene dibromide vomited 
immediately and several times more during the next 4 hours. Definite
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depression and increased salivation began 20 minutes after the 
administration of ethylene dibromide, but the animals did not become 
excited or uncoordinated at any time during the study. Blood was found in 
the feces when defecation occurred. The dogs died within 22 hours. 
Autopsies were performed, but the results were not given specifically for 
ethylene dibromide. However, all dogs that died had slight lung edema and 
engorged blood vessels in the lungs and liver. The authors concluded that 
the effects of exposure to ethylene dibromide on blood pressure, 
respiratory rate, and muscular reflexes were similar after injection or 
inhalation. The extent of the influence of the preexposure injection of 
sodium barbital on the results of the iv experiments is not known because 
concurrent control experiments were not described.
Merzbach [31], in 1929, subjected dogs for 1 hour to the vapor from 
1, 2, or 5 ml (2.2, 4.4, or 11.0 g, respectively) of ethylene dibromide in 
a 100-liter glass bell jar to determine the effects of inhalation on each 
dog. Ethylene dibromide was placed within the glass bell jar as a liquid 
and allowed to vaporize. The dog exposed to 5 ml (11.0 g) of vaporized 
ethylene dibromide became very restless and began to salivate strongly 
after 20 minutes. Five minutes later, the respiratory rate increased 
markedly to 120 breaths/minute. At that time, the dog lay on its side, and 
clonic twitches of the legs were noted. After 45 minutes of exposure, it 
lay quietly but responded to acoustic stimuli, the twitches ceased, and the 
respiratory rate dropped to 66 breaths/minute. When the 1-hour exposure 
ended, the dog immediately vomited several times, trembled severely, and 
fell immediately while trying to stand. Rales and rattling were audible in 
the chest. It lost consciousness 35 minutes after the exposure ended and
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died during the night. Autopsy indicated abundant blood in the right lung 
and in the lower lobe of the left lung. The heart was found in systole, 
and hemorrhages had occurred in the subendocardium and in the mucous 
linings of the intestines and rectum. The liver was congested. Fresh 
hemorrhages were noted on the surface of the dura mater, and both corneas 
were clouded.
The dog exposed to 2 ml (4.4g) of vaporized ethylene dibromide for 1 
hour developed toxic effects similar to those of the dog exposed at 5 ml 
(11.0 g), but the extent of effects was less pronounced [31]. This dog
also died between 12 and 18 hours after exposure. Autopsy results were 
similar to those for the other dog exposed to 5 ml (11.0 g), although the 
extent of cellular damage was slightly less and no blood was seen in the 
lungs.
The dog exposed to 1 ml (2.2g) of vaporized ethylene dibromide for 1 
hour showed signs of restlessness, ocular irritation, labored respiration, 
and increased respiratory rate during the exposure [31] . Five hours after 
the exposure ended, a milky-blue opacity developed in the corneas and 
became progressively more pronounced, developing into purulent 
conjunctivitis in both eyes with an ulcer in one cornea. The dog lost 
considerable weight, completely stopped eating, and died after 3 weeks. 
The autopsy showed bronchopneumonic foci and severe hyperemia in both 
lungs. A spherical thrombus was found in the heart, and the liver showed 
pronounced fatty degeneration.
The effects noted above in the hearts of the dogs exposed to ethylene 
dibromide were also found in isolated, perfused hearts from male frogs 
(Rana temporaria) subjected to 400, 800, or 1,600 ppm of ethylene dibromide
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in Ringer's solution [31]. Immediate diastolic arrest occurred at 800 and 
1,600 ppm with no recovery of function. At 400 ppm, there was diastolic 
arrest after 1 minute, but washing produced a gradual recovery to normal
function. No cardiac arrest or change in the heart rate was found at a
concentration of 200 ppm of ethylene dibromide.
In 1946, Aman et al [32] studied the effects of repeated oral 
administration of ethylene dibromide on rats and guinea pigs. Nineteen 
animals were administered ethylene dibromide at average daily doses of 0, 
3.4, 4.4, 7.1, 15.0, or 20.0 mg in oil or alcohol solution by gavage for 
77-95 days in approximately 4 months. Total accumulated dosages of
ethylene dibromide ranged from 0 to 1,420 mg. One rat, given 20 mg of
ethylene dibromide daily, died after 3 months. All other rats and guinea 
pigs appeared to have gained weight normally during the experimental 
periods, and no untoward signs of toxicity were noted. Autopsy and 
microscopic examinations were not mentioned. The authors concluded that 
daily administration of ethylene dibromide for periods up to 4 months did 
not adversely affect the growth and outward physical appearance of rats and 
guinea pigs. The lack of experimental detail and data, the ambiguity of 
the data given, the inadequate number of control and experimental animals, 
and the absence of autopsies make this study difficult to evaluate and its 
importance questionable.
In 1952, Rowe et al [33] investigated the effects of ethylene 
dibromide administered to rats, guinea pigs, rabbits, mice, chickens, and 
monkeys by single oral intubations, eye contact, dermal contact, dermal 
absorption, single exposure inhalation, or repeated exposure inhalations. 
The ethylene dibromide used in these studies was the 99% pure, commercial
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quality product, except that the inhalation studies were conducted with a 
repurified commercial product of essentially 100% purity. Ethylene 
dibromide was administered in undiluted form for eye and dermal contact, 
dermal absorption, and inhalation studies; in olive oil and acacia emulsion 
or olive oil solution for oral intubation studies; in propylene glycol 
solution for eye contact studies; or in butyl carbitol acetate solution for 
dermal contact studies.
Fifty-five female rabbits, 28 chicks, 40 male and female guinea pigs, 
40 female rats, 60 male rats, and 20 female mice were administered ethylene 
dibromide at sufficient doses to enable calculation of single oral-dose 
LD50's of 55 mg/kg, 79 mg/kg, 110 mg/kg, 117 mg/kg, 146 mg/kg, and 420 
mg/kg, respectively [33]. The LD50's for male and female rats were 
significantly different (P<0.05). Of the five species tested, rabbits were 
the most sensitive to ethylene dibromide and mice were the least sensitive.
Rowe et al [33] found that undiluted ethylene dibromide promptly 
caused obvious pain and conlunctival irritation when introduced into the 
eyes of rabbits. The undiluted material was in contact with the eyes for 
30 seconds before one eye was thoroughly flushed for 3 minutes with running 
water; the other eye was not washed. Both eyes of each rabbit were then 
observed for injury. The conjunctival irritation cleared within 48 hours, 
and a very slight amount of superficial necrosis of the cornea healed 
promptly and completely. When a 10% solution of ethylene dibromide in 
propylene glycol was tested in rabbits bv the same procedure used with the 
undiluted material, it produced a more severe response than did the 
undiluted material. Moderate conjunctival irritation developed within 2 
hours and persisted for 48 hours before remission began to occur.
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Moderate-to-severe corneal injury also persisted for about 48 hours before 
tissue repair became evident. Healing was complete 12 days after exposure 
without corneal scarring being evident. No injury to the iris or the lens 
of the eye was noted. A 1% solution in propylene glycol elicited a 
response in the rabbit eye very similar to that of the undiluted material. 
The authors noted that prompt washing of the treated eyes had a beneficial 
effect in all cases, slightly reducing the intensity of the response and 
shortening the healing time.
Application of undiluted ethylene dibromide or 10% solutions in butyl 
carbitol acetate to the shaved skins of rabbits killed the animals within 
24 hours [33]. It was apparent that a few hours of confined contact of the 
material with the skin caused marked erythema and edema. When evaporation 
was not inhibited by a covering, only slight erythema was noted. A 1.0% 
solution of ethylene dibromide in butyl carbitol acetate applied to rabbit 
ears 10 times in 14 days caused only slight erythema and exfoliation. When 
the solution was applied repeatedly for 10 times in 14 days onto the shaved 
abdomen of the rabbit and then bandaged, marked erythema and edema, which 
progressed to necrosis and exfoliation, were observed. Healing was 
complete without scarring within 7 days after termination of both 
exposures.
Rowe et al [33] found that absorption of undiluted ethylene dibromide 
at doses of 210, 300, 650, or 1,100 mg/kg through the intact skin killed 1 
of 15 rabbits at 210 mg/kg and all 5 rabbits at 1,100 mg/kg when the 
exposures lasted for 24 hours. In all of the exposed animals, the material 
produced a moderate-to-severe erythema, edema, and necrosis of the skin and 
caused scar formation in the survivors. Marked central nervous system
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(CNS) depression was seen in rabbits at all of the doses. At the 650 and
1,100 mg/kg doses, the animals felt cold to the touch. Deaths occurred
within 4 days or not at all. The authors did not calculate an LD50 for 
dermal absorption in the rabbits; however, an LD50 of approximately 400 
mg/kg for ethylene dibromide can be estimated from the dose-response data.
These investigators [33] also studied the effects of single exposures
of ethylene dibromide vapor to groups of 4-30 rats of both sexes at
concentrations of 100, 200, 400, 800, 1,600, 3,000, 5,000, or 10,000 ppm
(770, 1,540, 3,080, 6,160, 12,300, 23,100, 38,500, or 77,000 mg/cu m,
respectively) and to guinea pigs of both sexes at 200 or 400 ppm (1,540 or 
3,080 mg/cu m). At each concentration, the rats were exposed to the vapor 
for durations ranging from 0.02 to 16.0 hours to allow for the
determination of concentration versus period of exposure values that
represent death in essentially all of the rats, death in 50% of the rats,
and death in essentially none of the rats. The findings of this study are
presented in Table III-l. These data suggest that at concentrations above 
about 5,500 mg/cu m (715 ppm), the Haber product [the product of the 
exposure concentration (LC50) and the duration of exposure] becomes 
actually almost a constant but that, at lower concentrations of ethylene 
dibromide, the Haber product increases rapidly as the concentration is 
lowered further. This suggests, in turn, that exposure of the rat to 
a concentration of about 5,500 mg/cu m (715 ppm, 29.2 /jmoles/liter) of 
ethylene dibromide saturates some detoxification mechanism. Whether this 
is metabolic or excretory in nature cannot be judged from these data.
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TABLE III-l
VAPOR TOXICITY OF ETHYLENE DIBROMIDE IN RATS
Vapor Concentration Calculated Lethal Time (Hours)
mg/cu m ppm LC99.99 LC50 LC0.01
77,000 10,000 0.15 0.04 0.01
38,500 5,000 0.35 0.09 0.03
23,100 3,000 0.60 0.18 0.06
12,300 1,600 1.10 0.30 0.10
6,160 800 2.20 0.75 0.28
3,080 400 7.50 2.00 0.62
1,540 200 42.00 12.00 2.00
770 100 - - >10.00
Adapted from Rowe et al [33]
Ethylene dibromlde produced only slight anesthetic effects at the 
concentrations used [33]. Depression of the CNS was observed in rats 
exposed at the higher concentrations (unspecified). Deaths usually 
occurred within 24 hours at the higher concentrations and were caused by 
respiratory or cardiac failure. Deaths occurring from exposures at lower 
concentrations (unspecified) were generally delayed, sometimes for as long 
as 12 days after exposure. The majority of these deaths were caused by 
pneumonia. These animals usually lost weight, appeared rough and unkempt, 
became quite irritable, discharged what appeared to be a blood-tinged fluid
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from the nose, and finally died. Animals surviving the exposure at the 
lower concentrations exhibited a similar progression of toxic signs for 
several days before recovery was apparent. Rats exposed at concentrations 
producing mortality and killed for autopsy 16-24 hours after exposure 
showed an increase in the weight of the lungs, liver, and kidneys. The 
lungs were congested, edematous, hemorrhagic, and inflamed; the liver had
cloudy swelling, centrilobular fatty degeneration, and necrosis; and the
kidneys exhibited slight interstitial congestion and edema, with slight 
cloudy swelling of the tubular epithelium in some cases. Guinea pigs 
appeared to be slightly less susceptible than rats to the effects of 
ethylene dibromide vapor when exposed to the same concentrations. All 
guinea pigs exposed at 400 ppm (3,080 mg/cu m) for 7 hours died, whereas 
all those exposed at 400 ppm (3,080 mg/cu m) for 7 hours and at 200 ppm
(1,540 mg/cu m) for 7 hours lived. The authors made no attempt to 
determine concentrations and corresponding exposure durations that would 
produce an LD99.99, LD50, or LD0.01 in guinea pigs, but they did postulate 
that 30 ppm (231 mg/cu m) for 5 hours was the most severe repeated exposure 
without detectable adverse effects.
Rowe et al [33] subjected rabbits, monkeys, guinea pigs, and rats to 
7-hour exposures, 5 days/week, for approximately 6 months to ethylene
dibromide vapor at a concentration of 25 ppm (192.5 mg/cu m). To 
facilitate comparison of the data, a calculation of the amount of inhaled 
ethylene dibromide has been made by assuming a minute volume of 0.61 
liters/min/kg [34]. A rat maintained in a 25-ppm (192.5 mg/cu m) 
atmosphere would inhale approximately 0.12 mg/minute/kg or 49 mg/kg during 
a 7-hour exposure. Groups of 20 male and 20 female rats were given 151
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exposures in 213 days without evidence of adverse effects as judged by
general appearance and behavior, growth rate, final body and organ weights, 
blood urea nitrogen values, periodic hematologic examinations, and 
macroscopic and microscopic examination of tissues. The amount of inhaled 
ethylene dibromide during 151 7-hour exposures would total about 7.4 g/kg. 
Two groups of controls, well-matched with the experimental animals with 
respect to number, age, sex, and body weight, were used in the experiment.
One group was exposed to the same experimental regimen as the group exposed
to ethylene dibromide, but in a chamber ventilated with clean air. The
second control group was simply maintained in the animal quarters.
During the test period, 10 of 20 ethylene dibromide-exposed male rats 
died, primarily from pneumonia and upper respiratory tract infections, and 
3 of 20 ethylene dibromide-exposed female rats died from unspecified causes 
[33]. Twenty-three additional female rats subjected to 13 7-hour exposures 
at 25 ppm (192.5 mg/cu m) in 17 days showed no ill effects and were found 
to have total liver lipid contents similar to those of control rats. 
Groups of 8 male and 8 female guinea pigs tolerated 145 7-hour exposures at 
25 ppm (192.5 mg/cu m) in 205 days without evidence of adverse effects as 
judged by the same criteria used to evaluate the rat data, except that 
liver lipid determinations were not conducted. Mortality during the 
experiment, caused by pulmonary infections, was 50% in male and 25% in 
female guinea pigs exposed to ethylene dibromide. Eighteen of the 20 
animals in both the male and female control groups exposed to clean air 
survived the experimental regimen, but only 7 and 8 of the 20 females and 
males, respectively, in the unexposed control groups survived. An 
additional group of 8 female guinea pigs received 13 7-hour exposures at 25
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ppm (192.5 mg/cu m) in 17 days without exhibiting adverse effects. 
Rabbits, 3 male and 1 female, and monkeys, 1 male and 1 female, were 
subjected to 152 7-hour exposures in 214 days and 156 7-hour exposures in 
220 days, respectively, at 25 ppm (192.5 mg/cu m). There were no signs of 
adverse effects in the rabbits and monkeys when judged by the above 
criteria for the guinea pig data. Since an unusually high mortality rate 
was observed in the nonexposed control rats but not in the air-exposed 
control animals, no decisive conclusions can be drawn from the published 
data with respect to the hazard resulting from exposure to ethylene 
dibromide at 25 ppm (192.5 mg/cu m).
Rowe and his colleagues [33] found that rats, guinea pigs, monkeys, 
and rabbits did not tolerate ethylene dibromide well at a concentration of 
50 ppm (385 mg/cu m) administered 7 hours/day, 5 days/week, for 70-90 days. 
The group of 20 male and 20 female rats receiving 63 exposures in 91 days 
exhibited increased liver and kidney weights in both sexes, increased lung 
weights in males, decreased spleen weights in females, and decreased testis 
weights in males at autopsy. The group of 8 male and 8 female guinea pigs 
receiving 57 exposures in 80 days showed decreased rates of growth and 
final body weights, increased organ weights, slight central fatty 
degeneration of the livers, and slight interstitial congestion and edema 
with degeneration of the tubular epithelium in the kidneys. The 1 male and 
3 female rabbits receiving 59 exposures in 84 days showed only small 
increases in liver and kidney weights; no other adverse effects were noted. 
The male and female monkeys receiving 49 exposures in 70 days appeared ill, 
nervous, and unkempt throughout the experimental period. Liver weights 
were increased and very slight central fatty degeneration of the liver was
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noted; no other adverse effects were noted from microscopic examination of 
the body organs.
At concentrations of 100 ppm (770 mg/cu m) of ethylene dibromide 
vapor, 10 female rats steadily lost weight and 3 died after 1, 5, and 7
exposures, respectively, for 7 hours/day [33]. The remaining rats appeared 
thin and unkempt at the time of autopsy after seven exposures in 9 days. 
The stomachs were full of food which appeared blood tinged, and lung, 
liver, and kidney weights were increased markedly. Microscopic examination 
showed some thickening of the alveolar walls with slight leukocytic 
infiltration of the lungs, widespread cloudy swelling of the liver, and 
slight congestion and hemosiderin deposition in the spleen. Rabbits 
subjected to the same concentration suffered severe intoxication to the 
extent that two of four died after the second 7-hour exposure and the third 
died while receiving the third exposure. The fourth animal was killed 
after receiving the fourth exposure in 4 days. Microscopic examination of 
tissues from the last two rabbits showed widespread central fatty 
degeneration of the liver with some necrosis.
The authors [33] concluded from the above series of experiments that 
ethylene dibromide was a fairly toxic, markedly irritating material. They 
postulated that ingestion of 1.5-2.0 ml (3.3-4.4 g) of undiluted ethylene 
dibromide could jeopardize the life of the average human and that this 
amount of material could easily be swallowed by accident. Rowe et al 
pointed out that, although ethylene dibromide was not likely to cause 
permanent injury to the eye, it probably would cause appreciable pain and 
suffering; thus, eye protection was strongly recommended for those handling 
ethylene dibromide. Although the hazard of contact with uncovered skin was
55
not thought to be particularly serious unless repeated or prolonged, marked 
irritation and rapid absorption of ethylene dibromide occurred when it was 
confined to the skin. Ethylene dibromide vapor at 50 ppm (385 mg/cu m) 
repeated daily was not well tolerated by the species tested, whereas 
adverse effects were not believed to have resulted from exposure at 25 ppm 
(192.5 mg/cu m). It is difficult to accept this conclusion because both 
the colony controls and the groups exposed at 25 ppm (192.5 mg/cu m) had 
similar pulmonary involvement, whereas the control animals exposed in the 
chamber to clean air had none. The numbers of rabbits and monkeys used in 
the repeated inhalation experiments are too small to allow an adequate 
assessment of the value of the data concerning these two species.
Adams et al [35], in 1952, reported the results of an investigation 
to determine the single-exposure vapor toxicity of an ethylene dibromide 
fumigant mixture in albino rats. Dowfume EB-15, composed of 20.4% ethylene 
dibromide, 19.6% ethylene dichloride, and 60.0% carbon tetrachloride, was 
mixed with the air entering an exposure chamber at a constant rate. Vapor 
concentrations were calculated on the basis of an "average" molecular 
weight of 143 for the mixed vapor and expressed as ppm. Groups of 10-20 
adult albino rats were each exposed at concentrations of 200, 500, 1,100,
2,400, or 4,800 ppm (1,540, 3,850, 8,470, 18,480, or 36,960 mg/cu m,
respectively). The exposure duration depended on the concentration of 
Dowfume EB-15 being administered and ranged from 0.15 hour for 4,800 ppm 
(36,960 mg/cu m) to 7.0 hours for 200 ppm (1,540 mg/cu m). All of the 
concentrations of Dowfume EB-15, except the 200-ppm (1,540 mg/cu m)
concentration, produced visible signs of drowsiness, unsteadiness, 
weakness, and incomplete anesthesia. Mortality usually occurred within 24
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hours at the higher concentrations and within 1-6 days at the lower 
concentrations. An additional group of male rats exposed to the 500- and 
1,100-ppm (3,850 and 8,470 mg/cu m) concentrations for durations that 
produced 50% mortality showed consistent moderate microscopic injuries in 
the liver and kidneys at autopsy, 1 and 3 days after exposure. Liver 
damage consisted of centrilobular fatty degeneration with .general 
congestion and occasional hemorrhagic necrosis in rats at both 
concentrations, but it was more marked in the rats exposed at 500 ppm 
(3,850 mg/cu m). Kidney damage included a moderate-to-severe reaction
consisting of general congestion, cloudy swelling, and necrosis, as well as 
degeneration of the tubular epithelium. The injury to the kidneys was more 
severe in the rats killed and autopsied 3 days after exposure than in those 
killed and examined 1 day after exposure. Minor abnormalities, consisting 
of congestion and slight cloudy swelling, were observed in the adrenal 
glands and the epididymis. There were also increases in the absolute and 
relative weights of the liver and kidneys. No attempt was made by the 
authors to explain the significance of the marked microscopic changes
present in the liver at 500 ppm (3,850 mg/cu m) but absent at 1,100 ppm
(8,470 mg/cu m).
In another experiment, Adams et al [35] examined the effects of 
concentrations of the ethylene dibromide-containing vapor mixture (Dowfume 
EB-15) below the lethal range for male rats to determine the maximum 
concentration at which the rats could be exposed without developing
detectable adverse effects. Rats were exposed to Dowfume EB-15 vapor at 
concentrations of 50 ppm (380 mg/cu m) for 7.0 hours, 100 ppm (770 mg/cu m) 
for 7.0 hours, 200 ppm (1,540 mg/cu m) for 1.5 or 2.5 hours, 500 ppm (3,850
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mg/cu m) for 0.4 or 0.6 hour, and 1,100 ppm (8,470 mg/cu m) for 0.2 hour. 
Three to seven male rats from each exposure concentration were autopsied 
16-24 hours after single exposures to discern detectable injury. The 
criteria used to evaluate injury were organ weight and microscopic changes 
in the liver and kidneys. Adverse effects occurred with Dowfume EB-15 at 
100 ppm (770 mg/cu m) for 7.0 hours, 200 ppm (1,540 mg/cu m) for 2.5 hours, 
500 ppm (3,850 mg/cu m) for 0.6 hour, and 1,100 ppm (8,470 mg/cu m) for 0.2 
hour. No adverse effects were noted with Dowfume EB-15 at 50 ppm (385 
mg/cu m) for 7.0 hours, 200 ppm (1,540 mg/cu m) for 1.5 hours, or 500 ppm 
(3,850 mg/cu m) for 0.4 hour.
The investigators [35] concluded that the toxic effects caused by 
Dowfume EB-15 were essentially the same as those expected from a simple
summation of the separate actions of its constituents, as reported in the
literature; hence, there was no potentiation. In addition, they concluded
that an industrial hygiene standard for single exposures of employees to
Dowfume EB-15 vapor, which contains 20.4% ethylene dibromide, could be 
established, and that exposure should not exceed 7 hours at 75 ppm (577.5 
mg/cu m), 1 hour at 300 ppm (2,310 mg/cu m), and 0.1 hour at 1,500 ppm 
(11,550 mg/cu m). These conclusions, drawn in 1952, are of questionable 
relevance today since the current NIOSH recommendation for an occupational 
exposure limit for carbon tetrachloride (2 ppm) [36], which is 60% of the 
Dowfume EB-15 mixture, is well below these authors' recommendations.
In 1956, McCollister et al [37] described an investigation conducted 
to compare the effects of fumigant mixtures containing ethylene dibromide 
with those of ethylene dibromide alone. A total of 100 mature young adult 
male and female albino rats were given one of six amounts of ethylene
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dibromide administered as single oral doses in corn oil and acacia by 
intubation. A second group of 135 rats were given one of eight doses of a 
suspension containing 7.2% ethylene dibromide, 29.2% ethylene dichloride, 
and 63.6% carbon tetrachloride (Dowfume EB-5). A third group of 90 rats 
were given five doses of a suspension containing 20.4% ethylene dibromide, 
19.6% ethylene dichloride, and 60.0% carbon tetrachloride (Dowfume EB-15), 
as described above. The LD50's for the three dosage regimens were 140 
mg/kg for 100% ethylene dibromide, 290 mg/kg for Dowfume EB-15, and 660 
mg/kg for Dowfume EB-5. As the percentage of ethylene dibromide in the 
mixtures increased, the mixtures became more and more toxic to the rats, 
and the apparent toxicity of ethylene dibromide increased, based on the 
untrue assumption that it was the only toxic compound in the mixtures and 
on its percentages in the mixtures. The toxicity increased from an oral 
LD50 of 140 mg/kg for the pure chemical to one of 59.2 mg/kg in Dowfume EB- 
15 and to one of 47.5 mg/kg in Dowfume EB-5.
In a second experiment, McCollister and coworkers [37] compared the 
vapor toxicities of fumigant mixtures containing ethylene dibromide with 
the toxicity of ethylene dibromide alone in young adult albino rats. The 
concentration-duration of exposure lines to produce 50% mortality in rats 
were only slightly displaced from those calculated from the individual 
toxicities of the components, Dowfume EB-5 being slightly more than half as 
toxic as Dowfume EB-15 with 1-hour exposures. The lines for the two 
mixtures were not parallel, so it is inaccurate to try to compare their 
vapor toxicities in any general statement. At relatively high vapor 
concentrations, the mixtures produced CNS depression. Injury to the liver 
and kidneys was similar to that produced by the individual components of
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the mixtures when administered separately. It appears that potentiation 
occurs after ingestion of ethylene dibromide-containing mixtures with 
carbon tetrachloride and ethylene dichloride but not after inhalation of 
the same mixtures.
The authors [37] estimated safe concentrations and exposure times for 
human subjects exposed to undiluted ethylene dibromide at a single exposure 
to be 50 ppm (385 mg/cu m) for 7 hours, 200 ppm (1,540 mg/cu m) for 1 hour, 
and 800 ppm (6,160 mg/cu m) for 0.1 hour. The corresponding values for 
Dowfume EB-5, which contains 7.2% ethylene dibromide, and Dowfume EB-15* 
which contains 20.4% ethylene dibromide, were both 75, 300, and 1,500 ppm 
(577.5, 2,310, and 11,550 mg/cu m), respectively. Maximum safe daily
exposure concentrations for 7 hours/day were estimated to be 25 ppm (192.5 
mg/cu m) for ethylene dibromide and for mixtures containing ethylene 
dibromide. It is difficult to accurately assess the additive effects of 
carbon tetrachloride and ethylene dichloride in relation to the lethal 
effects that may have been caused by ethylene dibromide alone. In a 
similar study by these investigators [38] on rats with Dowfume EB-5, they 
pointed out the similar capacities of ethylene dibromide and carbon 
tetrachloride to cause tissue injury after the rats inhaled the vapors.
Since ethylene dibromide is used as a soil nematocide, Schlinke [39], 
in 1969, administered ethylene dibromide to yearling sheep and to 5- to 7- 
day-old calves. Single oral doses of 10, 25, or 50 mg/kg each were given 
in capsules to one calf and one sheep, or of 25 mg/kg to two sheep, after 
initial weights and preexposure blood samples had been taken. Both the 
calf and sheep receiving the 50 mg/kg dose developed stiffness, 
prostration, and anorexia and died within 3 days after administration. The
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calf receiving the 10 or 25 mg/kg dose showed no ill effects. One of the 
two sheep given 25 mg/kg developed signs similar to those occurring at the 
50 mg/kg dose and died within 2 days. The second sheep showed no signs of 
ill effects and appeared well. The one sheep receiving the 10 mg/kg dose 
also appeared normal. Animals dying as a result of ethylene dibromide 
poisoning required about 24 hours for signs to appear and become prominent, 
death occurring after 2-3 days. Ethylene dibromide caused a slight 
decrease in whole blood cholinesterase activities in some of the animals, 
but the author indicated that this was probably not significant. Schlinke 
concluded that similar effects appeared at a given dosage in both sheep and 
calves. Autopsies were not performed on enough animals to develop 
conclusions regarding gross abnormalities.
In 1970, Schlinke [40] reported the effects of ethylene dibromide 
administered orally to chickens reared from a specific pathogen-free flock. 
Ethylene dibromide at doses of 0, 50, 100, or 200 mg/kg/day was
administered in capsules or as an oral drench to groups of five to seven 
chickens between 6 and 7 weeks of age for 10 consecutive days. The 
chickens were weighed before and after administration to determine weight 
gain, and visual observations were made daily. All chickens receiving the 
200 mg/kg dose had anorexia and general depression prior to death, which 
occurred before the fourth dose could be given. The results of autopsies 
showed inflammation of the crop, excess pericardial fluid, and congestion 
of the liver. All chickens given the 50 or 100 mg/kg doses appeared normal 
and gained weight normally during the experiment. The short period of 
exposure in this study does not permit an estimation of possible effects 
from longer exposures.
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In 1977, Ter Haar (written communication, February 1977) submitted
the results of a study to determine the effects of repeated inhalation of
ethylene dibromide at concentrations of 3, 15, or 75 ppm (23.1, 115.5, or
577.5 mg/cu m) on B6C3F1 mice. Groups of 10 male and 10 female mice were 
exposed for 6 hours/day, 5 days/week, for 13 weeks in 100-liter plexiglass 
chambers operated at an airflow of 10 liters/minute inside a 6,000-liter 
chamber operated at an airflow of 1,500 liters/minute. A group of 10 male 
and 10 female mice serving as controls were similarly exposed but without 
the toxicant. Animals were observed daily for adverse effects and were
weighed weekly. Autopsies were planned to be performed on all animals that
died during the experiment or that were killed at the termination of the 
experiment.
According to Ter Haar, four of 10 males exposed at 3 ppm (23.1 
mg/cu m) of ethylene dibromide died during the experiment on weeks 8, 10,
11, and 13. One of 10 females exposed at 75 ppm (577.5 mg/cu m) was killed 
on week 5 because it was moribund. The others survived the experimental 
period. No tissues were examined from the animals receiving 3 ppm (23.1 
mg/cu m) of ethylene dibromide, although four mice died during the 
experiment. Tissues were considered to be normal in those from the 15-ppm 
(115.5 mg/cu m) group. The lungs of the animals exposed at 75 ppm (577.5 
mg/cu m) showed megalocytosis of the bronchiolar epithelium in both males 
and females, and the lungs of females had regenerative epithelial 
hyperplasia and cellular debris in the lumens. No other findings were 
reported and complete experimental data were not given.
Ter Haar (written communication, February 1977) stated that, of the 
rats exposed at concentrations of 3 and 15 ppm (23.1 and 115.5 mg/cu m) of
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ethylene dibromide for 90 days, only the males developed swelling of the 
hepatocytes. Animals exposed at 75 ppm (577.5 mg/cu m) had decreased 
thyroid follicular size and swelling or increased vacuolation of the zona 
reticularis cells of the adrenals. No further information was presented. 
Experimental design, data, and results of the autopsy were not included.
(b) Reproduction
In 1965, Amir and Volcani [41] described the effects of oral 
administration of ethylene dibromide on spermiogenesis in four Israeli- 
Friesian bulls fed an average of 2 mg/kg/day from the age of 4 days to 
approximately 24 months. For the first 3 months, 2 mg/kg of ethylene 
dibromide in an ethyl alcohol solution was added to the milk given daily to 
the bull calves. From the age of 3 months to 12 months, 2 mg/kg of 
ethylene dibromide was dissolved in soybean oil and administered daily in 
the feed concentrates, and after 12 months, the ethylene dibromide was 
administered in an oil mixture at the rate of 4 mg/kg every other day by 
capsule. Animal weight and height were measured throughout the study. 
Semen collections began when the bulls reached 14-16 months of age and 
continued weekly thereafter. Semen was collected from control bulls of the 
same age.
Ethylene dibromide did not affect growth or health of the bulls when 
compared with the controls [41]. Spermatozoic density of the semen 
collected from experimental bulls was low and spermatozoic motility was 
poor throughout the 8-10 months of semen collection. However, the reaction 
time until ejaculation was similar to that of the control animals. Semen 
smears revealed abnormal spermatozoa in experimental animals, with various 
degrees of degeneration and malformations, such as coiled tails, pyriform
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heads, and tailless spermatozoa.
Ethylene dibromide administration was discontinued in two of the four 
bulls to ascertain the reversibility of the exposure, and was later 
readministered to one of these two to determine the time needed for 
ethylene dibromide's action to be effective [41]. In the first animal, 
almost normal spermatozoa (the acrosomes were not entirely restored) were 
obtained after exposure had been discontinued for 1 month; semen of normal 
density, spermatozoic motility, and sperm cell forms was obtained 3.5 
months after discontinuation. In the second bull, normal semen was 
obtained 10 days after administration was stopped. After 2 further weeks 
of renewed exposure, semen from the second bull began exhibiting the same 
abnormalities as described above for bulls receiving ethylene dibromide on 
the continuous schedule. A previously unexposed 16-month-old bull of the 
same breed was fed ethylene dibromide at 2 mg/kg/day for 3 weeks. After 2 
weeks, his semen exhibited the abnormalities described above, which 
persisted for a month after exposure ended. The semen quality improved, 
but normal semen was not obtained until 2-3 months after administration 
stopped.
From these experiments, the authors [41] concluded that quantities of 
ethylene dibromide, equivalent to two or three times that expected in 
insufficiently aired grains, caused definite reproductive impairment when 
fed daily or every other day to bulls. Semen density and spermatozoic 
motility decreased sharply and the spermatozoa were of abnormal shape after 
only 2 weeks of exposure. Recovery occurred in 10 days-3 months in the 
animals tested. Resumption of exposure caused the abnormalities to return. 
Studies to determine whether the reproductive impairment was prolonged
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after repeated removal and reinstatement of ethylene dibromide diets were 
not conducted. However, in the one bull that was reexposed after a period 
of discontinuation, the time necessary for recovery of normal spermatozoic 
production increased from 10 days after the first discontinuation to 2-3 
months after the second.
In 1973, Amir [42] reported the effects of ethylene dibromide on 
spermiogenesis and sperm maturation in six 15- to 20-month-old Israeli- 
Friesian bulls by oral and intraperitoneal (ip) administration. Two bulls 
were given ethylene dibromide orally by capsule at a dose of 4 mg/kg on 
alternate days. One bull was killed after 12 days (7 doses) and the other 
castrated after 21 days (10 doses). Smears of spermatozoa from the testis, 
different parts of the epididymis, and the ductus deferens were observed 
microscopically for abnormalities. Samples of spermatozoa examined from 
the bull killed on the 12th day showed that more than 50% of the 
spermatozoa in the testis and about 10% of the spermatozoa in the first two 
segments of the head of the epididymis had deformed heads. Abnormal 
spermatozoa, almost all of which had tail and acrosomal defects, were found 
in differing percentages in the various segments of the epididymis. 
Samples of spermatozoa examined on the 21st day from the bull receiving 10 
doses indicated that spermatozoa with deformed heads constituted almost the 
entire population of the testis and head of the epididymis. The body and 
tail of the epididymis contained a mixture of abnormal and normal 
spermatozoa, the abnormal spermatozoa exhibiting head, tail, and acrosomal 
defects. Abnormal spermatozoa constituted 67% of the population in the 
ductus deferens and 77% of the ejaculate on day 21, with almost all of the 
abnormal spermatozoa showing tail and acrosomal defects.
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Tritium-labeled (3-H) ethylene dibromide was given orally by capsule 
to one bull on alternate days for 10 doses of 2 g each, and a second bull 
was anesthetized and injected once beneath the tunica vaginalis of each 
testis with 120 mg of 3H-ethylene dibromide [42]. Two other bulls were 
similarly injected with carbon-labeled (14 C) ethylene dibromide at doses 
of 220 or 350 mg. Ejaculates were collected two or three times a week 
before and during the oral administration, and for 2-3 months after the 
administration. Spermatozoa were observed microscopically for 
abnormalities. The seminal plasma was separated by centrifugation and the 
spermatozoa were resuspended for determination of the radioactivity by 
liquid scintillation spectroscopy. Two days after the last 3H-ethylene 
dibromide oral dose, or 4 days after the 3H- and 14C-ethylene dibromide 
injections, both of the bulls given 3-H and one of the bulls given 14-C 
were unilaterally castrated. Samples of the testes and parts of the head 
of the epididymis were sectioned, autoradiographed for 60 days, and then 
examined microscopically. Maximum concentrations of 3H- and 14C- 
radioactivity appeared in the seminal fluid samples collected 7-9 days 
aftet administration and in the spermatozoa about 1 week later. The 
percentage of abnormal spermatozoa resulting from 3H- and 14C-ethylene 
dibromide administration increased to a maximum after the radioactivity of 
the spermatozoa was minimal or not detectable. After the last 3H-oral dose 
or 3H- and 14C-injections, autoradiographic results showed labeling of the 
basal cells of the head of the epididymis and the smooth muscles enveloping 
the epididymal duct for oral 3H- and both 3H- and 14C-ethylene dibromide 
injections at 2 and 4 days, respectively. No 3H- or 14C-radiolabeling of 
the testes was noted through autoradiography. From the distributional
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pattern found in the genital tract of the two bulls given unlabeled 
ethylene dibromide, Amir concluded that the spermatozoa with deformed heads 
apparently originated in the testes under the influence of ethylene 
dibromide and gradually replaced spermatozoa with tail and acrosomal 
defects as they advanced through the epididymis. Furthermore, he noted 
that ethylene dibromide appeared to affect spermiogenesis while having no 
measurable direct toxic action on the spermatozoa. He postulated that the 
toxic action of ethylene dibromide most probably occurred through 
interference with the absorptive and secretory functions of the epididymis 
or by interfering with the process of nuclear chromatin condensation, but 
no experimental basis was given for this postulation.
In 1975, Amir [43, and written communication, August 1976] 
investigated the spermicidal effects of ethylene dibromide in Israeli- 
Friesian bulls administered 4 mg/kg every 2nd day in capsules for 10 doses. 
Eleven bulls (D Amir, written communication, August 1976) given ethylene 
dibromide in olive oil were 15-24 months of age and weighed 400-500 kg. 
The two remaining bulls given ethylene dibromide in olive oil were 4.5 and 
5 years of age and weighed 950 and 1,050 kg, respectively. Six young 
bulls, 15-24 months of age, were used as controls; three were given olive 
oil and three remained as negative controls. Six of the 11 young bulls 
given ethylene dibromide and the 6 control bulls were castrated or killed 
(number killed or castrated not specified) 1 day after receiving the last 
oral dose. Semen was collected from the seven remaining bulls two or three 
times a week for 2 months after the first dose and once or twice a week for 
the next 2 months. Spermatozoic concentration, motility, and malformation 
were determined microscopically from at least 400 randomly chosen
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spermatozoa from each semen sample. In the control bulls, 2-4% of the 
spermatozoa taken from various places along the genital tract had misshapen 
heads, and distribution of the malformed spermatozoa was uniform throughout 
the tract. In the animals that were killed or castrated, the number of 
spermatozoa exhibiting abnormal, mainly pear-shaped heads was markedly 
increased in the ethylene dibromide bulls over that of the controls and 
varied in distribution in the genital tracts of the different bulls. Amir 
[43] attributed the distributional pattern of abnormal spermatozoa in the 
genital tract to the variation in the time of release of the spermatozoa 
through the ductus deferens caused by individual variations in the dose- 
response threshold of the bulls.
In the semen samples collected from the five young bulls, maximum 
numbers of spermatozoa with misshapen heads appeared in the ejaculates 2-10 
days after the cessation of ethylene dibromide administration [43, and 
written communication, August 1976]. Again, these differences were thought 
to be caused by differences in the sperm transit time through the 
epididymis as well as to the variation in release time of the affected 
spermatozoa from the testes. The effect of ethylene dibromide was more 
acute in the adult than in the young bulls. The concentrations of 
spermatozoa in the younger bulls were only slightly affected by the doses, 
but were greatly reduced in the older bulls. Normal spermatozoic 
concentrations were regained after 1 and 4 months in the two older bulls. 
During the period of low spermatozoic concentration, the ejaculates of the 
older bulls contained much spermatozoic debris and many spermatids and 
spermatocytes; the debris presumably came from further disintegration of 
the abnormal spermatozoa. The number of abnormal spermatozoa in the young
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bulls decreased to about normal within 3 weeks after the last dose, but 
remained elevated in the two adult bulls for about 15 weeks. The author 
concluded that ethylene dibromide affected spermiogenesis in the young 
bulls since the abnormalities in the spermatozoa observed in the ejaculates 
persisted for a period that coincided with the duration of spermiogenesis 
in the bull, which is about 3 weeks. Amir also concluded that either
ethylene dibromide affected earlier stages of the spermatogenic process in
adult bulls or its elimination from the circulation of young bulls was more
rapid.
In 1955, Bondi et al [44] fed fumigated grain to laying hens to
determine its effects on egg laying and on the number and weight of eggs. 
The grain contained 10-320 ppm of ethylene dibromide mixed equally with 
standard laying rations that resulted in total ration concentrations of 5- 
160 ppm of ethylene dibromide. Twenty-five hens, 1.5 years of age, were 
divided into five groups of five hens each. Average egg weights and 
numbers were determined at the beginning of the experiment and weekly 
thereafter for 9 weeks. Sorghum grain for feeding was prepared by
fumigation with different amounts of ethylene dibromide to give grain 
concentrations of 0, 50-60, 80-100, 180-220, or 270-320 ppm of unchanged 
ethylene dibromide. The fumigated grain was then given with equal portions 
of a standard laying ration to each group. The weight and number of eggs 
decreased progressively in all ethylene-dibromide groups during the 5th and 
9th weeks (only data given) in relation to the concentration of ethylene 
dibromide in the feed. Cessation of egg laying occurred after 46 or 56
days of feeding in the five hens consuming ethylene dibromide in grain at
concentrations of 270-320 or 180-220 ppm, respectively. The authors also
69
stated that the eggs of five hens receiving ethylene dibromide 
concentrations of 50-60 ppm weighed less than eggs from control hens after 
3 weeks. They also observed that hens that had ceased egg production could 
not be induced to lay again by feeding them a bromide-free diet, even after 
feeding continued for several months.
To determine the effects of small amounts of ethylene dibromide in 
grain on egg laying, the authors [44] subjected 4 groups of 16 6-month-old 
hens each at concentrations of ethylene dibromide in grain ranging from 0 
to 30 ppm (total ration concentrations of 0-15 ppm). In addition to the 
ethylene dibromide, small amounts of "residual bromide," defined as the 
bromine-containing material remaining in sorghum grain that had been 
fumigated with ethylene dibromide and then aerated to remove free ethylene 
dibromide, were added to each feeding mixture, thus giving concentrations 
of 0 ppm (control), 0 ppm of ethylene dibromide plus 120 ppm of residual 
bromide, 10-15 ppm of ethylene dibromide plus 20 ppm of residual bromide, 
and 20-30 ppm of ethylene dibromide plus 50 ppm of residual bromide. The 
prepared grains were then fed with equal portions of a standard laying 
ration to each group of hens. Mean egg weights for each group were 
averaged over 4-week periods for 16 weeks. The 16 hens receiving the 
ethylene dibromide-free grain which contained 120 ppm of residual bromide 
did not differ from the control group, both showing the expected increase 
in egg weights as the hens grew older. Both groups of hens receiving 
ethylene dibromide were affected, but the group receiving the 20- to 30-ppm 
grain was influenced the most. Significant (P<0.01) differences were seen 
in egg weights after 8 weeks of exposure. In the 12th week, the group 
receiving ethylene dibromide grain at 10-15 ppm also differed significantly
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(P<0.05) from the control group in the weight of eggs laid. Although no 
experimental data were given, the authors stated that the number of eggs 
laid by the different groups was "practically the same" during the 
experimental period. When hens in the groups receiving ethylene dibromide 
were returned to control feed, the weight of the eggs laid increased to the 
same weight as those of the controls in 3 weeks for the group that had 
received grain concentrations of 10-15 ppm and in 6 weeks for the group 
that had received grain concentrations of 20-30 ppm.
The authors [44] concluded from the results of these two experiments 
that ethylene dibromide alone caused a significant reduction in the weight 
and number of eggs laid by hens fed grain containing ethylene dibromide. 
Even grain concentrations as small as 10-15 ppm (total concentrations of 5-
7.5 ppm) caused significant egg weight reductions within 10-12 weeks, but 
these effects were reversible and produced no long-term sequelae. Large 
amounts of ethylene dibromide in the grain, greater than 180 ppm (total 
concentrations of 90 ppm), caused an irreversible cessation of egg laying 
within 46-56 days. Bondi et al [44] also concluded that these observed
effects on egg production were the result of free ethylene dibromide in the 
diet, and were not caused by "residual bromides."
In 1968, Alumot et al [45] reported on the effects of prolonged 
feeding with ethylene dibromide-fumigated mash on the growth rate and 
sexual development of chicks and on the fertility of mature chickens. 
Sixty 1-day-old female chicks were divided equally into two groups, the 
first was fed twice daily a commercial mash containing 40 ppm of ethylene 
dibromide and the second served as controls in a paired-feeding design. 
Weights and feed consumption were recorded weekly up to 10 weeks of age.
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Feed intake, weight gain, onset of egg production at 4.5-5 months, and 
incidence of double-yolked eggs were the same for the experimental and 
control groups. The weight of eggs from the group receiving ethylene 
dibromide was significantly lower (P<0.01) than from the controls and the 
number of eggs laid by the hens receiving ethylene dibromide approached 
statistical significance, lowering below that of the control hens.
In a second experiment [45], two groups of 12 1-year-old hens in full
egg production were fed for 4 weeks a commercial mash with or without 100
ppm of ethylene dibromide. At the end of 4 weeks, egg weight in the hens 
fed ethylene dibromide had significantly decreased from an average of 63 to 
43 g. Both groups were then artificially inseminated twice at 7-day
intervals with 0.1 ml of semen/hen. Eggs collected between the 2nd day 
after the first insemination and the 7th day after the second insemination 
were examined for embryos. A striking reduction in the fertilization rate, 
with no live embryos at all, was noted in the ethylene dibromide-fed group; 
only 2 of 16 eggs were fertilized as compared with 48 of 56 eggs from the 
control group, and both fertilized eggs from the ethylene dibromide group 
contained dead embryos.
Similarly, a third experiment [45] was conducted to determine the 
effects of ethylene dibromide on male chicken growth rate and sexual 
development. Three groups of 20 3-day-old cockerels were fed mash
containing 0, 80, or 180 ppm of ethylene dibromide in which the amount of 
feed intake by the 180-ppm group determined the amounts of food given to 
the control and 80-ppm groups. Three additional groups of 25 cockerels 
were each fed mash containing 0, 150, or 300 ppm of ethylene dibromide 
without restrictions on the intake. At 6 weeks, the cockerels fed 150 ppm
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of ethylene dibromide showed a reduced weight gain when compared with the 
controls. Only cockerels fed the 300-ppm ethylene dibromide diet without 
restrictions on food intake showed significant growth retardation and an 
apparent feed intake depression at 12 weeks of age; however, the weight 
gain to feed intake ratio was not significantly different. The cockerels 
receiving the regulated diets were killed at 3 months of age, and the 
bromide content of the testes, spermatozoic count and activity, and testes 
weight were determined. Significant amounts of bromide were found in the 
testes of the ethylene dibromide-fed groups, but differences were not 
observed in spermiogenic activity, spermatozoic count, or testes weight 
between the control and ethylene dibromide-fed groups. The remaining 
unrestricted-intake cockerel groups were examined at the age of 9 months by 
collecting semen samples three times at weekly intervals and were killed at 
12 months of age for testicular examination and measurement of body, 
testes, and comb weights. Semen collected and examined from ethylene 
dibromide-fed cockerels did not differ significantly from that of the 
controls. Comb weights at death declined sharply with increasing
concentrations of ethylene dibromide in the diet; however, body and testes
weights were not affected by the ethylene dibromide.
Another experiment [45] was conducted to determine if ethylene 
dibromide administration to adult cockerels would affect fertility rates 
and hatchability of eggs. Eleven mature cockerels each were fed for 105
days a control mash or mash containing 300 ppm of ethylene dibromide.
Semen was collected about 2, 4, 8, and 10 weeks after the beginning of the 
experiment. No significant differences were seen between the semen of the 
controls and that of the cockerels fed ethylene dibromide with respect to
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ejaculated volume and spermatozoic motility and concentration. Subsequent 
fertilization tests in hens conducted with the pooled semen collected from 
the ethylene dibromide-fed and control groups gave no significant 
differences in fertilization rate or hatchability of eggs at 60 or 105 
days.
The authors [45] concluded that prolonged feeding of mash containing 
ethylene dibromide significantly depressed growth of male chickens when fed 
without restrictions, but that the depression seemed to result from reduced 
food intake and not from the direct action of ethylene dibromide. They 
also concluded that ethylene dibromide had no effect on the onset of egg 
production in hens fed from birth, on sexual development in males and 
females, and on sperm characteristics or fertility in mature males. 
However, statistically significant reductions in egg size and egg fertility 
were noted in hens fed ethylene dibromide.
In 1969, Alumot and Mandel [46] published the results of an 
investigation designed to measure the effects of ethylene dibromide 
administration on the formation and release of follicle-stimulating hormone 
(FSH) by the anterior pituitary gland in laying hens. FSH activity was 
determined by bioassay in groups of 20 1-week-old male White Rock cockerels 
by injecting pooled pituitary gland extracts. The changes in testicular 
weight were directly compared with those of control cockerels, and the 
increase in testes weight was used as an indication of FSH activity.
Ninety 3-month-old pullets were divided equally into three groups 
[46]. The first group was killed and FSH activity determined at the start 
of the experiment. The pullets in the second group were each fed 
approximately 10 mg/day of ethylene dibromide in fumigated feed for 4
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weeks. The third group served as controls for FSH activity at 4 months of 
age. No changes in the FSH concentration or activity were detected in the 
pullets fed mash containing ethylene dibromide.
In a second experiment [46], a group of 30 mature hens were each fed 
approximately 10 mg/day of ethylene dibromide in treated mash for about 2 
months until egg laying had almost ceased. FSH concentrations were 
examined as above and compared with those from 30 control hens. There were 
no appreciable differences between FSH concentrations in the hens fed 
ethylene dibromide and in the control hens. The authors [46] concluded 
that ethylene dibromide did not affect FSH formation or concentrations in 
the pituitary gland.
A further experiment [46] was conducted to determine whether hormone 
injections could counteract the decrease in egg sizes caused by ethylene 
dibromide. Four hens, laying very small eggs as a result of ethylene 
dibromide administration, were injected with a freeze-dried pituitary 
extract obtained from 7- to 11-week-old freshly killed broilers. Each hen 
received daily 4 mg of the preparation for 6 days. Egg weights recorded 
before, during, and 2 weeks after the last injection showed no significant 
differences. A purified FSH preparation, Ovine FSH-S2 from the National 
Institutes of Health, was injected into another group of four laying hens 
previously given ethylene dibromide as described above. The weights of 
whole eggs and yolks were compared for each hen prior to, during, and for 
10 days after the injections. Injection of the purified hormone did not 
change the total egg weight or the weight of the yolks, which both remained 
lower than comparable control values. The authors concluded from the above 
four experiments that ethylene dibromide did not affect pituitary FSH
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concentrations in treated hens. The injection of FSH preparations did not 
reverse the adverse effects of ethylene dibromide; therefore, the effects 
of ethylene dibromide on egg laying did not seem to be connected with 
impaired formation or release of FSH.
In an attempt to clarify the causes of smaller eggs in laying hens 
fed ethylene dibromide-fumigated mash [44], Alumot and Harduf [47] 
separated chick serum proteins into two crude fractions, globulin and 
albumin. The proteins in each fraction were labeled with 125-1 and 
injected iv into 14 hens that had been previously fed fumigated mash 
containing about 100 ppm of ethylene dibromide and into 14 control hens. 
The labeled proteins were injected into the hens when egg weights had 
decreased in the ethylene dibromide-fed hens to about 40 g as compared with 
60 g in the controls. The amount of radioactivity was measured in egg 
yolks collected daily for 2 weeks after injection and in ovarian follicles 
of hens killed 40 hours after injection. Eggs from control and ethylene 
dibromide-fed hens differed in the amount of radioactivity in the yolk 
protein fractions. The amount of radioactivity in yolks of eggs from hens 
fed ethylene dibromide was about half that of the controls when the albumin 
fraction was injected iv and about a third that of the controls when the 
globulin fraction was injected iv. Similar results were observed in the 
ovarian follicles, particularly in the radioactive uptake per unit of 
membrane area, but no differences were found between results obtained from 
albumin and globulin injections. The authors postulated that the impaired 
passage of proteins to the follicle may be related to the decreased egg 
weight caused by ethylene dibromide in hens. Since the globulin fraction 
was composed of high molecular weight proteins and the albumin fraction of
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low molecular weight proteins, the different ratio of radioactive 
incorporation into the yolk was thought by the authors to be an indication 
of an impairment of the permeability of the vitelline or follicular 
membranes to proteins induced by ethylene dibromide. These results 
indicate a significant difference in the metabolism of 125-I-labeled 
protein between the hens maintained on mash containing about 100 ppm of 
ethylene dibromide and the control population.
In 1970, Edwards et al [9] investigated the antifertility effects of 
ethylene dibromide in an unspecified number of adult male Wistar rats. 
Doses of 10 mg/kg were injected ip into 250-g rats for 5 consecutive days. 
The average live litter size from six female rats serially mated on a 
weekly schedule with the males receiving ethylene dibromide decreased 
substantially during the 3rd week and drastically (to zero) during the 4th 
week after administration. From the authors' data, the average litter size 
appears normal during the 5th week and for every week thereafter. The 
authors concluded that the antifertility effects resulted from ethylene 
dibromide selectively damaging the spermatid cells, since the short course 
of exposure produced only transient sterility in rats and corresponded in 
time to changes that would result from spermatid damage. In an additional 
study [9], the major metabolite of ethylene dibromide in urine, S—(2— 
hydroxyethyl)-cysteine, was reported to have produced no effect on male 
mouse fertility at a dose of 1,000 mg/kg when administered daily for 5 days 
by oral intubation, although experimental details and data were not 
presented. The data indicate that oral exposure to ethylene dibromide 
induces temporary sterility in male rats. However, further evaluation of 
the data is not possible because of the lack of experimental details, such
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as number of test animals or any data about control animals, that were not 
given by the authors in the publication.
(c) Metabolism
In 1940, Abreu and Emerson [48] reported that mice subjected to 
ethylene dibromide vapor at a concentration of 0.75 mM/liter (approximately 
18,350 ppm) for 1 hour had an increase in liver inorganic bromide 
concentrations when compared with controls. From the authors' data, this 
increase appeared to be highly significant. They concluded that the 
bromide concentrations found could hardly have caused the liver tissue 
damage previously thought to be caused by local concentrations of 
hydrobromic acid [28], and suggested that the tissue damage was the result 
of the intact molecule itself.
In 1948, Heppel and Porterfield [49] reported that rat liver 
fractions enzymatically dehalogenated ethylene dibromide. The enzymatic 
system required activation by cyanide and either glutathione or cysteine.
Mammalian liver extracts catalyze a reaction between ethylene 
dibromide and glutathione [49-52]. Under the assay conditions used, two 
moles of bromide ion were released for each mole of glutathione consumed, 
which suggests that the initial reaction product, S-(beta-bromoethyl)- 
glutathione, rapidly cyclizes to form an S-substituted thirane with 
concomitant release of the second bromide ion [6,7,9,11,50,53]. 
Spontaneous hydrolysis of the S-substituted thirane, which is a highly 
reactive alkylating agent, would yield S-beta-hydroxyethyl glutathione, a 
known metabolite of ethylene dibromide [50,51]. Hydrolysis and acetylation 
of the S-beta-hydroxyethyl glutathione would yield S-(beta-hydroxyethyl)- 
cysteine and S-(beta-hydroxyethyl) mercapturic acid, which have also been
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identified as metabolites of ethylene dibromide [51,52]. Other metabolites 
of ethylene dibromide may be formed in biologic systems by other metabolic 
pathways; however, a comprehensive study designed to isolate and identify 
metabolites is needed.
Further research from Nachtomi's laboratory [50,54] identified a 
characteristic decrease in the concentration of liver sulfhydryl groups 
during the 1st hours after administration of 110 mg/kg of ethylene 
dibromide in male and female rats and in male and female chickens, and a 
subsequent increase of liver sulfhydryl groups in both species after about 
20 hours [54]. This increase probably was caused by the enhanced synthesis 
of glutathione. There was no appreciable loss of ascorbic acid which
suggested to the authors that the extensive formation of peroxides, as
reported for the metabolism of carbon tetrachloride, did not occur. In 
1970, studies [50] conducted with rat liver homogenates supported the 
earlier conclusions by Nachtomi et al [51] when S-(beta-hydroxyethyl) 
glutathione was identified as the major in vitro product. In addition, 
small amounts of the symmetrical intermediate, S,S'-ethylene-
bis (glutathione) , were identified. The above two compounds and the
sulfoxide of S-(beta-hydroxyethyl)glutathione were identified in the livers 
of rats intubated with 120 mg/kg of carbon-labeled (14 C) ethylene 
dibromide, and S-(beta-hydroxyethyl) mercapturic acid was identified in the 
kidneys. The enzymatic reaction between ethylene dibromide and glutathione 
was found to occur primarily in the liver, and, to a lesser extent, in the 
kidneys [50]. The capacity of the liver and kidneys to metabolize ethylene 
dibromide was estimated to be 1.7 ± 0.02 and 1.4 ± 0.05 ¿imoles/minute/g of
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tissue, respectively. The subsequent degradation of the S-(beta- 
hydroxyethyl) glutathione and its sulfoxide to S-(beta-hydroxyethyl) 
mercapturic acid and S-(beta-hydroxyethyl) mercapturic acid sulfoxide was 
reported to occur primarily in the kidneys and was thought to involve more 
than one enzyme. These data indicate that the capacity of rat liver and 
kidney to metabolize ethylene dibromide exceeds the amount of ethylene 
dibromide inhaled from an atmosphere containing 25 ppm (192.5 mg/cu m) by a 
factor of about 100. Consequently, under steady-state exposure conditions, 
the concentrations of ethylene dibromide in tissues should be considerably 
less than the concentration in the inhaled air, which is about 1.02 
mmoles/liter.
Differences have been reported in the abilities of rats and chickens 
to detoxify ethylene dibromide. Nachtomi et al [55] and Nachtomi and 
Alumot [8] observed that rats possessed a much greater ability to conjugate 
glutathione with ethylene dibromide than chicks [55]. In addition, the rat 
liver formed significant amounts of lipids containing conjugated double 
bonds as a result of the peroxidation of lipids induced by ethylene 
dibromide in the liver microsomal supernatant fraction, whereas chicken 
liver was relatively inactive [8]. Also, the concentration of 
triglycerides increased significantly in the rat liver, probably as a 
direct result of the formation of conjugated double bonds discussed above.
In 1970, Edwards and coworkers [9] reported the tissue distribution 
of radioisotope at various time periods after an ip injection of 40 mg/kg 
of carbon-labeled (14 C) ethylene dibromide in mice. The data are 
presented in Table XII-3. One hour after injection, most of the 14C- 
radioactivity was found in the small intestine, with smaller amounts being
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found, in descending order, in the kidneys, liver, blood plasma, whole 
blood, large intestine, fat, and spleen. After 3 hours, the majority of 
the radioisotope was present in the large intestine, kidneys, and blood 
plasma, with smaller amounts being present in the whole blood, liver, small 
intestine, and spleen. After 24 hours, all tissues were below 1.0%
retention of 14C-radioisotope except for the whole blood, blood plasma, 
stomach, and kidneys. After 1 hour, essentially all of the administered 
radioisotope was present in the various mouse tissues, whereas only 89% was 
present after 3 hours and 16% after 24 hours. It is of interest to note 
that 3.1, 4.4, and 0.66% of the administered radioisotope was detected in
the tail of the epididymis 1, 3, and 24 hours after injection,
respectively. Smaller amounts of 14C-radioisotope, up to 1.5% at 3 hours, 
were also present in the testes. The data presented by the authors suggest 
that ethylene dibromide is rapidly distributed to a wide variety of
tissues. Major concentrations of radioisotope accumulated in the liver,
kidneys, and digestive tract. There also seems to be a rapid depletion of
radioisotope from the tissues, but the residual radioactive material is 
still widely distributed throughout the body tissues.
In 1976, Plotnick and Conner [10] conducted a similar study of the
tissue distribution of carbon-labeled (14 C) ethylene dibromide in guinea
pigs. The ethylene dibromide was administered in a single ip injection of 
30 mg/kg and tissue samples were collected 4-72 hours after the injection. 
The data are presented in Tables XII-4 and XII-5. At all intervals
studied, the highest concentration of radioactivity derived from ethylene 
dibromide as lig/g of tissue was found in the kidneys, liver, and adrenal 
glands. At all time periods studied, the organs containing the highest
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percentage of the administered dose were the liver and kidneys. 
Approximately 66% of the injected dose was excreted in the urine over the 
72-hour study, 15% of which was in the first 4 hours, and approximately 3%
was excreted in the feces. Plotnick and Conner mentioned that unpublished
preliminary studies by their laboratory "strongly suggest that excretion of 
unchanged ethylene dibromide in the expired air also represents a 
significant (10-12% of the dose) route of excretion."
From the data of Edwards et al [9] and Plotnick and Conner [10], it 
seems that a relationship may exist between the tissue distribution and the 
destructive tissue changes, particularly with respect to the liver and 
kidney damage, in other animal [27,33] and human [22,25] studies reported 
previously in this chapter.
Carcinogenic, Mutagenic, and Teratogenic Studies
(a) Carcinogenesis
In 1973, Olson et al [56] reported the results of a preliminary 
investigation to determine the potential carcinogenic effects of ethylene 
dibromide in rats and mice of both sexes by oral administration. Further 
statements by Powers et al [57] and Ward and Habermann [58,59] in
abstracts, and by Page (written communication, December 1976) have been
used to supplement the preliminary report by Olson et al [56]. Osborne- 
Mendel rats, 50 males and 50 females, 6 weeks of age, and (C57BL x C3H) FI 
mice, 50 males and 50 females, 6 weeks of age, were administered daily 
doses of ethylene dibromide dissolved in corn oil by gastric intubation. 
Each rat received either what was thought to be the maximum tolerated dose 
of 80 mg/kg/day or one-half that dose for 5 days/week, for 16 weeks. At 16
82
weeks, the 80 mg/kg/day dose was discontinued for 14 weeks because of 
cumulative toxicity. The 40 mg/kg/day dose continued without interruption 
for the full 54-week experimental period. At 30 weeks, the 80 mg/kg/day 
group of rats was placed on a 40 mg/kg/day regimen for the remainder of the 
experiment. The rats started on the 80 mg/kg dose received a total dosage 
of 11.2 g/kg of ethylene dibromide during the experiment and those given 
the 40 mg/kg dose received a total dosage of 10.8 g/kg. Control groups of 
rats and mice, 20 males and 20 females each, received intubations of corn 
oil or nothing for the duration of the test.
Initially the only deleterious effect of ethylene dibromide on the 
rats was a depression in weight gain [56]. As early as 10 weeks after the 
initiation of the experiment (dose not stated), one squamous cell carcinoma 
of the stomach was noted in one male and in one female rat. Squamous cell 
carcinomas of the stomach became more prevalent as the experiment 
progressed, developing in 83 of 100 male rats and in 70 of 100 female rats 
intubated with ethylene dibromide. The tumors originated in the 
forestomach, invaded locally, and eventually metastasized throughout the 
abdominal cavity. Only one mammary tumor in a female rat was noted in the 
concurrent corn oil controls; however, in the untreated control group, 6 of 
20 male rats and 14 of 20 female rats developed tumors, none of which were 
squamous cell carcinomas of the stomach. Tumor incidence was 68% in the 
male rats receiving ethylene dibromide at 80 mg/kg/day versus 98% in those 
receiving 40 mg/kg/day, and it was 58% in the female rats at 80 mg/kg/day 
versus 82% at 40 mg/kg/day. Olson et al [56] postulated that this 
decreased incidence of tumorigenesis may have resulted from the earlier 
death of the animals receiving the higher dose or because the animals did
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not receive ethylene dibromide for a 14-week period between weeks 16 and 
30. The induction sequence and results of microscopic examinations were 
discussed in detail only for the male rats receiving the 40 mg/kg dose, 
since the authors considered the induction and progression of the tumors to 
be similar in all experimental groups [59]. All 50 male rats had stomach 
lesions, although one did not contain a neoplasm. The forestomachs had 
diffuse squamous cell hyperplasia with many papillomatous projections. 
Focal areas of invasion were reported from the origin of the carcinomas. 
Invasion occurred through the stomach wall to the peritoneal cavity, where 
nodules were reported in 70% of the rats. The metastatic tumors were less 
differentiated or formed keratin pearls, often accompanied by abcesses or 
peritonitis. The authors [59] stated that other types of tumors and 
lesions were also present in a few rats, including mesotheliomas, 
intestinal tumors, nodular hyperplasias of the liver, and poorly 
differentiated stomach tumors.
Each group of mice received ethylene dibromide in doses of 60 or 120 
mg/kg/day for 13 weeks [56]. After 13 weeks, the doses were increased to 
100 and 200 mg/kg/day but were reduced to the original doses after 2 weeks 
because of toxicity. At 42 weeks, the daily dose of ethylene dibromide for 
all mice was changed to 60 mg/kg/day. At 42 weeks, one male and one female 
mouse developed squamous cell carcinomas of the stomach at the higher dose 
regimen, and three males and two females at the lower regimen. High early 
mortality was encountered in mice receiving the higher dose (40%). No 
squamous cell tumors were found in the concurrent controls, although 6 of 
40 males and 3 of 40 females developed other types of tumors. Squamous 
cell carcinomas of the stomach developed in 74% of the males and in 72% of
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the females at the terminal killings between weeks 59 and 90 (NP Page, 
written communication, December 1976).
It seems that ethylene dibromide caused an increased incidence of 
gastric carcinoma in rats treated by intubation with either 40 mg/kg/day or 
an ordered combination of 80, 0, and 40 mg/kg/day. Carcinomas were found 
to originate at the site of administration (the stomach) in both species, 
to invade locally, and eventually to metastasize throughout the abdomen 
[56,58,59]. Also, 72 of 145 mice that developed squamous cell carcinomas 
were diagnosed after week 59, whereas the vehicle controls were killed at 
week 59.
(b) Mutagenesis
In 1972, Buselmaier et al [60] reported the results of an
investigation to determine the potential for ethylene dibromide to induce
mutations in the host-mediated assay with Salmonella typhimurium G46 and 
Serratia marcescens a21 Leu- in NMRI mice and in the in vitro plate test 
with Salmonella typhimurium G46. Immediately after ip inlection of each 
bacterial strain, 500 mg/kg of ethylene dibromide emulsified in edible oil 
was injected subcutaneously into one hind leg of six 10- to 12-week-old 
mice. Three hours after the injections, they were killed and the fluid 
from the peritoneal cavity was collected for plating to determine the 
number of mutant colonies induced. In the comparative in vitro plate test 
with Salmonella typhimurium, a concentration equivalent to the 500 mg/kg 
dose was applied to a filter paper disc in the center of the plate, and 
after a 12-hour incubation, the number of mutant colonies were counted.
The investigators [60] found that ethylene dibromide was definitely
mutagenic in the host-mediated assay with Salmonella typhimurium G46 and in
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vitro with the same organism. The mutation frequencies for Salmonella 
typhimurium G46 in the host-mediated assay were 0.77 x 10“8 in the control 
test and 6.23 x 10-8 in the experimental test. The ethylene dibromide- 
exposed mutation frequency was significantly different (P<0.01) from the 
control. The in vitro plate test results were also positive. Ethylene 
dibromide did not induce a significant number of mutants in the host- 
mediated assay with Serratia marcescens a21 (6.93 x 10"7 for control, 2.43 
x 10“7 for ethylene dibromide-exposed). The authors [60] concluded that 
ethylene dibromide did not require activation through in vivo metabolism to 
exert its mutagenic effects on Salmonella typhimurium, nor did metabolism 
of ethylene dibromide sufficiently deactivate its mutagenic potential, 
since both the host-mediated assay and the in vitro plate tests were 
positive.
In 1972, Epstein et al [61] published the results of a screening 
study on the detection of chemical mutagens by a dominant lethal assay in 
ICR/Ha Swiss mice. Ethylene dibromide was tested along with 173 other 
industrially important chemicals or chemical mixtures. Ten male mice, 8- 
to 10-weeks-old, were given 0, 50, or 100 mg/kg of ethylene dibromide for 5 
consecutive days by oral administration and were then mated weekly with 
three different virgin 8- to 10-week-old female mice for 8 consecutive 
weeks. One male mouse died at the 50 mg/kg dose and two males died at the 
100 mg/kg dose during the experiment. Two different groups of seven or 
nine male mice received single ip injections of 18 or 90 mg/kg of ethylene 
dibromide, respectively, and were then mated as above. The mated females 
were killed about the 13th day after presumptive mating and were scored for 
the number of total implants, live implants, early fetal deaths, and
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pregnancies. The experimental animal scores were contrasted to concurrent 
control scores. The authors included ethylene dibromide in a class of 
agents which did not meet "any screening criteria for mutagenic effects," 
although specific data for ethylene dibromide were not presented. No 
effect of ethylene dibromide on fertility was reported in this paper, which 
differs from the finding of Edwards et al [9].
In 1973, Clive [62] tested the mutagenic potential of ethylene 
dibromide on the back mutation frequency of the thymidine kinase locus in a 
mammalian somatic cell tissue culture derived from mouse lymphoma cells. 
The L5178Y mouse lymphoma cells were exposed to ethylene dibromide at 
concentrations of 0.0-3.0 mM in culture media for 2 hours. The exposed 
cells displayed an induced mutational frequency that was dose related and 
typical of other alkylating agents, such as methyl methanesulfonate and 
ethyl methanesulfonate.
Thirteen new mutations for each 10,000 surviving cells were found 
under these experimental conditions [62]. The frequency of induced 
mutations generally increased monotonically after exposure of the cells to 
increasing concentrations of ethylene dibromide. The induced mutation 
frequency indicated that ethylene dibromide was mutagenic over the entire 
range of experimental concentrations when plotted against the growth 
inhibition, although less potent than ethyl methanesulfonate (an induced 
mutational frequency of about 2/10,000 cells versus one of 7/10,000 cells 
at 60% growth inhibition, respectively). The induced mutational frequency 
in L5178Y mouse lymphoma cells corresponded with that of a mutational 
frequency of over 600 R of X-irradiation at the highest concentration. 
Clive concluded that ethylene dibromide was mutagenic to the L5178Y mouse
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lymphoma cells although not as potent as ethyl methanesulfonate.
In 1974, Meneghini [5] reported the results of an investigation to 
determine the potential for ethylene dibromide to induce DNA repair 
synthesis in cultured opossum lymphocytes. Two-year-old opossums, 
Didelphis virginiana, were used to obtain lymphocytes for culture. Blood 
was removed from their tails and lymphocyte suspensions were prepared and 
maintained at 37 C. Samples containing about 5 x 10^ cells/ml were 
incubated with various concentrations of ethylene dibromide for 1 hour at 
37 C. At the end of this period, the cells were incubated in culture 
media with 3H-thymidine for 4 hours to allow for DNA radiolabeling to 
occur. Control cells were processed as above, but without exposure with 
ethylene dibromide.
At concentrations between 0.001 and 1 mM, ethylene dibromide was very 
effective in inducing DNA repair in opossum lymphocytes [5]. Repair 
induction decreased at a concentration of 10 mM of ethylene dibromide, 
which was presumed to be the result of repair-inhibition phenomena such as 
those observed for ultraviolet-induced repair. The author indicated that 
ethylene dibromide was very effective in inducing DNA repair in a manner 
similar to other alkylating agents, such as methyl methanesulfonate and 
ethyl methanesulfonate, which were also studied. He stated that only 
compounds that interact with DNA through covalent bonds induce repair 
synthesis. Therefore, these data suggest that ethylene dibromide, or its 
metabolites, may interact via covalent bonding with DNA.
In 1974, Vogel and Chandler [6] measured the possible genetic effects 
induced by ethylene dibromide in sex-linked lethal tests with fruit flies, 
Drosophila melanogaster. The adult Berlin K male flies were allowed to
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feed on a 0.3-mM ethylene dibromide solution for 3 days before being 
allowed to mate with two females for 3 days. A sequence of two 3-day brood 
periods was initiated (broods 1 and 2), followed by one 4-day brood period 
(brood 3). At the end of each 3-day breeding period, the treated males 
were transferred to a new vial and were allowed to mate with two new 
females. The frequencies of recessive lethal mutations in meiotic and 
postmeiotic germ cells were determined in the offspring of treated and 
control males. Ethylene dibromide induced significant numbers of recessive 
lethal mutations in the offspring of all three broods. These were 0.50, 
1.49, and 1.30% in broods 1, 2, and 3, respectively, and an average lethal 
frequency for all broods of 1.10%. The authors concluded that the brood 
pattern resulting from ethylene dibromide exposure was consistent with the 
action of chemicals that affect spermatids and spermatocytes because of the 
higher incidence of recessive lethal mutations in broods 2 and 3. The 
authors considered ethylene dibromide to be a bifunctional alkylating agent 
capable of introducing cross-links into large biologic molecules, and to be 
definitely mutagenic in Drosophila melanogaster.
In 1971, Ames [63] published the results of an experiment to 
determine the mutagenic potential of ethylene dibromide to the his-G46 and 
TA 1530 strains of Salmonella typhimurium. A 5—jlzI (11.0 mg) sample of 
ethylene dibromide was placed in the center of a petri plate previously 
seeded with bacteria that were unable to grow because of a deficiency 
mutation. The number of reverted mutant colonies was measured as an 
indication of the mutagenic potential. Ames reported that ethylene 
dibromide was a mutagen when tested in these systems, although experimental 
data were not reported.
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Brem and coworkers [64], in 1974, tested the possible mutagenic and 
DNA-modifying effects of ethylene dibromide on two bacterial systems, 
Escherichia coli and Salmonella typhimurium. E coli pol A+ or E coli pol 
Al- were spread onto the surface of agar plates and were exposed to lOjul 
(22.0 mg) of ethylene dibromide deposited directly onto a sterile disc 
centered in the plate. After an 8-hour incubation at 37 C, the diameter of 
the zone of growth inhibition in each plate from three replications was 
measured as an indication of the mutagenic potential. Salmonella 
typhimurium TA 1530, TA 1535, or TA 1538 were exposed to 0.0-11.5 fM of 
ethylene dibromide in a similar manner except that the plates were 
incubated in the dark for 54 hours. The number of reverted mutant colonies 
on each plate was counted and used as an indication of the mutagenic 
potential.
Ethylene dibromide inhibited the growth of the E coli pol Al- strain 
preferentially to isogenic pol A+ strain as indicated by zone of inhibition 
diameters of 20 versus 15 mm, respectively, at concentrations of 10 /¿I 
(22.0 mg)/plate [64]. Since the isogenic strains differed only in the 
structural gene for DNA polymerase A, it was concluded that ethylene 
dibromide affected cellular DNA in E coli. Ethylene dibromide was found to 
be mutagenic at 10.0 juM/plate to Salmonella typhimurium TA 1530 (1329 
revertants/plate versus 23 revertants/plate for the water control) and to 
Salmonella typhimurium TA 1535 (1438 revertants/plate versus 26
revertants/plate for the water control), but it was not mutagenic to 
Salmonella typhimurium TA 1538 (18 revertants/plate versus 19
revertants/plate for the water control). The authors suggested that 
ethylene dibromide induced mutations resulting from base substitutions, as
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indicated by the positive results with TA 1530 and TA 1535, and not by 
frame shifting, as indicated by the negative results with TA 1538. These 
data substantiate the earlier results of Buselmaier et al [60] for the 
induction of back mutations at the his-G46 locus in Salmonella typhimurium.
In 1975, Alper and Ames [65] published the results of a study to 
determine whether ethylene dibromide or 39 other agents could cause mutants 
by chromosomal deletions of various lengths in Salmonella typhimurium LT2 
and Salmonella typhimurium galE503. Bacteria were poured onto agar plates 
as suspensions in top agar and were incubated for 8 hours. A few drops of 
the test compound, 1-5 ¡il (2.2-11.0 mg), were placed near the edge of the 
plate immediately after the top agar had solidified. The number of 
colonies clustered within a 3.5-cm radius of the spot where the compound 
was applied was used as an index of the extent of mutagenesis. The zone of 
inhibition for ethylene dibromide was reported as less than 1.5 cm from the 
application spot, but specific data were not presented. Although no 
experimental data were given, ethylene dibromide was included in a list of 
compounds which failed to increase the frequency of deletion mutants by as 
much as fourfold over that of the control.
In 1974, Sparrow et al [66] investigated the effects of ethylene 
dibromide vapor on genetic mutagenesis in the interspecific hybrid clone 
4430 of Tradescantia plants heterozygous for flower color. Mutation 
frequencies were determined after doses of X-rays ranging from 0.0 to 432.0 
rads at 30 rad/minute, or after dynamic exposures to measured 
concentrations of gaseous ethylene dibromide ranging from 3.6 to 148.2 ppm 
(27.72 to 1,141.14 mg/cu m) for 6 hours. Mutation frequencies were 
obtained by averaging the mutant events from 11-15 days after irradiation,
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or 10-15 days after ethylene dibromide exposure.
The frequencies of pink flower mutations in Tradescantia was found to 
be linear for X-irradiation doses below 6 rads [66]. No linear dose- 
response relationship was observed above 50 rads, the mutation frequencies 
at higher doses actually decreasing below those for some lower doses. A
straight-line relationship was demonstrated for the entire range of
ethylene dibromide concentrations from 3.6 to 148.2 ppm (27.72 to 1,141.14
mg/cu m) for the pink mutant response in clone 4430 when the number of
induced mutations was plotted against the concentration of ethylene 
dibromide. The authors postulated that saturation, or the nonlinear, 
decreased mutation rates noted for X-irradiation at high doses, was not 
attained at the 148.2 ppm (1,141.14 mg/cu m) concentration of ethylene 
dibromide, even though plant damage was very apparent and flower production 
was considerably reduced.
Sparrow et al [66] concluded that ethylene dibromide was "highly
mutagenic" to Tradescantia, eliciting a well-defined dose-response 
relationship with surface exposures as low as 3.6 ppm (27.72 mg/cu m).
NIOSH has calculated the slope of the dose-response curve for the induction 
of pink mutants for Tradescantia clone 4430 to be 1.3 between 3.6 and 148.2 
ppm (27.72 and 1,141.14 mg/cu m), which is consistent with the prediction 
of the multi-hit theory for mutation induction in this species under these 
experimental conditions.
Ethylene dibromide has been reported to induce mutations in




In 1976, Short et al [69] examined the effects of ethylene dibromide 
vapor on rats and mice during organogenesis. The production of congenital 
defects was used as a measure of inherent toxicity. Female Charles River 
CD rats or female CD-I mice were caged overnight with proven male breeders; 
successfully bred females were identified the next morning by the presence 
of sperm in vaginal smears from rats or of copulation plugs in mice. 
Pregnant animals were divided into a control group of 18 rats and 17 mice 
which would receive a normal diet without inhalation exposure to ethylene 
dibromide, a group of 18 rats and 13 mice to receive 31.6 ppm (243.32 mg/cu 
m) of ethylene dibromide and a normal diet, and a group of 17 rats and 9 
mice to receive a restricted diet without exposure to ethylene dibromide. 
All groups of animals were housed in the inhalation chambers for 10 
consecutive days beginning on day 6 of gestation. During this time, the 
groups to be given ethylene dibromide were exposed to the vapor at an 
average concentration of 31.6 ±1.9 ppm (243.32 ± 14.63 mg/cu m) for 23
hours a day. Rats and mice were killed on gestational day 20 or 18, 
respectively. Fetuses were surgically removed from the dams, weighed, 
examined for external anomalies, and fixed for either soft-tissue or 
skeletal examinations. Ethylene dibromide exposure did not produce 
mortality in either pregnant rats or mice during the 10-day inhalation 
period; however, two of nine pregnant mice from the restricted diet group 
died. Both rats and mice exposed to ethylene dibromide consumed less feed 
and gained significantly (P<0.05) less weight than the controls during the 
exposure period, although feed consumption and weight gain returned to 
normal after cessation of the exposure on the 15th day of pregnancy.
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Ethylene dibromide-exposed rats consumed about twice as much food daily as 
did the feed-restricted rats (10.5 ± 0.6 versus 5.0 ± 0.1 g/day,
respectively), but only about one-half of that consumed by the controls 
(10.5 ± 0.6 versus 21.1 ± 0.4 g/day, respectively).
Rats exposed to ethylene dibromide at a concentration of 31.6 ppm 
(243.32 mg/cu m) had statistically significant decreases (P<0.05) when 
compared with the unexposed controls in the mean numbers of implants/dam 
(12.4 versus 15.4) and live fetuses/dam (12.2 versus 15.3) [69]. Also, the 
percentage of viable fetuses decreased slightly and the percentage of early 
resorptions increased slightly in ethylene dibromide-exposed rats. The 
number of male fetuses in the live litters also increased slightly in rats 
receiving ethylene dibromide from 48% males in control rats to 59% males in 
ethylene dibromide-exposed rats.
The only significant (P<0.05) difference in reproductive success 
found in mice exposed to ethylene dibromide at 31.6 ppm (243.32 mg/cu m) 
was a decrease in the live fetal weights, which also occurred in the feed- 
restricted mice [69]. Slight, but not significant, unfavorable changes in 
the number of implants/dam, viable fetuses, early resorptions, late 
resorptions, complete resorptions, fetuses/dam, and percentage of live 
males/litter were also found in both the ethylene dibromide-exposed and 
feed-restricted mice when compared with the controls.
Specific organogenic anomalies in the fetuses of rats exposed to 
ethylene dibromide at 31.6 ppm (243.32 mg/cu m) that were significantly 
different from controls included what the authors termed "hydrocephaly" of 
the fourth ventricle (P<0.10), decreased occurrence of the fourteenth pair 
of ribs (P<0.05), and wavy ribs (P<0.05), none of which were significantly
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different in the fetuses of the feed-restricted rats when compared with 
control fetuses [69]. Other noticeable but not significant changes found 
in the fetuses of rats exposed to ethylene dibromide included limb 
reduction, "hydrocephaly" of the lateral and third ventricles, 
hydronephrosis, club foot, incompletely ossified supraoccipital and 
parietal bones, and fused ribs. The incidence of "hydrocephaly" of the 
lateral ventricles and the incomplete ossification of the supraoccipital 
bone were also different in fetuses from the feed-restricted rats and 
fetuses from the controls.
Fetuses of mice exposed to ethylene dibromide vapor were found to 
have significant increases in skeletal anomalies when compared with those 
from control mice [69]. These anomalies included no ossification of the 
incus bone (P<0.01), incomplete ossification of the supraoccipital bone 
(P<0.01), and variations in ossification of the sternabrae (P<0.05 or 
P<0.01). Only the variations in the sternabrae (P<0.10 or PC0.05) were 
noted in the feed-restricted mice. Other changes in ethylene dibromide- 
exposed mice included an increase in "hydrocephaly" of the third and fourth 
ventricles and split sternabrae.
The authors [69] concluded that the above-mentioned effects of 
ethylene dibromide exposure in mice were most likely attributable to 
malnourishment rather than to ethylene dibromide exposure. It is apparent 
from the authors' data that some of the anomalies may be compounded by the 
presence of ethylene dibromide. In addition, if the malnourished controls 
and ethylene dibromide-exposed animals had been compared with the 
nonexposed controls at the same statistical probability levels, only the 
ethylene dibromide-exposed animals would have been significantly different
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from the controls. Skeletal anomalies, in particular the variations in 
ossification of the incus and supraoccipital bones, were much more 
prevalent in the ethylene dibromide-exposed mice than in the feed- 
restricted mice (80-90% of the litters versus 33-50%, respectively). The 
authors also attributed many of the observed anomalies in the rat dams and 
fetuses exposed to ethylene dibromide to malnutrition rather than to direct 
effects of ethylene dibromide exposure. However, they concluded that the 
increase in the fourth ventricular "hydrocephaly," the reduction in the 
occurrence of the fourteenth rib, and the increase in the frequency of wavy 
ribs could be correlated to ethylene dibromide exposure in the rat.
The significance of the effects of malnutrition in rats is not clear, 
and even though ethylene dibromide-exposed rats consumed less food than did 
controls, they consumed more food than did the rats in the feed-restricted 
group. It is apparent, however, that an increase in the incidence of 
anomalies in fetal rats was induced by exposure to the one concentration of 
ethylene dibromide, but no dose-response relationship for this action is 
available.
Correlation of Exposure and Effect
Neither studies that correlate workplace concentrations of ethylene 
dibromide with observed toxic effects nor any epidemiologic studies have 
been found. Few reports of human exposure to ethylene dibromide exist. 
Those that have been reported for occupational [23,24], accidental [22,25], 
and experimental [24] exposures do not present exact quantitative data 
concerning the concentrations or durations of exposure; thus, correlation 
of exposure and effect is exceedingly difficult and further correlation in
96
humans can be accomplished only partially from qualitative, and often 
subjective, symptomatic observations. In humans, ethylene dibromide vapor 
was reported to cause irritation of the eyes [23] and of the respiratory 
tract [22,23], headaches [23], anorexia [23], swelling of the glands 
beneath the chin and maxillary angles [23], a generalized body pallor [23], 
insomnia, dizziness, and vomiting [22]. Contact of the skin with liquid 
ethylene dibromide caused intense burning pain preceding a generalized 
hyperemia that developed into blisters [24]. Repeated contact with liquid 
ethylene dibromide in experiments with one volunteer caused skin 
sensitization [24].
Kochmann [23] reported that an employee repeatedly exposed to 
ethylene dibromide vapor during his employment suffered from conjunctival 
irritation, swelling of the glands in the neck, and a generally poor 
condition. After recovery, the employee returned to work, but became ill 
again after being reexposed to ethylene dibromide and reportedly suffered 
from conjunctivitis, pharyngeal and bronchial irritation, anorexia, 
headaches, and depression. Improvement was rapid after the employee was 
removed from exposure.
Marmetschke [22] described an accidental exposure to ethylene 
dibromide in a female patient who was supposed to be anesthetized by ethyl 
bromide. Instead, the woman inhaled an unknown portion of the 
approximately 70 g of ethylene dibromide mistakenly placed on an oronasal 
mask. She suffered from a burning in the chest, diarrhea, vomiting, 
restlessness, nervousness, labored breathing, abdominal pain, and uterine 
hemorrhaging. Death occurred 44 hours after the accidental administration 
of ethylene dibromide. Autopsy showed signs of upper respiratory tract
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irritation, swelling of the pulmonary lymph glands, advanced stages of 
muscular degeneration in the heart, liver, and kidneys, and hemorrhages in 
the trachea and along the mediastinum.
Pflesser [24] reported an incident in which a seaman spilled some 
ethylene dibromide-containing fluid into his boots but did not remove them. 
Blistering appeared on both feet some hours later, but no vascular or 
neurogenic disturbances were evident. The author discovered that ethylene 
dibromide was the active component of the fluid by subjecting himself and 
volunteers to the fluid and to each individual component. Covering the 
application site increased the severity of the reaction, with a very 
painful inflammation developing in 15-20 hours that included reddening, 
swelling, and blistering. He observed that a moderately strong, painful, 
local glandular swelling occurred after he had subjected himself to 
repeated doses of ethylene dibromide on the forearm. Swelling was not 
limited to the most recent application site, but appeared at all sites 
previously exposed; Pflesser, therefore, concluded that a sensitization
reaction to ethylene dibromide had developed.
Olmstead [25] described the only reported fatality from ethylene
dibromide ingestion in a case report of a 43-year-old woman who 
accidentally ingested about 140 mg/kg of ethylene dibromide. Immediately 
after swallowing the capsules, she began vomiting, and this recurred
periodically until just prior to death. Other symptoms of toxic effects 
included diarrhea, anuria, tachypnea, marked nervous agitation, abdominal 
pain, nausea, systolic heart murmurs, sinus tachycardia, and a weak, 
sporadic pulse. Death occurred 54 hours after ingestion. Autopsy showed 
lung edema and congestion, reddening of the intestinal mucosa, massive
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centrilobular liver necrosis, and damage to the tubular epithelium of the 
kidneys.
Adverse effects resulting from exposure of experimental animals to 
ethylene dibromide are similar to those described for human exposures and 
include ocular, dermal, and respiratory irritation and systemic effects on 
the liver, kidneys, spleen, circulatory system, and nervous system.
The effects of ethylene dibromide exposure on the eyes have been 
noted in several animal species. Merzbach [31] discovered that a dog
exposed for 1 hour to 1 ml (2.2 g) of ethylene dibromide vaporized into a 
100-liter chamber showed signs of ocular irritation during the exposure. 
Five hours after the exposure ended, a milky-blue corneal opacity developed 
which became more pronounced and developed into purulent conjunctivitis in 
both eyes and an ulcer in one eye. Kochmann [23] showed that 100 ppm (770
mg/cu m) of ethylene dibromide for 30 minutes/day produced conjunctivitis
in cats exposed to the vapor repeatedly until death occurred at 
approximately 10 days. Rowe et al [33] reported that instillation of 
undiluted ezhylene dibromide into the eyes of rabbits caused conjunctival 
izritation that cleared within 48 hours and left only very slight
superficial corneal necrosis which healed completely. Rowe et al [33] also 
found that a 10% solution of ethylene dibromide in propylene glycol 
produced a more severe reaction in the eye than did the undiluted material. 
Moderate conjunctival and corneal irritation developed and persisted for 48 
hours; healing was complete within 12 days without corneal scarring. A 1% 
solution produced an effect similar to that caused by the undiluted 
material. These reports indicate that ethylene dibromide can cause adverse
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ocular effects after exposure to 1 and 10% solutions, as well as to the 
undiluted material.
The skin of experimental animals is susceptible to penetration and 
local surface effects resulting from exposure to ethylene dibromide. 
Thomas and Yant [27] noted that liquid ethylene dibromide at doses of 0.25, 
0.50, and 1.0 ml (0.55, 1.1 and 2.2 g)/animal produced marked hyperemia of 
the small cutaneous blood vessels of the shaved abdomens of rats. All 
animals died within 6-18 hours after application. Rowe et al [33] found 
that undiluted ethylene dibromide or a 10% solution in butyl carbitol 
acetate killed within 24 hours all rabbits to which it was applied 
dermally; subsequent experiments showed that the dermal LD50 was about 400 
mg/kg. Marked erythema and edema were noted when the material was 
prevented from evaporating from the skin, whereas only slight erythema was 
noted when evaporation was not inhibited. Undiluted doses of about 210 
mg/kg produced a moderate-to-severe erythema, edema, and necrosis of the 
skin. Similar results were described by Pflesser [24] in human volunteers 
exposed to 0.5 ml (1.1 g) of liquid ethylene dibromide for 1-30 minutes by 
placing small quantities on their arms or hands. Confinement produced more 
extensive erythema and edema surrounding the application site, and, in one 
case, blistering occurred as a result of continued contact between ethylene 
dibromide and the skin. These investigations indicate that localized 
surface effects on the skin, such as erythema, edema, blistering, or 
necrosis, may occur after contact with either undiluted or 10% solutions of 
ethylene dibromide. Percutaneous absorption of 10% solutions has also 
caused death in experimental animals.
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Respiratory irritation after single exposures to ethylene dibromide 
vapor has been reported in guinea pigs at concentrations of 8,000 ppm 
(61,600 mg/cu m) for 30 minutes, 4,000 ppm (30,800 mg/cu m) for 60 minutes, 
and 2,000 ppm (15,400 mg/cu m) for 150 minutes [27], and in cats exposed at 
100 ppm (770 mg/cu m) for 30 minutes [23]. In cats, three 30-minute 
exposures at 100 ppm (770 mg/cu tn) produced signs of nasal irritation that 
consisted of a strong reddening of the nasal mucosa [23]. Lucas [28] 
demonstrated that a 12-minute exposure of a rabbit to ethylene dibromide 
vapor caused the lungs to become enlarged and filled with a frothy exudate. 
Merzbach [31] found that 5 ml (11.0 g) of ethylene dibromide allowed to 
vaporize in a 100-liter chamber produced severe bleeding in the right lung 
of a dog exposed for 1 hour. Another dog exposed to the vapor of 1 ml (2.2 
g) for 1 hour developed severe hyperemia and bronchopneumonic foci in both 
lungs. Rowe et al [33] showed that death occurring in rats exposed to 
ethylene dibromide at concentrations of 100-10,000 ppm (770-77,000 mg/cu m) 
for 0.02-16.0 hours was caused by respiratory or cardiac failure at the 
higher exposures and by pneumonia at the lower ones. The lungs of animals 
exposed at these concentrations were congested, edematous, hemorrhagic, and 
inflamed.
Respiratory irritation has also been noted after the repeated 
inhalation exposure of cats at 100 ppm (770 mg/cu m) to ethylene dibromide 
for 30 minutes daily for an average of 10 days. This concentration 
produced dark red discolorations in the lungs, and the lungs were partially 
nonfunctional [23]. Rowe et al [33] reported on lethal dose rates in rats 
exposed to ethylene dibromide for 0.02-16.0 hours at concentrations of 100-
10,000 ppm (770-77,000 mg/cu m). Death was caused by respiratory or
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cardiac failure at the higher concentrations and by pneumonia at the lower 
ones. Half of the male rats exposed at 25 ppm (192.5 mg/cu m) for 7 
hours/day for 151 exposures in 213 days died during the experiment, 
primarily from pneumonia and upper respiratory tract infection. Pulmonary 
infections were also responsible for a 50% mortality in male guinea pigs 
and a 25% mortality in females exposed at 25 ppm (192.5 mg/cu m) for 7 
hours/day for 145 exposures in 205 days [33].
Systemic parenchymal cell damage, particularly in the liver, kidneys, 
and spleen, develops after single and repeated exposure of experimental 
animals to ethylene dibromide vapor. Thomas and Yant [27] observed that 
guinea pigs receiving single exposures of ethylene dibromide vapor at 
concentrations of 8,000 ppm (61,600 mg/cu m) for 30 minutes, 4,000 ppm 
(30,800 mg/cu m) for 60 minutes, or 2,000 ppm (15,400 mg/cu m) for 150 
minutes had a slight granular degeneration of the parenchymal tissue of the 
liver. Rabbits exposed to an unknown concentration of ethylene dibromide 
vapor for 10 or 12 minutes had enlarged livers, with slight-to-moderate 
diffuse fatty changes evident in the rabbit exposed for 10 minutes [28]. 
Merzbach [31] published a study detailing similar results in a dog exposed 
to 1 ml (2.2 g) of vaporized ethylene dibromide in a 100-liter chamber for 
1 hour; autopsy showed that a pronounced fatty degeneration of the liver 
had occurred. Rowe et al [33] observed that rats exposed at 100-10,000 ppm 
(770-77,000 mg/cu m) of ethylene dibromide for 0.02-16.0 hours developed 
cloudy swelling, centrilobular fatty degeneration, and necrosis of the 
liver. Repeated exposure at approximately 100 ppm (770 mg/cu m) for 30 
minutes/day for up to 10 days caused incipient fatty degeneration in the 
liver of cats [23]. According to Rowe et al [33], rats exposed to 100 ppm
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(770 mg/cu m) of ethylene dibromide for 7 hours/day for seven exposures in 
9 days had a cloudy swelling of the liver, whereas rabbits exposed to the 
same concentration for three or four exposures had widespread central fatty 
degeneration and some necrosis of the other cells of the liver. Rowe et al 
[33] reported that slight central fatty degeneration of the liver developed 
in guinea pigs repeatedly exposed to 50 ppm (385 mg/cu m) of ethylene 
dibromide for 7 hours/day for 57 exposures in 80 days and in monkeys 
repeatedly exposed to the same concentration for 49 times in 70 days.
Renal damage, in the form of pronounced granular degenerative changes 
in the parenchymal tissues, occurred in guinea pigs exposed to ethylene
dibromide at concentrations of 8,000 ppm (61,600 mg/cu m) for 30 minutes,
4,000 ppm (30,800 mg/cu m) for 60 minutes, or 2,000 ppm (15,400 mg/cu m) 
for 150 minutes [27]. Rowe et al [33] demonstrated that the kidneys of 
rats exposed at 100-10,000 ppm (770-77,000 mg/cu m) of ethylene dibromide 
vapor for 0.02-16.0 hours showed slight interstitial congestion and edema, 
with slight cloudy swelling of the tubular epithelium in some cases.
Repeated exposures at approximately 100 ppm (770 mg/cu m) for 30
minutes/day for an average of 10 days in cats produced a swelling and
discoloration of the kidneys and possibly a slight degeneration of the
tubules [23]. Rowe et al [33] reported that repeated exposure of guinea 
pigs at 50 ppm (385 mg/cu m) of ethylene dibromide for 7 hours/day for 57 
times in 80 days produced a slight interstitial congestion and edematous 
condition in the kidneys which was accompanied by degeneration of the 
tubular epithelium. From these data, it can be concluded that renal damage 
can occur in experimental animals after exposure to single or repeated 
exposures of ethylene dibromide.
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Adverse splenic effects have been seen in experimental animals after 
exposure to ethylene dibromide. Single exposures of ethylene dibromide at
8,000 ppm (61,600 mg/cu m) for 30 minutes, 4,000 ppm (30,800 mg/cu m) for 
60 minutes, or 2,000 ppm (15,400 mg/cu m) for 150 minutes produced a slight 
granular degeneration of the parenchymal tissue in the spleen of guinea 
pigs [27]. Rats exposed to 0.25, 0.50, or 1.0 ml (0.55, 1.1, or 2.2 g) of 
ethylene dibromide applied on the abdomen died within 6-18 hours; autopsy 
showed that the spleens of these animals were highly congested and 
edematous [27]. Kochmann [23] noted a slight enlargement of the spleens of 
cats exposed at 100 ppm (770 mg/cu m) of ethylene dibromide for 30 
minutes/day for an average of 10 days. Rowe et al [33] observed that rats 
receiving seven exposures to ethylene dibromide at 100 ppm (770 mg/cu m), 7 
hours/day, for 9 days developed a slight congestion of the spleen and some 
hemosiderin deposition. The results from these experiments indicate that 
adverse effects to the spleen can occur after exposure to ethylene 
dibromide by inhalation or by percutaneous absorption.
Cardiovascular system effects have been noted in experimental animals 
subjected to single or multiple exposures of ethylene dibromide. 
Concentrations of 8,000, 4,000, and 2,000 ppm (61,600, 30,800, and 15,400 
mg/cu m) of ethylene dibromide for 30, 60, and 150 minutes, respectively, 
produced a slight granular degeneration of the muscular tissue of the heart 
and a generalized interstitial edematous degeneration of the endothelial 
lining in the abdominal vascular system in guinea pigs [27]. Merzbach [31] 
exposed a dog to the vapor of 5 ml (11.0 g) of ethylene dibromide in a 100- 
liter chamber for 1 hour and found subendocardial hemorrhages; a dog 
exposed to 1 ml (2.2 g) of ethylene dibromide under the same conditions
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developed a thrombus in the heart. Subsequent in vitro experiments with 
isolated frog hearts produced deleterious effects on the heart rate, 
causing cardiac arrest without recovery at 800 ppm [31]. Kochmann [23] 
postulated that death resulting from exposure of cats and rabbits at 50-100 
ppm (385-770 mg/cu m) of ethylene dibromide for up to 22 days was caused by 
injury to the circulatory system, especially to the heart and blood 
vessels. Rowe et al [33] also concluded that deaths occurring at the 
higher concentrations after exposure of rats at 100-10,000 ppm (770-77,000 
mg/cu m) of ethylene dibromide for 0.02-16.0 hours were caused by cardiac 
or respiratory failure.
Few studies have specifically addressed the potential of ethylene 
dibromide to adversely affect the CNS. Rowe et al [33] reported that CNS 
depression was observed at the higher concentrations in rats exposed to 
100-10,000 ppm (770-77,000 mg/cu m) for 0.02-16.0 hours, but did not 
further elucidate the nature of the effects. Rowe et al [33] also observed 
marked CNS depression in rabbits when ethylene dibromide was applied 
dermally at doses of 210, 300, 650, and 1,100 mg/kg. CNS effects, such as 
agitation [23], restlessness [31], body tremors [23,31] or unconsciousness 
[31], have been mentioned in various papers, but not in sufficient detail 
to enable a conclusive evaluation to be made to determine their validity or 
relevance.
Carcinogenicity, Mutagenicity, Teratogenicity, and Effects on Reproduction
Quantitative data that indicate a nonhazardous concentration for 
exposure to ethylene dibromide have not been found.
Abnormalities in the reproductive process have been demonstrated in
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bulls [41-43], rats [9], and chickens [44-46]. Newborn, young adult, and 
mature adult bulls receiving an average of 2 mg/kg/day of ethylene 
dibromide for various periods in their development exhibited abnormalities 
in their reproductive systems, including the production of abnormal 
spermatozoa [41-43], decreased spermatozoic motility [41], and decreased 
spermatozoic count [41]. Abnormal spermatozoa with various degrees of 
degeneration and malformations, such as coiled tails, pyriform heads, and 
tailless spermatozoa, have been reported in semen from experimental bulls 
receiving ethylene dibromide for 14-16 months [41]. These reproductive 
abnormalities were reversible after administration of ethylene dibromide 
was discontinued, but reinstatement produced recurring effects that 
persisted longer after discontinuing administration again [41]. 
Experiments with bulls receiving 4 mg/kg on alternate days for 7 or 10 
doses showed that the abnormal spermatozoa were present in both the 
epididymis and testes after 7 doses. After 10 doses, abnormal spermatozoa 
constituted 67% of the population in the ductus deferens and 77% of the 
ejaculate, with almost all the abnormal spermatozoa exhibiting tail and 
acrosomal defects [42] . These spermatozoic abnormalities may lead to a 
decrease in the fertility of the bulls and might induce sterility if they 
continued long enough, although reports have not been found that 
experimentally test this hypothesis. In rats, ip injections of ethylene 
dibromide at a dose of 10 mg/kg for 5 days produced a decrease in the 
average live litter size in female rats mated with experimental males [9]. 
This decrease in fertility occurred during the 3rd and 4th weeks following 
administration, which corresponds to the maturation cycle of spermatids in 
the genital tract of rats. This finding, which corresponds with the
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findings of the reports of spermiogenic impairment in bulls, supports the 
postulated sterilizing effect discussed above. It is important to point 
out that reports have not been found delineating a no-effect level for the 
reproductive system abnormalities caused by the repeated administration of 
ethylene dibromide to bulls.
In chickens, the function of the female reproductive system is 
impaired by ethylene dibromide exposure [44-46], but the male system 
appears to be unaffected [45]. Cockerels fed 300 ppm of ethylene dibromide 
for 12 months showed significant growth retardation at 12 weeks of age; 
however, semen collected between 9 and 12 months did not differ from 
control semen, and body and testicular weights were comparable with those 
of controls [45]. Semen collected between 2 and 10 weeks from cockerels 
fed 300 ppm for 105 days showed no significant differences when compared 
with control semen with respect to ejaculated volume and spermatozoic 
motility and concentrations. Subsequent fertility tests at 60 or 105 days 
in hens gave no significant differences in fertilization rates or 
hatchability of eggs. These results indicate that the reproductive system 
in male chickens was not detectably affected by ethylene dibromide under 
these experimental conditions. This is in contrast to the effects reported 
in two mammalian species, cattle and rats, in which definite impairments of 
the male reproductive system have been noted.
Laying hens fed grain containing 10-40 ppm of ethylene dibromide for 
approximately 4-5 months were found to have a reduction in the weight of 
eggs laid [44,45]. A cessation of egg laying was observed when hens were 
fed 180-320 ppm of ethylene dibromide for 46-56 days [44], and a reduction 
in egg laying was observed when hens were fed 10 mg/day for 2 months [46].
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A striking reduction (12 versus 86% in the control) in the fertilization 
rate was seen in hens fed 100 ppm of ethylene dibromide for 4 weeks; all 
embryos in the eggs from the experimental group were dead [45] . These 
results indicate that the female reproductive system in chickens is 
affected by ethylene dibromide. Although no reports have been found that 
explore the potential of ethylene dibromide to affect fertility in females 
of mammalian species, the avian data suggest the potential of ethylene 
dibromide to impair female fertility. However, until experiments are 
conducted with mammalian species to assess this potential, extrapolation 
of the effects seen in chickens to mammals and humans must be uncertain.
There has been only one study concerning the potential of ethylene 
dibromide to induce cancer in rats and mice [56-59]. In this study, rats 
and mice were given the maximum tolerated dose (80 mg/kg for rats, 120 
mg/kg for mice) and one-half the maximum tolerated dose by daily intubation 
for 54 or 62 weeks, except when toxicity forced the total discontinuation 
of administration or reduction of the maximum tolerated dose to that of 
one-half the maximum tolerated dose during the experiment. The tumors 
(squamous cell carcinomas), which were first noted during the 10th week of 
ethylene dibromide administration in rats, originated in the forestomach, 
invaded locally, and metastasized throughout the abdominal cavity. The 
fraction of animals with tumors was greater in the male rats than in the 
females (an average of 83% of the males developed tumors versus 70% of the 
females), and was greater at the lower dose than at the higher dose in rats 
at the termination of the experiment at 54 weeks (98 versus 68% in males 
and 82 versus 58% in females, respectively). The concurrent control 
populations did not develop squamous cell carcinomas of the stomach. The
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fraction of mice that developed squamous cell carcinomas was 74% in males 
and 72% in females by the termination of the experiment at 90 weeks [57].
The irregularities in the dose regimens of both species, the use of 
the suggested maximum tolerated dose, and the route of administration do 
not negate the importance of the fact that ethylene dibromide has induced 
carcinomas in two mammalian species. The data from this single study 
indicate that ethylene dibromide is a carcinogen after daily introduction 
of about one-half the maximum tolerated dose into the stomach of rats and 
mice for up to 62 weeks.
The mutagenic potential of ethylene dibromide has been established in 
a wide spectrum of procaryotic and eucaryotic mutational test systems. It 
has induced mutations in vertebrate cell cultures [62], insects [6], 
bacteria [60,63,64], plants [66], and fungi [67,68]. It has induced 
mutations or mutagenic events in a number of experimental test systems, 
including the recessive lethal test in Drosophila melanogaster [6], the 
host mediated assay in mice with Salmonella typhimurium [60], and a 
backward mutation system with mouse lymphoma cells [62]. In addition, 
positive mutagenic induction has been reported in tests with back 
mutational systems in certain strains of Salmonella typhimurium [60,63,64]. 
Ethylene dibromide has also been reported to have given negative results in 
the dominant lethal test in mice [61] and in the back mutational test 
system with Serratia marcescens in the host mediated assay [60].
The dominant lethal test conducted in male mice given 50 or 100 mg/kg 
of ethylene dibromide for 5 consecutive days by oral intubation or given 18 
or 90 mg/kg by ip injection did not induce a significant increase in the 
number of dead implants when compared with controls [61], although specific
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data were not presented for evaluation. Buselmaier et al [60] reported 
that ethylene dibromide was mutagenic in the host mediated assay with 
Salmonella typhimurium G46 at a dose of 500 mg/kg injected subcutaneously 
in mice and in vitro with the same organism at an equivalent dose. The 
mutational frequency for the experimental group was significantly (P<0.01) 
different from the control mutational frequency. The positive results in 
the in vivo and in vitro tests indicate that metabolic activation is not 
necessary for ethylene dibromide to exert its mutagenic effects and that 
metabolic deactivation does not reduce the mutagenic effect. Buselmaier et 
al [60] reported that a similar in vivo test with Serratia marcescens, also 
a back mutational test system, was negative; this finding may only indicate 
that species differences exist in reactions with ethylene dibromide.
In a recessive lethal test with Drosophila melanogaster, Vogel and 
Chandler [6] reported that 0.3 mM of ethylene dibromide fed to adult males 
for 3 days induced significant numbers of recessive lethal mutations in the 
offspring of three successive broods. The brood patterns resulting from 
ethylene dibromide exposure indicated that ethylene dibromide affected 
spermatozoic maturation more than spermatozoic formation. The authors 
considered ethylene dibromide typical of a bifunctional alkylating agent 
and capable of introducing cross-links into biologic molecules.
A mammalian somatic cell tissue culture of L5178Y mouse lymphoma 
cells was exposed to 0.0-3.0 mM of ethylene dibromide in culture media 
[62]. The induced mutagenic frequency was dose related, typical of other 
alkylating agents tested, and approximately equivalent to a dose of 600 R 
of X-irradiation at the highest concentration. Meneghini [5] noted that 
ethylene dibromide very effectively induced DNA repair synthesis in opossum
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lymphocyte cell cultures at concentrations between 0.001 and 1 iriM but 
decreased at 10 mM. Only compounds that interact with DNA through covalent 
bonds induce repair synthesis; therefore, ethylene dibromide is typical of 
other alkylating agents in forming covalent bonds with DNA.
Bacterial and other plant systems have also been used to show the 
mutagenic potential of ethylene dibromide. Ames [63] reported that 
ethylene dibromide induced mutations in two backward mutation test strains 
of Salmonella typhimurium, his G46 and TA 1530, at a concentration of 5 
/il(11.0 mg)/plate. Brem et al [64] observed similar positive results in 
Salmonella TA1530 and TA1535 at 10 juM/plate. Ethylene dibromide did not 
induce mutations in the frame shift indicator strain, Salmonella 
typhimurium TA 1538 [64], indicating that the action exerted by ethylene 
dibromide in inducing mutations is not through frame shifts during the 
reading of the genetic code, but rather is through cross-linking and 
covalent bonding with DNA. Sparrow et al [66] published that ethylene 
dibromide was highly mutagenic in a plant system, Tradescantia clone 4430. 
A linear relationship for mutation responses over the range of 3.6-148.2 
ppm (27.72-1,141.14 mg/cu m) was observed, with a well-defined dose 
response occurring with exposures as low as 3.6 ppm (27.72 mg/cu m) for 6 
hours.
The ability of ethylene dibromide to induce mutations in a wide 
variety of test systems is suggestive of its potential to induce mutations 
in human populations, but there is no evidence available to enable an 
adequate assessment of the quantitative aspects of the relative risks for 
human populations. Since ethylene dibromide is a bifunctional alkylating 
agent, the most plausible basis for the induction of mutations in these
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systems is the covalent bonding of ethylene dibromide to the genetic 
material, DNA. The linear relation between the number of induced mutations 
and the concentration of ethylene dibromide in Tradescantia [66] is 
consistent with the idea of covalent bonding between ethylene dibromide and 
DNA.
Only one study pertaining to the potential of ethylene dibromide to 
induce fetal anomalies has been found [69]. Fetuses from pregnant mice and 
rats exposed to approximately 31.6 ppm (243.32 mg/cu m) of ethylene 
dibromide for 23 hours/day during days 6-15 of gestation were significantly 
different from fetuses of pregnant control mice and rats. These 
differences include costal anomalies and hydrocephaly in rat fetuses, and 
additional anomalies in other ossification processes in mice fetuses. 
Fetuses from control mice fed a feed-restricted diet during the experiment 
to simulate malnourishment exhibited some of the effects found in ethylene 
dibromide-exposed mice fetuses; however, the frequency of the type and 
number of anomalies formed in the malnourished group was reduced, but the 
degree of significance was not as great as that found in the ethylene 
dibromide-exposed mice fetuses. Although it can be argued that the effects 
produced by ethylene dibromide exposure are similar in part to those 
produced by malnourishment, the anomalies in both rat and mouse fetuses 
from ethylene dibromide-exposed dams were significantly different from 
those produced by malnourishment alone when both were compared with those 
found in fetuses from control dams. From these data, it is evident that 
ethylene dibromide caused fetal abnormalities in mice and rats that were 
not caused by malnourishment alone.
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In summary, it is concluded from the data from human and experimental 
studies that the adverse systemic effects resulting from exposure to 
ethylene dibromide may include ocular, dermal, and respiratory irritation, 
in addition to systemic effects on the liver, kidneys, spleen, 
cardiovascular system, and nervous system. Although dose-response 
relationships or no-adverse-effect levels have not been established for 
ethylene dibromide, experimental data from animals strongly suggest that 
exposure to ethylene dibromide may induce 'sterility, malformations and 
heritable damage in offspring, and cancers in these systems.
Summary Tables of Exposure and Effect
The effects of short- and long-term exposures to ethylene dibromide 
in humans and animals which were presented in detail in Chapter III are 
summarized in Tables III-2, III-3, III-4, III-5, and III-6. Human data 
appear in Table III-2, general animal toxicity data appear in Table III-3, 
carcinogenic animal data appear in Table III-4, mutagenic data appear in 














70 g Vomiting, abdominal pain, diar­
rhea, difficulty in breathing, 
restlessness, nervousness, diz­
ziness, death by 44 hr
22
ft Unknown Irritation of conjunctiva, 
swelling of eyelids and glands 
under chin
23
Dermal 0.5 ml* 
30 min
Painful inflammation, swelling, 
and blistering of skin
24
Tt 0.5 ml* 
10 min
Heat sensation, slight burning, 
painful swelling and reddening 
of skin for next 24 hr
24
tl 0.5 ml* 
30 min
Swelling, reddening, and itch­




Painful burning of feet with 
reddening and blisters between 
toes
24
Oral 140 mg/kg 
1  dose
Vomiting, abdominal pain, diar­
rhea, nausea, anuria, death by 
54 hr
25
*Skin was washed with soap and water after the exposure. 
**Unknown quantity mixed with gauge fluid.
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TABLE III-3
SUMMARY OF EFFECTS OF ETHYLENE DIBROMIDE EXPOSURE IN ANIMALS
Route of
Admin- Concentration Ref-
istration Species and Duration Observed Effects erence
Respi­
ratory
Rats 100 ppm 
7 hr/d 
x 7 exposures 
in 9 d
Weight loss, increased 
weight of kidneys , lungs, 
and liver; cloudy swell­
ing of liver and conges­
tion of spleen; lung ir­





























Increased weight of kid­
neys, lungs, and liver; 




No adverse effects 
reported
Weight loss; decreased 
rate of growth; conges­
tion and parenchymatous 
degeneration of kidneys; 
fatty degeneration 
of liver
6/16 deaths because 
of pulmonary infections



















Rabbits 100 ppm 
7 hr/d 
2-4 d
Fatty degeneration of 
liver, 3/4 deaths
33
I I I t 50 ppm 
7 hr/d 
x 59 exposures 
in 84 d
Small increase of liver 
and kidney weights
33
f t I I 25 ppm 
7 hr/d 
x 152 exposures 
in 214 d
No adverse effects 
reported
33
I t Monkeys 50 ppm 
7 hr/d 
x 49 exposures 
in 70 d




I t I t 25 ppm 
7 hr/d 
x 156 exposures 
in 220 d
No adverse effects 
reported
33
Dermal Rabbits 1,100-210 mg/kg 
24 hr
CNS depression, erythe­





SUMMARY OF CARCINOGENIC EFFECTS 











80 mg/kg/d Squamous cell carcino­ 56
5 d/wk mas of the stomach in
x 16 wk, then 68% of males and in 58%
no dose for of females; total dosage
14 wk, then of 11.2 g/kg
40 mg/kg/d
x 24 wk
40 mg/kg/d Squamous cell carcino­ 56
5 d/wk mas of the stomach in
54 wk 98% of males and in 82%
of females; total dosage
of 10.8 g/kg
120 mg/kg/d Squamous cell carcino­ 56
5 d/wk mas of the stomach in
x 13 wk, then 73%; 40/100 deaths
200 mg/kg/d
x 2 wk, then
120 mg/kg/d
x 27 wk
60 mg/kg/d Squamous cell carcino­ 56
5 d/wk mas of the stomach in
x 13 wk, then 73%
100 mg/kg/d





SUMMARY OF MUTAGENIC EFFECTS OF ETHYLENE DIBROMIDE
Species
or
System Strain Dose Results i
Ref-
srence
Salmonella G 46 5 Ml Positive mutagenic response 63
typhimurium TA 1530 by reversion of growth 
deficiency







Base substitution mutation 
for TA 1530 and TA 1535, no 
frame-shift mutation for 
TA 1538
64
Escherichia pol A+ 10 Ml Damage to cellular DNA and 64
coli pol A- X 8 hr growth inhibition of pol A-, 
preferential to A+
Salmonella LT 2 1-5 a»1 No long deletions of chromo­ 65








500 mg/kg Host mediated assay compared 
to in vitro indicate no 
metabolic activity is neces­
sary for ethylene dibromide 











L5178Y 0.0-3.0 mM Mutational frequency equiva­
lent to 600 R of X-irradi- 





- 0.001-1 mM 
X 1 hr







Induction of significant 
number of recessive lethal 
mutations
6





TERATOGENIC AND OTHER REPRODUCTIVE EFFECTS 
OF ETHYLENE DIBROMIDE IN ANIMALS
Route of
Adminis- Concentration Ref-
tration Species and Duration Observed Effects erence


























Abnormal spermatozoa in 42 
testes, epididymis, 





Decreased weight and 44
number of eggs, cessa­
tion of egg laying af­
ter 46-56 d and lasting 
for several months af­
ter exposure ended
Decreased growth, feed 45
intake, and comb weight ; 
normal fertilization 
rate and weight gain
Decreased egg weight 45
and fertilization rate
Anorexia, general de- 40
pression, liver conges­
tion, crop inflammation, 
excess pericardial 




TERATOGENIC AND OTHER REPRODUCTIVE EFFECTS 





and Duration Observed Effects
Ref­
erence
Oral Chickens 40 ppm 
twice daily 
4.5-5 mon
Decreased weight and 
number of eggs
45
ip Rats 10 mg/kg/d 
5 d
Decreased average size 
of live litter in 
females mated after 
3 wk of exposure; no 




11 31.6 ppm 
on d 6-15 of 
gestation
Decreased number of im­
plants/dam, live fetus­
es/dam, % of viable fe­
tuses , and % of early 
resorptions; hydroceph­
aly of fourth ventricle, 
decreased incidence of 
14th pair of ribs, wavy 
ribs
69
11 Mice 31.6 ppm 
on d 6-15 of 
gestation
Decreased live fetal 
weights, no ossifica­
tion of incus, incom­
plete ossification of 
supraoccipital, varia­
tion in ossification 
of sternabrae
69
*Adapted from reference 43 and D Amir (written communication, August 1976)
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IV. ENVIRONMENTAL DATA AND ENGINEERING CONTROLS
Environmental Concentrations
Little information has been found on concentrations of airborne 
ethylene dibromide in industrial or ambient air. In 1975, the 
Environmental Protection Agency (EPA) [19] reported measurements of 
atmospheric ethylene dibromide concentrations at selected sites near 
sources which were generally related to gasoline production, distribution, 
use, and manufacture of ethylene dibromide. Urban locations near major 
streets were selected in three Western cities to represent worst-case 
ambient concentrations of ethylene dibromide. Each site was within 200-300 
feet of 2 or more gasoline service stations and was located near roadways 
carrying traffic loads of 25,000-50,000 vehicles/day. At each site, tandem 
TENAX-GC adsorption tubes with the necessary collection assembly were 
directed into the wind and positioned 5-6 feet above the ground. The 
collection assembly consisted of a prefilter of 8 jum mean pore size, a 
drying tube packed with silica gel, a tandem adsorption train packed with 
TENAX-GC support material housed in a dry-ice chest, and a vacuum pump 
controlled by a critical orifice needle to maintain a constant flowrate of 
1 liter/minute. Adsorbed ethylene dibromide was extracted from the 
adsorbent with hexane and the hexane-ethylene dibromide mixture was stored 
in a freezer until analyzed. The analyses were performed by a gas-liquid 
chromatograph equipped with an electron capture detector capable of 
detecting as small a quantity of ethylene dibromide as 1-2 
picograms/injection. All samples were initially identified on a Carbowax 
20M column and further identified by analysis on a QF-1, DEGS, or OV-lOl
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column, although unequivocal characterization by an independent method of 
analysis was not done. The results of the urban study, presented below in 
Table IV-1, suggest that urban workers may be continually exposed to 
miniscule quantities of ethylene dibromide. The significance of such an 
exposure is not known at present.
TABLE IV-1
AMBIENT AIR CONCENTRATIONS OF ETHYLENE 
DIBROMIDE AT URBAN ROADWAY SITES
City Concentration
Mg/cu m PPb
Phoenix, Arizona 0.069 0.008
Los Angeles, California 0.11 0.013
Seattle, Washington 0.083 0.010
Adapted from reference 19
The concentration of airborne ethylene dibromide on the premises of 
an oil refinery ranged from 0.23 to 1.65 Mg/cu m (0.00023 to 0.00165 mg/cu 
m) at two locations 50-400 feet downwind of a bulk transfer and a tank 
truckloading operation [19]. Sampling and analytical methods were those 
described for the urban air study above. Atmospheric concentrations of 
ethylene dibromide measured at the production facilities of two major
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manufacturers were reported to be between maximum values of 90 and 115 
H g / c u m (0.090 and 0.115 mg/cu m) at downwind locations near the perimeters 
of the plant boundaries.
In 1975, the EPA [70] estimated the potential emission concentrations 
of ethylene dibromide from refueling losses and automotive evaporative or 
exhaust emission. In this report, both the most likely and worst-case
emission concentrations were calculated, using the average value of 0.9-1.3 
g of ethylene dibromide/gal of automotive fuel (one equivalent of organic 
bromine is added to gasoline for each two equivalents of lead added). The 
estimated emission rate for ethylene dibromide by measurement was reported 
to be 0.000063 g/g lead/gal. The reported losses for entrainment and
spillage each were 0.000047 g/g lead/gal. Thus, the total loss because of 
refueling was reported to be 0.000157 g/g lead/gal. Evaporative losses 
were calculated to be 0.00014 g/g lead/gal from the automobile fuel tanks. 
The most likely estimate of loss from the carburetor was 0.0016
g/g lead/gal, whereas the worst case was 0.0043 g/g lead/gal. Exhaust 
emissions were also calculated, the most likely being 0.0065 g/g lead/gal 
and the worst case being 0.3 g/g lead/gal. Summarizing the three types of 
emissions, the total emissions calculated for refueling, evaporation, and 
exhaust was most likely 0.008397 g/g lead/gal and the worst case, 0.304597 
g/g lead/gal. The total emissions can also be estimated directly in terms 
of ethylene dibromide by expressing the relative percentages of ethylene 
dibromide/lead in a gallon of gasoline. Usually, a gallon of leaded
gasoline contains between 1.9 and 3.0 g of lead/gal [70]. Therefore, the
total ethylene dibromide emissions would calculate to 0.02099 g/gal for the 
most likely situation and to 0.76149 g/gal for the worst-case situation,
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assuming an average lead content of 2.5 g/gal [70], Therefore, NIOSH 
estimates that between 21 and 761 mg of ethylene dibromide may be released 
to the environment for every gallon of gasoline sold.
The Dow Chemical Company [71] submitted information from limited 
studies on the exposure of gas station operators to ethylene dibromide 
during their work that indicated that these workers were exposed to about 7 
ppb (0.054 mg/cu m) while near the gas pump and had an 8-hour time-weighted 
average (TWA) exposure of about 5 ppb (0.038 mg/cu m). The 8-hour TWA 
concentration for garage mechanics was 3 ppb (0.023 mg/cu m). No further 
information or data were given in the submission.
Ethyl Corporation submitted data from personal and area monitoring by 
job classification for its ethylene dibromide-manufacturing plant at 
Magnolia, Arkansas, and provided a description of the sampling and 
analytical methods used [15]. Personal monitoring was conducted with a 
calibrated, battery-operated pump and charcoal collection tubes. The 
method for area monitoring was not specified. Carbon disulfide was used to 
desorb the ethylene dibromide, and the subsequent analyses were conducted 
in a gas-liquid chromatograph equipped with a flame ionization detector. 
Sampling times varied from 147 to 397 minutes and actual exposure 
concentrations ranged from 0.02 to 3.47 ppm (0.154 to 26.72 mg/cu m) of 
ethylene dibromide. The results of this monitoring are summarized in Table
IV-2.
Ethyl Corporation also submitted environmental monitoring results for 
various worksites within its Magnolia manufacturing plant and within its 
blending plant at Baton Rouge, Louisiana [15]. Sampling times ranged from 
129 to 309 minutes and ethylene dibromide concentrations varied from
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nondetectable to 18.25 ppm (140.525 mg/cu m). The results of this survey 
are presented in Table IV-3. For the most part, the environmental 
concentrations were lower in the blending plant than in the manufacturing 
plant, and within each plant, specific worksites had consistently lower 
concentrations than others. Samples taken at worksites where ethylene 
dibromide was unloaded, transferred, or stored, or where maintenance of 
process vessels was being done, were consistently higher than samples taken 
around the manufacturing or blending equipment itself.
E. I. du Pont de Nemours and Company submitted similar data from its 
blending facility in Deepwater, New Jersey [15]. The results of this 
survey are summarized in Tables IV-4 and IV-5.
These environmental and personal monitoring data suggest that current 
industrial operating procedures may maintain workplace air concentrations 
of ethylene dibromide substantially below the current federal standard 
8-hour TWA concentration of 20 ppm.
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TABLE IV-2
ETHYLENE DIBROMIDE CONCENTRATIONS BY
PERSONAL MONITORING AT ETHYL CORPORATION
Sample Reported
Job Function Date Time Concentration
(min) ppm mg/cu m
EDB control room operator 01/19/76 319 0.16 1.23
01/20/76 397 0.69 5.31
01/21/76 332 0.23 1.77
01/21/76* 234 0.44 3.39
01/22/76 313 0.225 1.73
01/23/76 201 0.42 3.23
Vinyl bromide control 01/19/76 314 0.10 0.77
room operator 01/20/76 270 0.02 0.15
01/21/76 319 0.14 1.08
01/21/76* 217 <0.04 <0.31
01/22/76 352 0.06 0.46
Loaders of EDB or VBr** 01/19/76 250 1.31 10.09
01/19/76 241 1.64 12.63
01/20/76 365 0.22 1.69
01/20/76 204 1.67 12.86
01/21/76 386 0.39 3.00
01/21/76 208 0.06 0.46
01/22/76 293 0.045 0.35
01/22/76 221 0.04 0.31
01/23/76 191 1.85 14.24
01/23/76 180 1.57 12.09
Laboratory technician 01/19/76 121 3.47 26.72
(Plant chemist) 01/20/76 212 0.45 3.46
01/21/76 147 0.09 0.69
01/22/76 209 0.13 1.00
Production supervisor 01/22/76 250 0.04 0.31
*Denotes evening shift workers
**Load ethylene dibromide (EDB) or vinyl bromide (VBr), but at different 
times
Adapted from reference 15
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TABLE IV-3
ETHYLENE DIBROMIDE CONCENTRATIONS IN AIR BY









Reaction building 07/14/75 234 0.59 4.54
Bulk storage 07/15/75 257 3.90 30.03
EDB* load rack 07/16/75 180 0.41 3.16
EDB surge tank 07/16/75 129 0.47 3.62
Top EDB-Br2 building 07/17/75 265 0.05 0.38
West of VBr** reactor 01/19/76 257 0.23 1.77
Alumina scrubber area 01/20/76 248 18.25 140.52
by EDB building
East of VBr reactor 01/21/76 262 1.64 12.63
EDB storage area 01/21/76 265 1.40 10.78
East of VBr reflux pump 01/22/76 299 0.08 0.62
(by stairs)
Portapak purge area 01/22/76 309 - -
EDB surge (make) tank 01/23/76 208 4.81 37.04
Blending plant
Load rack 04/01/75 240 0.56 4.31
t l 04/18/75 274 0.21 1.62
t l 07/23/75 275 0.10 0.77
Pump house 04/18/75 268 0.30 2.31
t l 07/23/75 270 0.03 0.23
1st floor - blender tank 07/23/75 255 0.02 0.15
1st floor - blenders 07/09/75 247 <0.02 <0.15
2nd floor - blenders 07/09/75 249 0.04 0.31
3rd floor - EDB weigh 07/09/75 254 <0.03 <0.23
tank




Adapted from reference 15
127
TABLE IV-4
ETHYLENE DIBROMIDE CONCENTRATIONS 
BY PERSONAL MONITORING AT 
E. I. DU PONT DE NEMOURS AND COMPANY













Laboratory technician 02/24/75 <0.007 <0.05
Blender operator 11/05/75 <0.114 <0.88
Adapted from reference 15
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TABLE IV-5
ETHYLENE DIBROMIDE CONCENTRATIONS IN AIR BY
ENVIRONMENTAL MONITORING AT E. I. DU PONT DE NEMOURS AND COMPANY
Site Date Sample Time Reported Concentration
(min) ppm mg/cu m
Top of tank car 11/21/74 2.7 3.068 23.60(A)












Between blenders 3 & 4 08/12/74 - <0.001 <0 .01(C)
EDB* pumphouse 11/05/75 330.0 <0.046 <0.35
Chainer transfer 11/05/75 180.0 <0.118 <0.91
Top EDB tank 11/06/75 290.0 1.109 8.53(D)
Top of TS-8** 11/10/75 485.0 <0.034 <0.26
Compound bulk 5 feet 
above ground
11/10/75 490.0 <0.048 <0.37
*Ethylene dibromide
**Tank storage unit 8
(A) Breathing zone of workers
(B) 18 inches above ground during hookup, emptying, and disconnecting, re­
spectively
(C) Spot sample
(D) 2 cars unloaded into tank during sampling period 
Adapted from reference 15
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Sampling and Analytical Methods
(a) Sampling
Most analytical methods are dependent on the reproducibility and 
effectiveness of the adsorption of ethylene dibromide by the different 
collection media and the subsequent desorption, chemical treatment, or 
extraction efficiencies. Air samples are normally collected and 
transported to a laboratory where chemical treatment or desorption and 
analysis occur at a later time.
Liquid absorption media, such as a 1:1 mixture of monoethanolamine 
and dioxane, have been used as trapping solutions for ethylene dibromide 
[72,73]. This medium decomposes ethylene dibromide and many other 
brominated organic contaminants to inorganic bromide and, as such, is not 
specific for ethylene dibromide.
Porous polymer beads have been used as a collection medium for 
chlorinated and brominated hydrocarbons [74]. This procedure has not been 
tested specifically for ethylene dibromide but has been used successfully 
for closely related halogenated hydrocarbons; thus, it seems feasible that 
ethylene dibromide could also be collected by this method. The same column 
is used for sample collection and gas-liquid chromatographic analysis, but 
only one analysis can be made on each sample.
Silica gel has been used as a collection medium for ethylene 
dibromide [75]. One advantage of using a solid adsorbent is that sample 
loss cannot occur from spillage during sampling or in transit for analysis. 
However, silica gel is a polar adsorbent and shows pronounced selectivity 
in adsorbing polar molecules, particularly water [76]. Studies with silica 
gel tubes indicated that water vapor could displace organic molecules
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during a normal sampling operation [77]. Although similar studies have not 
been conducted for ethylene dibromide, it is reasonable to assume that 
similar displacement of significant quantities of ethylene dibromide by 
water vapor could occur.
Activated charcoal has been used as an adsorbent in conjunction with 
gas-liquid chromatography [78,79]. Charcoal is an excellent collecting 
medium because of its nonpolarity and its affinity for organic vapors and 
gases. As such, water vapor does not readily displace organic molecules as 
is the case with silica gel. However, adsorption and desorption 
efficiencies may vary with different batches of charcoal; therefore, it is 
necessary to determine the desorption efficiency for each new batch of
charcoal. Charcoal tubes containing as much as 600 mg of activated
charcoal are commercially available [1],
In the past several years, direct-reading instruments and devices 
have been developed which make continuous or "on-the-spot" monitoring of 
halogenated hydrocarbons, including ethylene dibromide, feasible. These 
devices, when properly calibrated and used within their performance
characteristics and limitations, can be helpful in monitoring airborne 
halogenated hydrocarbons [80]. Colorimetric indicator tubes are available 
from at least three sources [81-83] which provide semiquantitative
measurement in the range of 1-200 ppm, although no detector tubes have been 
certified as yet by NIOSH for response to ethylene dibromide. The use of 
infrared light absorption at a wavelength of 8.4 jum [84] is claimed to 
detect airborne ethylene dibromide at a concentration of 0.1 ppm. These 
direct-reading instruments are portable and also may be used as part of a 
multipoint sampling system for continuous, unattended monitors.
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Other sampling devices used for the collection of organic solvents 
and halogenated hydrocarbons may be adaptable to ethylene dibromide 
collection. These include sampling bottles [85], bubblers [86], and 
plastic bags [87,88]. No specific tests have been reported on the use of 
plastic bags for sampling ethylene dibromide. However, studies by Stewart 
et al [89], Smith and Pierce [90], and Calibrated Instruments, Inc, [91] 
indicate that halogenated hydrocarbons, such as vinyl chloride, 
dichloromethane, perchloroethylene, and trichloroethylene, may be 
successfully collected in plastic bags made of Saran, aluminimzed Scotch 
Pak, and Mylar. Sampling bags are commercially available with capacities 
ranging from approximately 0.5-96 liters. Although plastic bags have the 
disadvantage of being bulky when handled or transported to the analytical 
laboratory, they have the advantage of enabling samples of the collected 
air to be injected directly into the gas-liquid chromatograph, thus 
eliminating the need for sorbant materials, such as activated charcoal, 
alumina, and silica gel. Before actual field use can be evaluated, 
controlled laboratory experiments must be conducted to determine the 
effectiveness and practicality of these procedures.
(b) Analysis
Chemical analysis has been used to estimate ethylene dibromide 
concentrations in the collection media. Aeration has been used by Peterson 
et al [75] to desorb ethylene dibromide from the silica gel; pyrolysis of 
the free ethylene dibromide produced bromine and hydrobromic acid. These 
products were collected in a second absorption solution of 1% sodium 
carbonate and 1% sodium formate in deionized water and quantitated by 
titrimetric analysis of the inorganic bromide present. Aman et al [32]
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estimated the airborne ethylene dibromide concentration by absorbing the 
free ethylene dibromide with 1% sodium hydroxide and by quantitating the 
hypobromite formed iodometrically. Dumas [92] determined airborne ethylene 
dibromide concentrations by coulometric titration of sodium bromide after 
absorption of ethylene dibromide in methanolic sodium hydroxide and 
digestion by boiling under reflux for 15 minutes on a steam bath. These 
methods, like most chemical methods, require somewhat bulky apparatus and 
are not specific for ethylene dibromide since any aliphatic brominated 
compound will interfere and be included in the quantitative estimate.
Physicochemical methods have been developed or adapted to identify 
and quantitate concentrations of airborne ethylene dibromide. Christie et 
al [93] modified a refrigerant leak-detector lamp to detect organic halogen 
compounds, including ethylene dibromide, in the atmosphere at a minimum 
concentration of 5 ppm. The procedure is dependent on visual estimation of 
the intensity of a flame color in response to the vapor concentration and 
is not specific for ethylene dibromide.
Flame chemiluminescence has been reported by Crider [94] to detect 
ethylene dibromide concentrations in air of 0.03 ppm. This method has not 
been tested on mixtures of halogenated hydrocarbons, and it is too early in 
its development to enable prediction of the practicality of the method for 
area or personal monitoring in an occupational environment.
Other physicochemical methods have been developed for halogen 
compounds, but they have not been tested for identification and 
quantitation of ethylene dibromide. One of these methods, based on 
nitrogen enhancement of an AC spark, has been used for continuous 
measurement of halogenated compounds in field situations [95]. The
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instrument is lightweight, portable, fast-responding, and reportedly 
capable of detecting halogenated hydrocarbons in the ppm range. However, 
until testing with ethylene dibromide has been conducted, the feasibility 
and reliability of this instrument is not known.
In recent years, gas-liquid chromatography has become the most 
prevalent method for the detection and analysis of organic materials 
[1,96-101]. Direct analysis of airborne ethylene dibromide has been 
reported to result in measurement of amounts as small as 0.002 ng/cu m 
(0.000002 mg/cu m) [96]. Gas samples were drawn into a gas flask and 
subsequently injected directly into a gas-liquid chromatograph equipped 
with a hydrogen flame ionization detector system. This method has not been 
tested for ethylene dibromide personal monitoring in an occupational 
environment. However, it should be easily adaptable to surveying the 
workplace environment on a periodic basis should the need arise.
The combination of charcoal tube sampling followed by desorption and 
gas-liquid chromatographic analysis [78] has been developed and used in the 
occupational environment [15]. These procedures involve the use of 
charcoal tubes for sampling of the breathing zone, with subsequent benzene- 
methanol (99:1) desorption and analysis by a gas-liquid chromatograph 
equipped with an electron capture detector (S Tucker, written
communication, March 1977) . The quantitation range of the detector (40-800 
monograms/sample solution) allows this method to be used to measure air 
concentrations of ethylene dibromide ranging from 1.6 /ig/cu m (0.0002 ppm) 
to concentrations above 16 mg/cu m (2 ppm). The relative standard
deviation for this analytical method in the range of 203-2,370 
nanograms/charcoal tube sample is 0.070. The advantages of this combined
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method are that the sampling device is small, portable, and involves no 
liquids, and the analytical method is sensitive, rapid, and subject to 
minimal interference. These NIOSH recommended sampling and analytical
methods are described in detail in Appendices I and II.
Engineering Controls
Engineering design and work practices for operations with ethylene 
dibromide should be oriented toward minimizing the vapor concentrations and 
toward preventing skin and eye contact with liquid ethylene dibromide. The 
achievement of these goals can be accomplished by the use of a properly 
constructed and maintained closed-system operation with appropriate safety 
precautions. Closed-system operations are effective only when the 
integrity of the system is maintained by frequent inspection for, and 
prompt repair of, any leaks. Where closed systems cannot be adequately 
designed and effectively used, local exhaust ventilation systems must be 
provided to direct vapor away from employees and to prevent the 
recirculation of exhaust air. Guidance for designing a local exhaust 
ventilation system can be found in Industrial Ventilation— A Manual of 
Recommended Practice [102], or more recent revisions, and in Fundamentals 
Governing the Design and Operation of Local Exhaust Systems, ANSI Z9.2-1971 
[103]. Ventilation systems of this type will require regular inspection 
and maintenance to ensure effective operation. These regularly scheduled 
inspections should include face velocity measurements of the collecting 




Strict adherence to stringent and detailed work practices is required 
to prevent hazardous occupational exposure to ethylene dibromide. The 
potential hazards from exposure to ethylene dibromide which determine to a 
large extent the nature of necessary work practices are: (1) the delayed
and insidious onset of symptoms, (2) an odor threshold which is not 
adequate to provide warning of dangerous concentrations, (3) its irritating 
and penetrating effects on the skin, and (4) its potential for causing 
cancer, mutations, sterility, and fetal anomalies.
The principal method for manufacturing ethylene dibromide is the 
bromination of ethylene [1]. Small quantities of vinyl bromide, ethyl 
bromide, and ethyl chlorobromide may be formed as impurities in the 
production of ethylene dibromide [15], and caution must be taken to avoid 
exposure to these substances as well.
Ethylene dibromide is nonflammable and nonexplosive at ordinary 
temperatures, but since it can be decomposed to toxic and corrosive 
compounds, such as hydrobromic acid, by contact with open flames or red-hot 
surfaces [1], it should be appropriately stored and handled to prevent such 
contacts. Special precautions are necessary for maintenance and emergency 
repair work, such as welding, cutting, or any spark- and flame-generating 
operations. Furthermore, it is recommended that smoking be prohibited in 
workplace areas where ethylene dibromide is manufactured, handled, blended, 
or stored. Since decomposition may occur [16] and highly toxic aldehyde 
vapors and acid gases may be emitted [104], ethylene dibromide must be
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protected from direct light and excessive temperature. Ethylene dibromide 
reacts rapidly with certain metals, such as aluminum and magnesium, to form 
combustible and explosive organometallic compounds [104] and with liquid 
ammonia [16], Therefore, it is recommended that reasonable precautions be 
taken to keep ethylene dibromide separated from these materials.
Engineering controls should be used to keep the concentration of 
airborne ethylene dibromide below the recommended occupational exposure 
limit. Ethylene dibromide should be used only in a closed system. Proper 
ventilation, consisting of forced-draft exhaust systems and tempered makeup 
air systems, should be used to minimize employee exposure to ethylene 
dibromide in the workplace, and to aid in reducing the extent of exposure 
in such routine operations as systems maintenance, routine cleanup, and 
daily sanitation practices. Design principles for all exhaust and 
ventilation systems should be in accordance with common engineering 
practices [102,103]. Portable exhaust systems should be used to reduce the 
concentrations of airborne ethylene dibromide in such situations as cleanup 
of small leaks and spills, line and vessel entry, and emergency 
decontamination. Periodic inspections by trained personnel should be made 
to determine the proper functioning of exhaust and ventilation systems by 
measuring airflow, static pressure, and leakage.
Untrained or nonessential personnel should be restricted from 
entering areas where ethylene dibromide is manufactured, handled, blended, 
or stored. Storage areas where ethylene dibromide is kept in large 
quantities, such as tanks and tank cars, should be diked with a system of 
sufficient volume to prevent contamination of surrounding areas in the 
event of a leak. Drainage within the diverting dikes should be channeled
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to a collection area for reclamation or disposal. Floors in the ethylene 
dibromide work areas should be constructed of ethylene dibromide-resistant 
materials and sealed or made impervious to ethylene dibromide to prevent 
adsorption, in the event of a spill or leak, and subsequent delayed release 
to the atmosphere. Periodic scheduled inspections should be made to ensure 
the proper functioning of dikes, collection systems, and floors. Any 
malfunctions should be immediately corrected.
All containers used to transport, hold, or process ethylene dibromide 
should be made of ethylene dibromide-resistant materials, such as lined 
steel or stainless steel, and should be periodically inspected for signs of 
wear, corrosion, or leaks by manual and instrumental means. All valves, 
pipes, and seals used in pumping ethylene dibromide from processing areas 
to storage areas or transportation loading sites should be made of ethylene 
dibromide-resistant materials and should be periodically inspected for 
possible leaks, weak points, or signs of wear.
Ethylene dibromide is a severe eye and skin irritant in humans (G Ter 
Haar, written communication, January 1977) and can be absorbed through the 
intact skin of animals in quantities sufficient to present an imminent 
hazard [33]. In view of this, the use of personal protective equipment, 
including nylon-impregnated neoprene gloves [105], ethylene dibromide- 
resistant and fire-retardant clothing, rubber boots or overshoes, bib-type 
aprons, and chemical safety goggles is recommended when contact by liquid 
ethylene dibromide with the skin and eyes is possible. In addition, it is 
recommended that proper respiratory protection be worn when entering an 
area where the concentration of the vapor of ethylene dibromide may be 
greater than the recommended occupational exposure limit. Clothing should
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be immediately removed if it becomes contaminated, and the skin of the 
exposed area should be thoroughly washed with water.
Personnel working with ethylene dibromide must be instructed in 
emergency procedures and participate in periodic, simulated emergency 
drills. All personnel not involved in the specified emergency operations 
must be immediately evacuated from the area. Special training sessions 
must be held and written emergency procedures must be updated periodically. 
These should include the location, use, and maintenance of first-aid, 
firefighting, and decontamination equipment.
To prevent the adverse effects caused by ethylene dibromide, it is 
recommended that exposure to ethylene dibromide vapor or liquid be kept at 
a minimum. Routine visual and functional inspections must be made by 
trained personnel to ensure that processes in which ethylene dibromide is 
used are completely closed. If leaks or spills occur in the processing, 
handling, or storage of ethylene dibromide, these must be promptly 
corrected, regardless of the ethylene dibromide concentration in the 
environment. It is recommended that nonessential personnel be evacuated 
from the immediate area where a leak or spill has occurred until 
decontamination of the area is complete. If employees must withdraw 
samples from a process involving the use of ethylene dibromide, an 
impervious suit, including gloves, boots, and air-supplied hood, should be 
worn. An effective exhaust system for trapping any ethylene dibromide 
vapor may be used in place of the air-supplied hood. Any waste or residues 
containing ethylene dibromide should be incinerated, buried, or otherwise 
disposed of so that no ethylene dibromide is released into the environment. 
Applicable local, state, and federal regulations should be followed. Air
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exhausted from ethylene dibromide workplace areas must be decontaminated by 
incineration, chemical treatment, or other effective means so that the 
release of ethylene dibromide into the environment will be minimized.
Safety showers and eyewash fountains should be located in or near 
areas where ethylene dibromide exposures are likely to occur and should be 
properly maintained. It is recommended that employees immediately remove 
contaminated clothing, flush all affected skin surfaces with water for at 
least 15 minutes, and then obtain medical attention.
Since ethylene dibromide is toxic when ingested and has caused death 
in a woman after ingestion [25], it is recommended that handwashing 
facilities, soap, and water be made available to the employees. As a good 
hygiene practice, it is recommended that employees wash their hands before 
consuming beverages or food, using tobacco, or using toilet facilities. 
The employer should provide lunchroom facilities physically separated from 
the ethylene dibromide work areas.
It is recommended that any contaminated article of personal 
protective equipment be discarded or, if feasible, decontaminated with soap 
and water. It is also recommended that employer-supplied clothing be worn 
while working with ethylene dibromide and that the employer arrange to have 
this clothing laundered daily and properly maintained. The employer should 
inform the launderers of the possible hazard of coming into contact with 
contaminated clothing and advise him on safe methods of handling such 
material. The employer should provide separate locker and change 
facilities for work and street clothes. As a good hygiene practice, it is 
recommended that shower facilities be provided for the employees and that
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they be required to shower before leaving the workplace at the end of the 
work shift.
Since ethylene dibromide is a component of some insecticidal 
fumigants and conventional work practice guidelines are inappropriate to 
protect agricultural workers from the hazards of exposure, it is 
recommended that the label precautions on such pesticides be followed and 
stringently adhered to. These label requirements usually specify allowable 
time limits before a fumigated space or area may be reentered and safe 
practices for the application of the particular fumigant mixture. Specific 
requirements of worker protection standards for agricultural pesticides can 
be found in 40 CFR 170.
In summary, precautions should be exercised with ethylene dibromide 
to prevent serious consequences which may result from ingestion, 
inhalation, and skin or eye contact. Processes in which ethylene dibromide 
is used in large quantities should be carried out in closed systems. 
Well-designed hoods, ventilation systems, and exhaust systems should be 
used to maintain concentrations below those specified by this standard. 
Personal protective equipment and clothing should be worn by employees 
engaged in the manufacture, handling, or blending of ethylene dibromide. 
It is important that employees be informed of the hazards associated with 
ethylene dibromide before job placement and whenever changes are made in 
any process that may alter their exposure. Appropriate posters and labels 
should be displayed. The US Department of Labor form OSHA-20, "Material 
Safety Data Sheet," or a similar OSHA-approved form, should be filled out 
and posted. All employees in the ethylene dibromide exposure area should 
know where the safety sheet is posted. Safety showers, eyewash fountains,
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and fire extinguishers should be located in areas where ethylene dibromide 
exposures are likely to occur, and employees should be instructed in their 
proper use and maintenance.
Records of maintenance schedules, written work practices, emergency 
procedures, storage locations and quantities of ethylene dibromide present 
in each location, employee accidents, and employee exposures should be kept 
and readily accessible to employees and management.
The safe handling of ethylene dibromide depends to a great extent on 
the effectiveness of employee education, proper safety instructions, 
intelligent supervision, and the use of proper and safe equipment. The 
education and training of employees to work safely and to use the personal 
protective equipment are the responsibility of management. Training 
classes for both new and current employees should be conducted frequently 
to maintain a high degree of safety in working with ethylene dibromide.
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VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1953, the American Conference of Governmental Industrial 
Hygienists (ACGIH) adopted a threshold limit value (TLV) of 25 ppm as an 8- 
hour TWA concentration for 1,2-dibromoethane (ethylene dibromide) [106]. 
No specific basis for this TLV has been found. In 1954, the ACGIH [107] 
changed the name to ethylene dibromide in the official TLV list, and, in
1956, they added the value of 190 mg/cu m to the official entry [108]. In
1962, the ACGIH [109] restored 1,2-dibromoethane as the principal 
designation of the compound and reported in the Documentation of the
Threshold Limit Values of Substances in Workroom Air that the TLV of 25 ppm
as a TWA concentration was based on the report of Rowe et al [33]. Rowe et
al [33] reported that ethylene dibromide was readily absorbed through the 
intact skin of rabbits and from the gastrointestinal tract of rats, mice, 
guinea pigs, chickens, and rabbits. Ethylene dibromide vapor caused CNS 
depression, pulmonary irritation, and liver and kidney damage in rats and
guinea pigs after single exposures. Rats, guinea pigs, monkeys, and 
rabbits tolerated repeated exposures of ethylene dibromide vapor at 25 ppm 
for 7 hours/day, 5 days/week, for about 6 months without adverse effects, 
but these species did not tolerate well a similar exposure at 50 ppm.
In 1965, the ACGIH [110] recommended that special emphasis be given 
to the potential for skin absorption of 1,2-dibromoethane by adding the
designation "skin" after the name in the TLV list. Such a notation refers 
to the potential contribution to overall exposure by the dermal route, 
including mucous membranes and eyes, either by airborne, or more 
particularly, by direct contact with ethylene dibromide. This designation
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was intended to indicate that measures for the prevention of absorption 
from skin and mucous membranes were necessary if the TLV was to be 
successful in limiting occupational exposure to a safe level. In 1965, the 
ACGIH [110] also recommended that the TLV of 25 ppm as a TWA concentration 
for ethylene dibromide be tentatively changed to a ceiling limit of 25 ppm. 
The basis [111] for this limit was primarily the report by Rowe et al [33], 
discussed previously, and the paper by Lucas [28]. Lucas [28] observed 
that single 10- to 12-minute exposures of rabbits to a concentration of 
ethylene dibromide vapor sufficient to produce anesthesia resulted in rapid 
breathing, phonation, and death within 15-18 hours. The shift of the TLV 
from a TWA value to a ceiling limit was made final in 1967.
In 1971, the ACGIH [112] recommended changing the ceiling limit of 25 
ppm to an 8-hour TWA concentration of 20 ppm (145 mg/cu m). The 1971 
Documentation of the Threshold Limit Values for Substances in Workroom Air 
[113] cited several studies with no particular emphasis on how the limit 
was set. These reports included Rowe et al [33], Lucas [28], Kochmann 
[23], Olmstead [25], Rowe et al [38], and McCollister et al [37], which are 
discussed in Chapter III. Presumably, the study by Rowe et al [33] was the 
principal basis on which the new limit was set. The proposed value of 20 
ppm as a TWA concentration was adopted in 1973 [114]. The basis for this 
change as stated in the 1974 supplement of the 1971 Documentation [113], 
did not differ from that stated in 1971.
In 1976, the ACGIH [115] added to the TWA value a tentative short­
term exposure limit (STEL) of 30 ppm (220 mg/cu m), which is defined as a 
maximal concentration to which workers can be exposed for a period up to 15 
minutes continuously. No more than 4 such excursions are permitted each 
day, with at least 60 minutes between successive exposure periods. Also,
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the daily TLV-TWA is not to be exceeded.
Florida, Mississippi, Pennsylvania, and South Carolina have adopted a 
TWA concentration of 25 ppm (190 mg/cu m) as their environmental limit for 
ethylene dibromide [116].
In Finland, the German Democratic Republic, and Yugoslavia, the 
maximum allowable concentration (MAC) for the workplace environment is 190 
mg/cu m (25 ppm) [116]. In the Rumanian Socialist Republic, 200 mg/cu m 
(approximately 26 ppm) of ethylene dibromide is the maximum concentration 
allowed in the occupational environment, whereas in Poland, the MAC allowed 
for ethylene dibromide is 100 mg/cu m (13 ppm) [116]. Although the USSR 
does not currently recommend a standard for ethylene dibromide, the US 
recommendation of 145 mg/cu m (20 ppm) is stated to be inadmissibly high. 
The 1976 edition of the Handbook for Chemists, Engineers and Physicians 
[117] states that, in all likelihood, the permissible concentration should 
be on the same order as the Russian MAC for dichloroethane (12.5 ppm) or 
lower [117]. No bases for these standards have been found.
The current federal standard (29 CFR 1910.1000) for occupational 
exposure to ethylene dibromide is 20 ppm as an 8-hour TWA limit, with an 
acceptable ceiling concentration of 30 ppm. A maximum peak above the 
acceptable ceiling concentration for an 8-hour work shift of 50 ppm not to 
exceed 5 minutes (Federal Register 40:103, May 28, 1975) is also permitted. 
This standard was adopted from the American National Standards Institute 
(ANSI) recommendation Z37.31-1970 [3], which was based on the 
reports of Rowe et al [33] and Olmstead [25], and the summary presentation 
by Irish [4], which includes synopses of several other reports
[23,24,27,33] discussed in Chapter III.
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Basis for the Recommended Standard
(a) Environmental (Workplace Air)
Employees exposed to ethylene dibromide vapor may suffer deleterious 
effects which may be delayed in their onset. Single short-term exposures 
to sublethal concentrations have resulted in conjunctival irritation, 
glandular swelling, and a generally poor condition, while repeated 
exposures to sublethal concentrations have resulted in conjunctivitis, 
pharyngeal and bronchial irritation, anorexia, headaches, and depression 
[23]. Exposure to a lethal inhaled dose of ethylene dibromide vapor 
derived from some unknown portion of an estimated 70 g of the liquid 
applied to an anesthesia mask produced nervousness, vomiting, diarrhea, 
abdominal pain, upper respiratory irritation, degeneration of the 
parenchymal tissue in the heart, liver, and kidneys, and hemorrhaging into 
the trachea, blood vessels, and along the sternum, culminating in death 
about 44 hours after the exposure [22].
Ethylene dibromide in humans produces blistering when the liquid is 
allowed to remain in contact with the skin for more than 10 minutes and can 
cause death when ingested. Volunteers subjected to dermal contact with 
ethylene dibromide for up to 10 minutes, developed burning pain and 
reddening of the skin; blistering occurred after prolonged contact [24]. 
Repeated dermal exposure caused a skin sensitization to ethylene dibromide 
in one of the volunteers. Ingestion of about 4.5 ml (140 mg/kg) of 
ethylene dibromide caused the death of a 43-year-old woman [25] . Prior to 
death 54 hours after ingestion, she developed diarrhea, vomiting, anuria, 
tachypnea, nervous agitation, abdominal pain, systolic heart murmurs, sinus 
tachycardia, and an arrhythmic, sporadic pulse. Autopsy results indicated 
edema and congestion of the lungs, intestinal mucosal erythema, massive
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centrilobular liver necrosis, and tubular epithelial damage in the kidneys.
Animal experiments confirm and extend the clinical observations of 
the effects reported in humans that have been exposed to ethylene 
dibromide. A dog exposed to 1 ml of vaporized ethylene dibromide (a 
calculated concentration of about 2,830 ppm or 21,790 mg/cu m) for 1 hour 
showed signs of ocular irritation, including corneal opacity, that 
developed into purulent conjunctivitis in both eyes and ulceration of one 
cornea [31]. Conjunctivitis also developed in cats exposed to 100 ppm (770 
mg/cu m) of ethylene dibromide for 30 minutes/day for approximately 10 days 
[23], and conjunctival irritation was noted in rabbits after instillation 
of undiluted, 10%, or 1% solutions of ethylene dibromide [33]. The 
irritation subsided within 2-12 days in the rabbits without causing corneal 
scarring. Marked hyperemia of the cutaneous blood vessels surrounding the 
application site was found after 0.25, 0.50, or 1.0 ml (0.55, 1.1, or 2.2 
g) of ethylene dibromide was applied to the abdomen of rats [27]. Rabbits 
responded similarly when undiluted or 10% solutions of ethylene dibromide 
were applied to the abdomen [33]. Application of 210 mg/kg of the 
undiluted chemical caused marked erythema, edema, and necrosis of the skin.
Respiratory tract irritation caused by ethylene dibromide vapor has 
been seen in guinea pigs after single exposures at 2,000 ppm (15,400 
mg/cu m) for 150 minutes [27], and for cats after exposures as low as 100 
ppm (770 mg/cu m) for 30 minutes [23]. A strong reddening of the nasal 
mucosa was observed after three 30-minute exposures at 100 ppm (770 mg/cu 
m) [23]. A dog exposed to 5 ml (11.0 g) of vaporized ethylene dibromide 
for 1 hour in a 100-liter chamber developed severe bleeding in the right 
lung, and another dog exposed to 1 ml (2.2 g) for 1 hour had severe 
hyperemia and bronchopneumonic foci in both lungs [31]. The lungs of rats
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exposed to ethylene dibromide at concentrations between 100 and 10,000 ppm 
(770 and 77,000 mg/cu m) for 0.02-16.0 hours were congested, edematous, 
hemorrhagic, and inflamed [33].
Repeated exposure of cats to concentrations of ethylene dibromide of 
100 ppm (770 mg/cu m) for 30 minutes daily for an average of 10 days caused
discoloration and partial dysfunction of the lungs [23]. Pulmonary
infection, probably a secondary result of the irritation of the lungs by 
ethylene dibromide, was responsible for a 50% mortality in male rats and 
guinea pigs and a 25% mortality in female guinea pigs exposed repeatedly to 
25 ppm (192.5 mg/cu m) of ethylene dibromide for 7 hours/day, 5 days/week, 
for about 6 months [33]. Similar mortality was not observed in the control 
group exposed in a chamber ventilated with clean air, although high 
mortality was observed in the control animals simply maintained in the 
colony.
Other systemic damage also occurred in animals after single and 
repeated exposures to ethylene dibromide vapor. Guinea pigs exposed at
concentrations of ethylene dibromide of 2,000 ppm (15,400 mg/cu m) for 150
minutes developed a pronounced granular degeneration of the parenchymal 
tissue of the kidneys and a slight degeneration of the parenchymal tissue 
of the liver, spleen, and heart [27]. Rats exposed at concentrations 
between 100 and 10,000 ppm (770 and 77,000 mg/cu m) of ethylene dibromide 
for 0.02-16.0 hours developed cloudy swelling, centrilobular fatty 
degeneration, and necrosis of the liver, cloudy swelling and a slight 
interstitial congestion and edema of the kidneys, and CNS depression at the 
higher concentrations [33].
Repeated inhalation exposures of rats for 7 days and rabbits for 3-4 
days at 100 ppm (770 mg/cu m) of ethylene dibromide for 7 hours/day
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produced slight congestion of the spleens of rats, cloudy swelling and a 
slight leukocytic infiltration in the livers of rats, and widespread 
central fatty degeneration and some necrosis in the livers of rabbits [33]. 
Exposure of guinea pigs and monkeys at 50 ppm (285 mg/cu m) of ethylene 
dibromide for 7 hours/day, 5 days/week, for 70-80 days caused only slight 
central fatty degeneration of the liver [33]. Cats exposed at 100 ppm (770 
mg/cu m) of ethylene dibromide for 30 minutes/day for about 10 days had 
enlarged spleens. Death resulted from circulatory system damage to the 
heart and vessels [23].
CNS effects, such as agitation, restlessness, body tremors, or
unconsciousness, are caused by exposure to ethylene dibromide [23,29-31],
but they have not been sufficiently described to permit an adequate 
evaluation or quantitation of their relevance or validity.
The information provided by the few reports on humans [22-25] and 
such experimental animal data as those given in the following references
[23,27,31,33] indicates that many effects produced by ethylene dibromide on 
humans and animals are similar and differ only in magnitude. Respiratory 
tract irritation, damage to the liver, kidneys, spleen, and lungs,
irritation of the skin and eyes, and gastrointestinal disturbances are the 
predominant effects of ethylene dibromide exposure. Since systemic effects 
may occur from ingestion, inhalation, or dermal contact with ethylene 
dibromide, NIOSH recommends that work practices be used to minimize
employee exposure to ethylene dibromide liquid or vapor through inhalation, 
body or eye contact, or ingestion.
Mammalian studies indicate that reproductive abnormalities, including 
antifertility [9] and spermatozoic anomalies [41-43], occur from exposure 
to ethylene dibromide. One report [9] indicated that five ip injections of
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10 mg/kg given to male rats produced a decrease in fertility only during 
the 3rd and 4th weeks after injection. Since spermatids require about 3-4 
weeks to mature into spermatozoa in the rat, the evidence indicates that 
ethylene dibromide affects the development of the spermatids that were 
present at the time of injection. This is further supported by the return 
of normal fertility 5 weeks after the injection. Three studies with bulls 
[41-43] that received an average daily dose of 2 mg/kg of ethylene 
dibromide for various periods during their development indicated that the 
abnormalities expressed in their reproductive systems were the result of 
the action of ethylene dibromide on the maturation step in the 
spermatogenic cycle and not a direct action of ethylene dibromide on the 
germinal tissue. Discontinuance of administration of ethylene dibromide 
resulted in reversal of the impairment, and the bulls produced normal semen 
and spermatozoa until ethylene dibromide administration was begun again in 
one of the studies [41]. In another experiment [42], production of 
abnormal spermatozoa occurred with a dose as small as 4 mg/kg given on 
alternate days for seven doses. These spermatozoic abnormalities would 
greatly reduce the fertility, even if they did not cause total sterility. 
Although these effects were from the ingestion of ethylene dibromide and 
not from inhalation or dermal contact, they indicate that a hazard, 
including decreased fertility and even temporary sterility, may result from 
inhalation or percutaneous absorption of ethylene dibromide.
One study, reported by several authors [56-59], was conducted to 
determine the carcinogenic properties of ethylene dibromide. Rats and mice 
given daily oral doses by gavage of ethylene dibromide at 40 and 60 mg/kg, 
respectively, for 52-64 weeks developed squamous cell carcinomas in the 
stomach. These carcinomas invaded locally and metastasized throughout the
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abdominal cavity. Male and female rats developed stomach carcinomas as
early as 10 weeks after the start of administration of ethylene dibromide. 
The carcinomas became more prevalent as the daily doses of ethylene 
dibromide were continued, and the final percentage of male rats with tumors 
after administration of 40 mg/kg/day was 98% after termination of the 
experiment at 54 weeks. Male rats were more susceptible to tumorigenesis 
than female rats; 80% of all the males in the study developed tumors versus 
38% of all the females. The concurrent control populations did not develop 
squamous cell carcinomas. More than 70% of all the mice were reported to 
have developed squamous cell carcinomas of the stomach by the termination 
of the experiment at 62 weeks. Since the numbers of tumors induced by 
nearly equivalent quantities of ethylene dibromide administered at 
different dose rates and on different schedules were substantially 
different, the experimental data are not consistent with a single-hit model 
of cancer induction for ethylene dibromide after administration by gastric 
tube in the rat. However, these data suggest that repeated ingestion of 
ethylene dibromide by humans may result in gastric carcinomas. At the 
present time, the induction of cancers by ethylene dibromide by other
routes of exposure has not been demonstrated.
The mutagenic potential of ethylene dibromide is well established in 
both animal and plant systems. It induces mutations in vertebrate cell
cultures [62], insects [6], bacteria [60,63,64], plants [66], and fungi
[67,68] .
One study with Drosophila melanogaster [6] showed that ethylene 
dibromide induced a significant number of recessive lethal mutations in 
three successive broods of offspring. The adult males fed 0.3 mM of 
ethylene dibromide for 3 days produced subsequent brood patterns indicative
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of impaired spermatozoic maturation rather than of impaired formation. 
Studies with mouse lymphoma cells [62] indicated that a dose-related
effect, typical of those of other alkylating agents tested, existed over 
the range of 0.0-3.0 mM ethylene dibromide. The effect of the highest 
concentration was approximately equal to that of a dose of 600 R of X- 
irradiation.
A study in a host-mediated assay system [60] with Salmonella 
typhimurium G46 in mice suggested that ethylene dibromide was mutagenic at 
a dose of 500 mg/kg. A second part of this study [60] showed that an 
equivalent dose produced a positive mutagenic effect on Salmonella
typhimurium G46 in vitro, indicating that ethylene dibromide did not 
require metabolic activation and was not deactivated by metabolism.
Similar positive mutagenic results occurred in Salmonella typhimurium TA 
1530 at 5 idl (11.0 mg)/plate [63] or 10 ^M/plate [64] and in Salmonella 
typhimurium TA 1535 at 10 /uM/plate [64]. A linear relationship for
mutation responses occurred over the range of 3.6-148.2 ppm (27.72-1,141.14 
mg/cu m) in Tradescantia clone 4430 [66], exhibiting a well-defined dose 
response with single exposures to as little as 3.6 ppm (27.72 mg/cu m) of 
ethylene dibromide for 6 hours.
Several studies [5,6,64] suggest that the mechanism of mutagenic 
activity of ethylene dibromide is based on its ability to alkylate, or 
covalently bond to, DNA in the exposed cells. Ethylene dibromide is a 
bifunctional alkylating agent capable of introducing cross-links into 
biologic materials [6] by displacement of the two reactive bromine atoms by 
reacting with amine, sulfhydryl, carboxy or other electron-donating groups. 
Ethylene dibromide, or its metabolites, has interacted with DNA through 
covalent bonds to induce DNA repair synthesis in opossum lymphocyte cells
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[5]. Another indication of ethylene dibromide's ability to alkylate DNA is 
that ethylene dibromide is mutagenic in Salmonella typhimurium TA 1530 and 
TA 1535, both transitional mutational systems [64]. These data [5,6,64] 
suggest strongly that the most plausible chemical basis for the mutagenic 
activity of ethylene dibromide in procaryotic and eucaryotic organisms is 
its alkylation of cellular constituents such as DNA. This broad biologic 
reactivity suggests that ethylene dibromide may be capable of increasing 
spontaneous mutation rates in humans. However, the quantitative aspects of 
this potential have not been determined. Since the process of induction of 
mutations is a stochastic, virtually irreversible process, any increased 
frequency of mutation in exposed populations would accumulate as a function 
of the total absorbed dose of ethylene dibromide. Therefore, an adequate 
assessment of the importance of the plant and submammalian animal data in 
extrapolating to the concentrations of airborne ethylene dibromide present 
in the workplace environment is difficult, but the widespread mutagenic 
activity of ethylene dibromide does give cause for concern about damage to 
the genetic mechanisms in employees working with it.
The teratogenic effects found in a rat and mouse study [69] involved 
brain and costal anomalies in the offspring of dams exposed to ethylene 
dibromide. Pregnant rats and mice were exposed at a concentration of about 
32 ppm of ethylene dibromide for 23 hours/day on days 6-16 of gestation. 
Some of the effects were attributed to malnourishment, but the 
abnormalities in the ethylene dibromide-exposed rats and mice were 
significantly different, both qualitatively and quantitatively, from those 
in the nonexposed controls; some of these abnormalities did not appear in 
mice fed a restricted amount of the normal diet whereas others appeared in 
both the restricted and the control mice with about the same incidences.
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These data suggest that ethylene dibromide causes fetal anomalies in mice 
and rats that are not caused by malnourishment alone. Since inhalation is 
one of the major routes of exposure for the employee, these data suggest 
also that the babies of female employees may be subject to increased risks 
of developmental defects if their mothers are exposed to ethylene dibromide 
in the workplace during the critical phases of pregnancy.
The total risk to the health of employees exposed to ethylene 
dibromide is the result of the compounded risks from carcinogenicity, 
mutagenicity, teratogenicity, sterility, and damage to the kidneys, liver, 
spleen, respiratory tract, central nervous system, circulatory system, 
skin, and eyes. Although no comprehensive epidemiologic studies have been 
conducted to assess adequately these risks in the industrial environment, 
evidence of their existence in experimental animal systems or in isolated 
human exposures to ethylene dibromide has been discussed above and in 
Chapter III. Experimentation conducted with animal models, as outlined 
above, generally supports the findings observed in the limited number of 
human exposures.
Concern for employee health requires that the probability of the 
occurrence of long-term effects of ethylene dibromide be minimized. The 
preliminary report available to NIOSH from a review of the mortality 
experience of 161 employees of one manufacturer [26,71] may indicate that 
employees exposed to unknown concentrations of ethylene dibromide from 
industrial processes operating under the current federal standard of 153 
mg/cu m (20 ppm) are not suffering measurable long-term effects. The 
authors (26), while recognizing the limitations posed by the small study 
group and the variety of toxic agents to which the employees may have been 
exposed stated, however, that an indication of increased mortality due to
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ethylene dibromide exposure may have existed in one of the plants. An 
individual exposed to 153 mg/cu m (20 ppm) of ethylene dibromide for 40-46 
weeks/year with a calculated minute volume of about 10 liters/minute would 
inhale approximately 6,700 g during 40 years of occupational exposure, 
which is about 8.7 times the lifetime oral doses (10.8 and 11.2 g/kg) that 
induced stomach cancer in the rat. In addition, the extensive experimental 
evidence on the induction of adverse effects in lower species [5-7,9,33,41- 
43,56-60,62,66,69] and the formation of stable covalent bonds between 
ethylene dibromide and cellular constituents [7,11] indicate that the 
occupational exposure limit should be lowered to decrease the potential 
hazard to employees.
Because of the intrinsic, stochastic, and virtually irreversible 
character of the chemical reactions that initiate the carcinogenic and 
mutagenic processes, the risk of adverse effects is a function of the rate 
of absorption and the total absorbed dose. Consequently, this risk can be 
reduced to any value necessary to protect the employees by decreasing both 
the absorption rate (to prevent saturation of the enzymatic detoxification 
mechanisms) and the total lifetime dose (to reduce the probability of 
deleterious stochastic processes, such as carcinogenesis and mutagenesis, 
from occurring).
The unusual complexity of the dynamics of the cellular response 
mechanisms to ethylene dibromide intoxication is emphasized by the dose- 
rate effect relationship observed for induction of gastric neoplasms. 
Daily intragastric doses of 40 and 60 mg/kg induced tumors in rats and mice 
within 10 weeks [56], whereas daily 7-hour inhalation exposures of about 49 
mg/kg did not result in the observation of tumors even after 30 weeks [33]. 
The data suggest that one of the major factors in the development of gastic
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carcinomas is direct contact between the mucosal cells and ethylene 
dibromide, and that a major difference in tumor induction may exist between 
the two routes of exposure. However, the animals used in the inhalation 
study were not maintained until the end of their normal lifespan; 
therefore, a direct comparison between the final incidences of tumors 
initiated by the two routes of exposure cannot be made.
A plausible pharmacokinetic explanation for the observed differences 
exists. Since the rat's capacity to metabolize ethylene dibromide [50] 
exceeds the rate of absorption (at 25 ppm) by a factor of at least 100, the 
concentration of ethylene dibromide in tissues should be considerably less 
than that in the air, which is about 1.02 /umoles/liter at 25 ppm [33]. The 
concentration of ethylene dibromide in corn oil used in the intubation 
study ranged between 0.066 and 0.132 moles/liter. Consequently, the 
mucosal cells of the stomach may have been exposed for short periods to 
concentrations of ethylene dibromide up to 100,000 times that to which lung 
tissue would be exposed during inhalation exposures at 25 ppm (192.5 
mg/cu m). The saturation of enzymatically catalyzed detoxification and 
repair mechanisms may occur in the stomach tissues, resulting in an 
amplification of the tissue damage, which otherwise may be minimal. These 
pharmacokinetic considerations are consistent with the experimental results 
of Rowe et al [33], where the product of the concentration and duration of 
exposure to produce 50% mortality among the exposed rats was found to be 
approximately constant for higher concentrations of ethylene dibromide but 
not for lower ones. The evidence indicates that tissue detoxication and 
repair mechanisms exist, but that they cannot negate completely the 
intrinsic capacity of ethylene dibromide to alkylate cellular constituents. 
Because of this, exposure to ethylene dibromide has potentials for the
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induction of adverse effects by both local and systemic actions. Reducing 
the concentration of ethylene dibromide in the air should optimize the 
protection to the organism afforded by cellular detoxication and repair 
mechanisms, thus minimizing the accumulation of ethylene dibromide in 
tissues and decreasing the subsequent cellular damage to a negligible 
level.
In summary, the limited reports of effects on humans along with 
experimental animal data indicate that the adverse effects which have been 
observed from exposure to ethylene dibromide are similar and that 
differences are primarily ones of magnitude. Epidemiologic evidence of 
adverse effects in workers is confined to a single mortality study which 
was hampered by small cohort size, mixed exposures, and minimal findings 
which were not sufficeint to adequately identify a worker problem. The 
findings are regarded as little more than preliminary observations; 
nevertheless, increased deaths from malignancies cannot be ruled out and 
seem to have been most apparent in employees having 6 or more years 
exposure in ethylene dibromide operations. Available animal data indicate 
reversible reproductive abnormalities manifested as abnormal development of 
spermatozoa in young bulls and decreased fertility in rats at a time which 
indicated interference with the normal development of spermatids into 
mature spermatozoa. Carcinomas of the stomach invading into the abdominal 
cavity have been produced in mice and rats administered ethylene dibromide 
by direct intubation into the stomach. Cancers resulting from ethylene 
dibromide administration have not been demonstrable by any other route of 
administration. A major factor in the development of gastric carcinoma in 
the rats and mice is considered to be the direct contact between mucosal 
cells and concentrated ethylene dibromide in a quantity which exceeded the 
ability of the tissues to handle the chemical. Mutagenic effects from
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ethylene dibromide have been demonstrated in microbes, plants, insects, and 
mammalian cells in vitro, presumably due to its ability to alkylate, or 
covalently bond, to DNA in a cross-linking mechanism by virtue of its 
bifunctional structure. Although this potential has not been demonstrated 
in humans, the broad biologic activity of ethylene dibromide warrants 
concern about possible damage to genetic mechanisms in employees exposed to 
it. Teratogenic effects which seem to be due to maternal exposure to 
ethylene dibromide have been confined to brain and costal anomalies in 
fetal mice and rats, but malnourishment as a contributing factor cannot be 
discredited unequivocally.
Although it is not possible at this time to state categorically an 
exposure concentration at which ethylene dibromide may be regarded to be 
completely without risk, NIOSH considers that the recommended occupational 
exposure limit should be substantially lower than the current federal 
standard of 20 ppm as an 8-hour TWA limit, 30 ppm ceiling. The recommended 
occupational exposure limit for ethylene dibromide, at the least, should be 
reduced sufficiently to keep the total lifetime dose well below the 
cumulative doses shown to be hazardous in animal experiments. In 
considering the alkylating capability of ethylene dibromide and the 
potential adverse effects on the organism which may result, especially at 
the subcellular level, NIOSH recommends that the occupational exposure 
limit for ethylene dibromide be reduced to a ceiling concentration of 1.0 
mg/cu m (0.13 ppm) for any 15-minute sampling period. This represents a 
reduction to one-two-hundred and thirtieth of the current federal ceiling 
limit for ethylene dibromide and is a level at which an employee would 
inhale a maximum of about 686 mg/kg of ethylene dibromide during a 40-year 
working lifetime, which is substantially below that total dose known to 
induce adverse effects in experimental animals. It is believed that so
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long as care is taken to prevent entrance of any appreciable amount of 
ethylene dibromide into the digestive tract, adherence to this exposure 
limit will protect against acute adverse effects and will reduce the 
potential long-term effects to a negligible level. NIOSH concludes that 
reduction to a ceiling concentration of 1.0 mg/cu m (0.13 ppm) will protect 
employees from acute illness resulting from exposure to ethylene dibromide 
and will reduce markedly, and perhaps remove entirely, any hazard of 
adverse effects on health from long-term exposure to this chemical.
It is recognized that many employees work with solid or liquid forms 
of ethylene dibromide in situations where there may be contact with the
substance, resulting in dermal, ocular, or systemic effects. Consequently, 
appropriate work practices, training, and other protective measures should 
be required regardless of concentrations of airborne ethylene dibromide. 
Therefore, occupational exposure to ethylene dibromide has been defined as 
work in an area where ethylene dibromide is manufactured, blended, stored, 
used, handled, or otherwise present. The action level is defined as one- 
half the recommended occupational exposure limit, thereby delineating those 
work situations which do not require the expenditure of resources for
environmental monitoring and associated recordkeeping.
(b) Sampling and Analysis
The technology is currently available to sample and analyze ethylene 
dibromide at the recommended occupational exposure limit to allow
institution of the proper engineering controls. As discussed in Chapter IV 
and presented in greater detail in Appendices I and II, a charcoal tube 
method is recommended for personal breathing zone sampling of airborne 
ethylene dibromide. Gas-liquid chromatography is recommended for analyzing 
the trapped ethylene dibromide.
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(c) Medical Surveillance and Recordkeeping
Several human [22-25] and animal [23,27,31,33] studies reported that 
exposure to ethylene dibromide vapor or liquid produced skin, eye, or 
respiratory irritation, CNS disorders, systemic damage in the liver, 
kidneys, spleen, lungs, and heart, and death. Thus, a medical surveillance 
program should include preplacement and periodic medical examinations that 
give attention to the nervous system, skin, eyes, lungs, kidneys, spleen, 
liver, and circulatory system. Medical attention should be provided for 
employees accidentally exposed to ethylene dibromide. Because ethylene 
dibromide induces cancer and mutations in experimental animals, it is 
recommended that all medical and other pertinent records involving ethylene 
dibromide exposure be kept for 30 years after termination of employment. 
This will allow enough time for future detection of chronic sequelae which 
may be related to the employee's known occupational exposure. Because of 
the possibilities of impaired development of fetuses and of the induction 
of sterility in men, employees of reproductive age must be counseled to 
minimize exposure to ethylene dibromide.
(d) Personal Protective Equipment and Clothing
Dermal [24,33] and ocular [23,33] contact with liquid ethylene 
dibromide induces irritation of the skin and eyes in humans and animals. 
Therefore, care must be exercised to ensure adequate protection against 
contact with ethylene dibromide. Personal protective clothing, including 
ocular protective devices and impervious work clothes, should be available 
and worn where exposure to ethylene dibromide is likely. Work practices 
that prevent skin and eye contact must be followed. Showers and eyewash 
fountains must be available for immediate use if accidental contact occurs.
(e) Informing Employees of Hazards
A continuing education program is an important part of a preventive 
hygiene program for employees occupationally exposed to hazardous materials
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such as ethylene dibromide. Properly trained persons should periodically 
apprise employees of possible sources of ethylene dibromide exposure, the 
adverse health effects associated with such exposure, the engineering and 
work practice controls in use and being planned to limit exposure, and the 
environmental and medical monitoring procedures used to check on control 
procedures and on the health status of employees. Personnel occupationally 
exposed to ethylene dibromide must be warned and advised of the adverse 
effects of accidental exposure and must be informed of the signs and 
symptoms of the disorders. Employees should be warned that the onset of 
these symptoms may be delayed. If skin or eye contact occurs, the affected
areas should be immediately flushed with copious amounts of water and
examined by a physician.
(f) Work Practices
Because ethylene dibromide can produce death from ingestion [25] and 
has been found to induce gastric cancers in experimental animals [56], it 
is recommended that food storage, handling, dispensing, and eating be 
prohibited in ethylene dibromide work areas regardless of the air 
concentrations. In addition, it is recommended that employees who work in 
an ethylene dibromide area thoroughly wash their hands before eating, 
smoking, or using toilet facilities.
Engineering controls must be used whenever possible to control 
concentrations of airborne ethylene dibromide within the recommended 
occupational exposure limit. Where ethylene dibromide is present, a closed 
system of control should be used. During the time required to install
adequate controls and equipment, to make process changes, to perform
routine maintenance operations, or to make emergency repairs, exposure to 
ethylene dibromide can be minimized by the use of respirators and 
protective clothing. However, respirators should not be used as a 
substitute for proper engineering controls for normal operations.
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VII. RESEARCH NEEDS
Research is needed in the following areas to provide a better 
scientific basis for the recommended occupational health standard.
(a) Epidemiologic Study
A limited examination of the health records of employees at the Dow 
Chemical Company did not reveal any adverse health effects associated with 
exposure to ethylene dibromide [71]. In the absence of any published data, 
it is not possible to critically evaluate the basis of this conclusion or 
to estimate the significance of any effects which may have been induced by 
ethylene dibromide. A retrospective cohort study of a working population 
exposed primarilv to ethylene dibromide for a long duration should provide 
valuable information. Such a study should also address the effects of 
alcohol consumption, smoking habits, and obesity on the assessment of 
occupational hazards and risks. A study of a large population, such as 
gasoline station operators, chronically exposed to very low but measurable 
concentrations of ethylene dibromide should be given consideration.
A group of manufacturers and users has informed NIOSH that they are 
currently planning to conduct an epidemiologic study of employees with a 
history of exposure to ethylene dibromide.
(b) Carcinogenic Study
One carcinogenic study [56] has been found. However, because the 
route of exposure was by gastric intubation and the dosages were quite 
large, they do not provide a substantive basis for estimating the risk for 
human populations exposed to low concentrations of ethylene dibromide 
throughout their working lifetime. Properly designed and performed studies
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should be conducted on at least two mammalian species by inhalation and 
dermal absorption over a range of doses to further determine the risk of 
neoplastic induction by ethylene dibromide at concentrations and dosages 
approaching the recommended environmental limit. In addition, studies 
should be conducted to determine the cocarcinogenic or promotion potential 
of ethylene dibromide with substances with which it is commonly used, such 
as with ethylene dichloride, tetraethyl lead, and tetramethyl lead, or with 
carbon tetrachloride, ethylene dichloride, and carbon disulfide.
(c) Mutagenic Effect
This effect must be systematically investigated in greater detail 
with respect to dose, time, and route of exposure in both lower organisms 
and mammals. Animal tests using a variety of doses, schedules, and routes 
of administration should be performed to further elucidate the mutagenic 
potential of ethylene dibromide. Specific locus tests, heritable 
translocations, and multigeneration studies should be considered. Animals 
should also be tested to determine whether ethylene dibromide has any 
cytogenic effects. Experiments designed to either establish or refute the 
general applicability of the linear dose-response relationship for mutation 
induction found in Tradescantia [66] should be conducted in mammalian and 
submammalian species for both point mutations and chromosomal aberrations.
(d) Teratogenic and Related Reproductive Effects
Terata have occurred in the offspring of mammals as a result of 
exposure to ethylene dibromide vapor [69], and definite impairment of the 
reproductive system has occurred in mammals and avians as a result of 
ingesting ethylene dibromide [41,42,44,45]. Definitive experiments are 
needed with exposure concentrations approaching the recommended
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environmental limit to determine the effects of these small concentrations 
of airborne ethylene dibromide on the reproductive processes in a variety 
of mammalian species, such as dogs or monkeys. Additional studies are 
needed to determine whether sufficient quantities of ethylene dibromide can 
be absorbed through the skin to produce abnormal reproductive effects.
(e) Kidney and Liver Function Studies
The impairment of kidney and liver functions as a result of ethylene 
dibromide exposure has occurred in animals and in humans. As yet, there is 
no evidence that functional damage occurs in workers exposed to ethylene 
dibromide. Since a portion of a working population exposed primarily to 
ethylene dibromide can easily be identified, kidney and liver function 
tests should be given periodically to see whether any changes are occurring 
as a result of occupational exposure to ethylene dibromide.
(f) Skin Sensitization
Ethylene dibromide has been implicated in one study [24] on humans as 
being a skin sensitizer. However, the data presented in this study are far 
from complete or unequivocal. Additional information on the degree and 
character of skin sensitization of humans is highly desirable.
(g) Biologic Monitoring
Studies should be conducted to determine the feasibility of using 
body fluids, such as blood or urine, as the basis of a method for biologic
monitoring of workers that are occupationally exposed to ethylene
dibromide.
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(h) Long-term Animal Exposure Studies
Long-term exposure of several animal species at a variety of 
concentrations of ethylene dibromide vapor approaching the recommended 
environmental limit is needed. These studies should simulate occupational 
exposure conditions of 8-10 hours/day, 4-5 days/week, for at least 18-24 
months and the animals maintained until the end of their natural life. 
These studies should be properly designed and performed to allow for 
assessment of general body parameters, biochemical/physiologic parameters, 
and gross or microscopic examinations of involved organs including at least 
the liver, lungs, spleen, kidneys, CNS, and circulatory system.
In addition, repeated long-term experiments should be performed to 
determine the effects of ethylene dibromide absorption through the skin. 
Similar schedules and experimental designs as those for inhalation studies 
should be followed.
The National Cancer Institute has informed NIOSH that a long-term 
experiment to study the possible carcinogenic effects from the inhalation 
of ethylene dibromide is presently being conducted.
(i) Metabolism and Distribution
The pathways of metabolic transformation, distribution, and 
elimination of ethylene dibromide as a function of the dose rate and route 
of administration in mammals have not been adequately investigated. It is 
critical to determine the fraction of the dose that is converted into 
harmless metabolites and the dependence of the magnitude of this fraction 
on the dose rate. Both in vivo and in vitro studies should be conducted to 
determine the pathways. It is also essential to determine the
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concentration at which partial impairment of the detoxification mechanisms 
begin to occur.
(j) Excretion in Biologic Fluids
Several studies [9,10] have indicated that ethylene dibromide, or its 
metabolites, is widely circulated throughout the body and remains widely 
distributed in the body tissues for a considerable time. These studies 
also indicated that ethylene dibromide, or its metabolites, is excreted in 
the urine and eliminated in the feces. No studies have been conducted to 
determine whether ethylene dibromide is excreted intact in the milk of 
lactating mammals. It is imperative to determine whether ethylene 
dibromide is excreted in the milk of mammals and, if so, at what 
concentrations and for how long.
(k) Electroencephalographic (EEG) Studies
The reports of possible CNS effects in animals [23,31,33] and the 
broad chemical reactivity of ethylene dibromide toward all classes of 
cellular nucleophiles suggest a careful study of CNS function by 
noninvasive techniques in human populations exposed to ethylene dibromide. 
A thorough study of EEG patterns may provide useful information.
(1) Personal Protective Equipment
Materials impervious to ethylene dibromide should be identified for 
use in protective clothing, boots, gloves, and air-supplied hoods. 
Materials chemically resistant to ethylene dibromide should be identified 
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IX. APPENDIX I
The following sampling method is adapted from Method No. S104 of the 
Physical and Chemical Analysis Branch of NIOSH [78, and S Tucker, written 
communication, March 1977].
Atmospheric Sampling
Collect breathing zone or personal samples representative of the 
individual employee's exposure. At the time of sample collection, record a 
description of sampling location, equipment used, time and rate of 
sampling, total sample volume, temperature, atmospheric pressure, relative 
humidity, and any other pertinent information. Collect enough samples to 
permit calculation of an exposure for every operation or location in which 
there is exposure to ethylene dibromide.
(a) Equipment
The sampling train consists of a charcoal tube and a vacuum pump.
(1) Charcoal tubes: Glass tubes, with both ends flame-
sealed, 7-cm long, with a 6-mm OD and a 4-mm ID, containing two sections of 
20/40 mesh activated charcoal separated by a 2-mm portion of polyurethane 
foam. The activated charcoal is prepared from coconut shells and is fired 
at 600 C prior to packing. The primary section contains 100 mg of 
charcoal, the backup section, 50 mg. A 3-mm portion of polyurethane foam 
is placed between the outlet end of the tube and the backup section. A 
plug of silylated glass wool is placed in front of the primary section.
METHOD FOR SAMPLING ETHYLENE DIBROMIDE IN AIR
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The pressure drop across the tube when in use must be less than 1 inch of 
mercury at a flowrate of 1 liter/minute. Tubes with the above 
specifications are commercially available.
(2) Pump: A battery-operated pump, complete with clip for
attachment to the employee's belt, capable of operation at 200 ml/minute or 
less with a controlled accuracy of + 5%.
(b) Calibration
The accurate calibration of a sampling pump is essential for the
correct interpretation of the volume sampled. The frequency of calibration 
is dependent on the use, care, and handling to which the pump is subjected. 
Pumps should also be recalibrated if they have been misused or if they have
just been repaired or received from a manufacturer. If the pump receives
hard usage, more frequent calibration may be necessary. Maintenance and 
calibration should be performed on a regular schedule and records of these 
should be kept.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. The accuracy of calibration is dependent on the 
type of instrument used as a reference. The choice of calibration
instrument will depend largely on where the calibration is to be performed. 
For laboratory testing, a soapbubble meter is recommended, although other 
standard calibrating instruments can be used. The actual setups will be 
similar for all instruments.
Instructions for calibration with the soapbubble meter follow. If 
another calibration device is selected, equivalent procedures should be 
used. The calibration setup for personal sampling pumps with a charcoal
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tube is shown in Figure XII-1. Since the flowrate given by a pump is 
dependent on the pressure drop across the sampling device, in this case a 
charcoal tube, the pump must be calibrated while operating with a 
representative charcoal tube in line.
(1) Check the voltage of the pump battery with a voltmeter 
to ensure adequate voltage for calibration. Charge the battery if 
necessary.
(2) Break the tips of a charcoal tube to produce openings 
of at least 2 mm in diameter.
(3) Assemble the sampling train as shown in Figure XII-1.
(4) Turn on the pump and moisten the inside of the 
soapbubble meter by immersing the buret in the soap solution. Draw bubbles 
up the inside until they are able to travel the entire buret length without 
bursting.
(5) Adjust the pump flowmeter to provide the desired
flowrate.
(6) Check the water manometer to ensure that the pressure 
drop across the sampling train does not exceed 2.5 inches of water at 200 
ml/minute.
(7) Start a soapbubble up the buret and measure with a 
stopwatch the time it takes the bubble to move from one calibration mark to 
another.
(8) Repeat the procedure in (7) above at least three times, 
average the results, and calculate the flowrate by dividing the volume 
between the preselected marks by the time required for the soapbubble to 
traverse the distance. If, for the pump being calibrated, the volume of
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air sampled is calculated as the product of the number of strokes times a 
stroke factor (given in units of volume/stroke), the stroke factor is the 
quotient of the volume between the two preselected marks divided by the
number of strokes.
(9) Data for the calibration include the volume measured,
elapsed time or number of strokes of the pump, pressure drop, air
temperature, atmospheric pressure, serial number of the pump, date, and
name of the person performing the calibration.
(c) Sampling Procedure
(1) Break both ends of the charcoal tube to provide
openings of at least 2 mm, which is half the ID of the tube. A smaller 
opening causes a limiting orifice effect which reduces the flow through the 
tube. The smaller section of charcoal in the tube is used as a backup
section and therefore is placed nearest the sampling pump. Use tubing to
connect the back of the tube to the pump, but tubing must never be put in 
front of the charcoal tube. The tube is supported in a vertical position 
in the employee's breathing zone.
(2) Sample a maximum of 25 liters of air at a flowrate of
200 ml/minute. For the determination of ceiling concentrations, the
sampling time is 15 minutes.
(3) Measure and record the temperature and pressure of the
atmosphere being sampled.
(4) Treat at least one charcoal tube in the same manner as
the sample tubes (break, seal, and ship), except draw no air through it. 
This tube serves as a blank.
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(5) Immediately after samples are collected, cap the 
charcoal tubes with plastic caps. Do not use rubber caps. To minimize 
breakage during transport, pack capped tubes tightly in a shipping 
container.
(6) Along with collected samples, send reference samples of 
the suspected compounds in a glass container capped with a teflon-lined 
cap. Do not transport these bulk liquid samples in the same container with 
the collected charcoal tubes.
(7) Low levels of 1,2-dibromoethane cannot be stored on 
charcoal at ambient temperatures for long periods of time. Therefore, if 
the analysis cannot be performed within 16-24 hours after sampling has been 
completed, the samples must be stored at -25 C or below. Refrigerated 
samples may be stored for two weeks.
(8) For shipment to the laboratory, the samples are packed 
firmly in an insulated container cooled with dry ice.
(9) If appropriate, a sample of the bulk material in a 
glass container with a teflon-lined cap is prepared and shipped to the 
laboratory in a separate container.
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X. APPENDIX II
ANALYTICAL METHOD FOR ETHYLENE DIBROMIDE
The following analytical method is adapted from Method No. 260 of the 
Physical and Chemical Analysis Branch of NIOSH [78, and S Tucker, written 
communication, March 1977].
Principle of the Method
Ethylene dibromide vapor trapped on charcoal from a known volume of 
air is desorbed with a 99:1 mixture of benzene-methanol (v/v). A portion 
of the desorbed sample is injected into a gas-liquid chromatograph equipped 
with an electron-capture detector. The area of the resulting peak is 
determined and compared with those obtained from injection of standards.
Range and Sensitivity
This method was used to analyze ethylene dibromide over the range of 
1.6 Mg/cu m to 16 mg/cu m (0.0002-2 ppm) at an atmospheric temperature and 
pressure of 25 C and 738 mmHg for a 25-liter air sample [78, and S Tucker, 
written communication, March 1977]. Under the conditions of sample size 
(25 liters), the probable range of this method is 40-800 nanograms/sample 
solution at a detector sensitivity that gives nearly full deflection on the 
strip chart recorder for a 1-mg sample. The method may be capable of 
measuring much smaller amounts if the desorption efficiency is adequate and
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if a photon-ionization detector is used on the chromatograph. Desorption 
efficiency must be determined over the range used.
The upper limit of the range of the method is dependent on the 
adsorptive capacity of the charcoal tube. This capacity varies with the 
concentrations of ethylene dibromide and other substances in the air. The 
first section of the charcoal tube held at least 21.4 mg of ethylene 
dibromide when a test atmosphere containing 446 mg/cu m of ethylene 
dibromide in dry air was sampled at 200 ml/minute for 240 minutes; at that 
time, the concentration of ethylene dibromide in the effluent was less than 
2% of that in the influent. If a particular atmosphere is suspected of 
containing a large amount of contaminant, a smaller sampling volume should 
be taken.
Interferences
Compounds which have about the same retention time as ethylene 
dibromide and which are detected by the electron capture detector will 
interfere with the analysis. This type of interference can be overcome by 
changing the operating conditions of the instrument, usually by modifying 
the column, the column temperature, or both.
Ethylene dibromide will not be efficiently trapped when the amount of 
water vapor in the air is so great that condensation occurs in the trapping 
media. Lesser amounts of water vapor in the air may severely decrease the 
breakthrough volume. When interfering compounds are known or suspected to 
be present in the air, such information including their suspected 
identities could be transmitted with the sample.
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Precision and Accuracy
The relative standard deviation for the combined analytical and 
sampling method in the prescribed range of 203-2,370 nanograms/charcoal 
tube was 0.070.
Advantages and Disadvantages of the Method
This method uses a sampling device that is small, portable, and 
involves no liquids. Interferences are minimal and can usually be 
eliminated by altering chromatographic conditions. Analysis of the 
charcoal tubes can be accomplished rapidly. Simultaneous analysis of two 
or more compounds suspected of being present in the same sample can usually 
be accomplished by simply changing chromatographic conditions.
One disadvantage of the method is that the amount of sample which can 
be collected by this method is limited by the weight of ethylene dibromide 
which the tube will hold before breakthrough. When the sample value 
obtained for the backup section of charcoal exceeds 25% of that found in 
the front section, the possibility of appreciable sample loss exists. 
Recoveries of ethylene dibromide from charcoal are decreased upon storage 
of the charcoal tube samples at room temperature, particularly with lesser 
amounts of analyte. The use of an internal standard is required in order 
to attain good precision. Other organic compounds in high concentrations 
may displace ethylene dibromide from the charcoal. High humidity may 
decrease the absorptive efficiency and capacity of the charcoal. The 
precision of the method is limited by the reproducibility of the pressure 
drop across the charcoal tube. This drop will affect the flowrate and the 




(a) Gas-liquid chromatograph equipped with an electron capture 
detector. A glass tube filled with 20/40 mesh activated charcoal should be 
attached to the exit port in order to trap the ethylene dibromide in the 
effuent gas stream.
(b) Gas chromatography column. 1.8 m x 4 mm (ID) constructed from 
borosilicate glass and packed with 3% OV-210 on 80/100 Gas Chrom Q. Other 
columns which achieve the desired separation may be used.
(c) A mechanical or electronic integrator or a recorder for 
determining peak area.
(d) Small glass-stoppered test tubes or equivalent.
(e) A 10—¿zl syringe and other conveniently sized syringes for 
preparation of the standards.
(f) Pipets, 10.0 ml and 1.0 ml.
(g) Volumetric flasks, 10-ml capacity for standard dilutions. 
Reagents
(a) Benzene, pesticide quality.
(b) Methanol, pesticide quality.
(c) Ethylene dibromide of known purity.
(d) An appropriate internal standard, such as
1,1,2,2 ,-tetrachloroethane or 1,2 dibromopropane.
(e) A solution of internal standard in 99:1 
benzene-methanol (v/v).
(f) 99:1 Benzene-methanol (v/v).
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Analysis of Samples
All glassware used for the laboratory analysis should be washed in 
detergent and rinsed with tap and distilled water.
(a) Preparation: Score each charcoal tube, including the blank
from field samples, with a file and break open in front of the first 
section of charcoal. Remove and discard the glass wool. Transfer the 
charcoal in the first (larger) section to a small stoppered test tube. 
Remove and discard the separating section of foam and transfer the second
section of charcoal to another test tube. Analyze the two charcoal
sections separately.
(b) Desorption: Prior to analysis, pipet 10.0 ml of benzene-
methanol (99:1) into each test tube to desorb the ethylene dibromide from 
the charcoal. For the internal standard method, a 0.2% solution of n- 
pentadecane in benzene-methanol (99:1) is used for desorption. Sample 
vials should be capped after adding solvent to minimize volatilization. 
Desorption is complete in 30 minutes if the sample Is stirred occasionally. 
Recoveries of the analyte from charcoal decrease with increasing storage
times at room temperature. The decreases are more pronounced at lower 
levels of analyte. The recoveries after storage are adequate, however, 
when the charcoal tube samples are refrigerated. If analyses cannot be 
performed within 3-5 hours after sampling, the charcoal tube samples must 
be stored at -25 C. The refrigerated samples may be stored for up to two
weeks.
BENZENE CAN CAUSE SERIOUS BLOOD ABNORMALITIES INCLUDING LEUKEMIA. 
EXTREME CAUTION MUST BE EXERCISED AT ALL TIMES WHEN USING BENZENE BECAUSE 
OF ITS HIGH TOXICITY AND FLAMMABILITY. ALL WORK WITH BENZENE MUST BE 
PERFORMED UNDER AN EXHAUST HOOD.
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(c) Typical gas-liquid chromatographic operating conditions for
analysis:
(1) Nitrogen carrier gas flow: 35ml/min
(2) Inlet temperature: 175 C
(3) Detector temperature: 315 C
(4) Column temperature: 50 C
(5) (63Ni) detector operating mode: DC at 90 to 95%
standing current
(d) Injection: The first step in the analysis is the injection of
the sample into the gas-liquid chromatograph. Employ the solvent flush 
injection technique. This eliminates difficulties arising from blowback or 
distillation within the syringe needle, thus increasing the accuracy and 
reproducibility of the injected sample volume. First, flush the 10.0-jul 
syringe with solvent several times to wet the barrel and plunger, then draw
3.0 Ml of solvent into the syringe. Next, remove the needle from the 
benzene-methanol (99:1) and pull the plunger back about 0.2 fxl to separate 
the solvent flush from the sample with an air pocket to be used as a 
marker. Immerse the needle in the sample and withdraw a 5.0-m 1 portion, 
taking into consideration the volume of the needle since the sample in the 
needle will be completely injected. After the needle is removed from the 
sample and prior to injection into the gas-liquid chromatograph, pull the 
plunger back a short distance to minimize sample evaporation from the tip. 
Make duplicate injections of each sample and of the standard. No more than 
a 3% difference between the peak areas of the similar injections should be 
accepted. Automatic sample injectors may be used if shown to give 
reproducibility at least as good as the solvent flush injection technique. 
In this case, injections of 2 ¡xl are satisfactory.
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(e) Measurement of area: The areas of the sample peaks are
measured by electronic integration or some other suitable method of area 
measurement. Preliminary sample results are read from a standard curve 
prepared as outlined below.
(f) The approximate retention times of ethylene dibromide and two 
potential internal standards under the GC conditions described in this 
method are:




2.2 min 131 C
2.9 min 140 C
4.1 min 146 C
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Determination of Desorption Efficiency
The desorption efficiency of a particular compound can vary from one 
laboratory to another and also from one batch of charcoal to another. 
Thus, it is necessary to determine at least once the percentage of ethylene 
dibromide that is removed in the desorption process. Repeat this procedure 
for each new batch of charcoal used.
Place the same amount of activated charcoal as in the first section 
of the sampling tube (100 mg) into a 5-cm, 4-mm ID glass tube; flame seal 
at one end. This charcoal must be from the same batch as that used in 
sampling and can be obtained from unused charcoal tubes. Cap the open end 
with Parafilm or equivalent. Inject a known amount of n-heptane solution 
containing 55 mg/ml of ethylene dibromide directly into the activated 
charcoal with a microliter syringe and recap the tube with more Parafilm or 
equivalent. The amount injected is equivalent to that present in a 1-liter 
sample at the selected level.
Prepare at least six tubes in this manner for each concentration and 
allow to stand overnight or longer to ensure complete adsorption of the 
ethylene dibromide on the charcoal. These six tubes are referred to as the 
"desorption samples." Treat a parallel blank tube in the same manner, 
except add no ethylene dibromide to it. Desorb and analyze the desorption 
samples and blank tubes in exactly the same manner as the sampling tube 
described for unknown air samples.
Prepare two or three standards by injecting the same volume of 
ethylene dibromide into 10.0 ml of the 99:1 benzene-methanol mixture 
(containing 0.2% n-pentadecane if the internal standard method is used) 
with the same syringe used in the preparation of the desorption samples.
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These are analyzed with the desorption samples.
The desorption efficiency equals the difference between the average 
peak area of the desorption samples and that of the blank divided by the 
average peak area of the standards, or:
desorption efficiency = area of sample - area of blank
area of standard
The desorption efficiency is dependent on the amount of ethylene 
dibromide collected on the charcoal. Plot the desorption efficiency versus 
the weight of ethylene dibromide found. This curve is used to correct for 
adsorption losses when sample concentrations are calculated.
Calibration and Standards
It is convenient to express the concentration of standards in terms 
of mg ethylene dibromide/ml of benzene-methanol because samples are 
desorbed in 10 ml of benzene-methanol. Use the density of ethylene 
dibromide to convert milligrams into microliters for easy measurement with 
a microliter syringe. Prepare a series of standards varying in 
concentration over the range of interest and then analyze them under the 
same gas-liquid chromatographic conditions and during the same time period 
as the unknown samples. To minimize error, inject 10 times the desired 
weight of ethylene dibromide into 10 times the desired volume of benzene- 
methanol. Prepare standard curves by plotting concentration in mg/ml 
versus peak area.
In the case of the internal standard method, prepare standard curves 
by plotting concentration in mg/ml versus the ratio of the peak areas of 
ethylene dibromide to n-pentadecane.
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Calculations
Read the weight in milligrams of ethylene dibromide corresponding to 
the total peak area from the standard curve. No volume corrections are 
needed because the standard curve is based on mg ethylene dibromide/ml of 
benzene-methanol and the volume of sample injected is identical to the 
volume of the standards injected.
Make corrections for the blank from the field sampling for each
sample by subtracting the amounts of ethylene dibromide found on the front 
and back sections of the blank from the amounts found in the respective
sections of the sample:
corrected amount ■ amount on sample - amount on blank
Add the corrected amounts present in the front and in the backup
sections of the same sample tube to determine the total amount of ethylene 
dibromide in the sample. Divide this total amount by the desorption
efficiency to obtain the adjusted total amount of ethylene dibromide in the 
sample:
adjusted total amount =  total amount__
desorption efficiency
The concentration of ethylene dibromide in the air sampled, expressed 
in mg/cu m, is given by the quotient of the adjusted amount in mg divided 
by the volume of air sampled in cu m:
concentration (mg/cu m) = adjusted amount (mg)
volume (cu m)
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Another method of expressing concentration is ppm:
concentration (ppm) = concentration (mg/cu m) x 24.45 x 760 x
MW P
where:
24.45 = molar volume (liter/mole) at 25 C and 760 mmHg 
760 = standard atmospheric pressure (mmHg)
P = pressure (mmHg) of air sampled
T = temperature (degrees C) of air sampled
MW = molecular weight of ethylene dibromide (g/mole)
298 = standard atmospheric temperature (degrees K)
(T + 273) 
298
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X. APPENDIX III 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read 
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identif ication System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of 
Section I. The company listed should be a source of detailed backup 
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50- 
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity
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or similar descriptive data may be used to indicate flammability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in
parts/hundred parts of water by weight; specific gravity (water = 1);
percent volatiles (indicated if by weight or volume) at 70 degrees
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is 
also useful for design and deployment of adequate fire and spill
containment equipment. The appearance and odor may facilitate
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the
product, including flashpoint and autoignition temperature in degrees
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to 
cleanup detail. Specific neutralizing chemicals or procedures should be 
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill," or "incineration." Warnings such as "comply with 
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Mines 
approval class, ie, "Supplied air," "Organic vapor canister," etc. 
Protective equipment must be specified as to type and materials of 
construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on 
any aspect of safety or health not covered in other sections should be 
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous substance. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M A N U F A C T U R E R 'S  N A M E R E G U L A R  TELEPHONE NO 





M A T E R I A L  OR COMPONENT % H A Z A R D  D A T A
III PHYSICAL DATA
B O IL IN G  POINT, 760 MM HG M E L T IN G  POINT
SPECIFIC G R A V IT Y  ( H j O - l ) VAPOR PRESSURE
VAPO R DE NS ITY  ( A lR  = 1) S O L U B IL IT Y  IN H jO .  % BY WT
% V O L A T IL E S  BY VO L E V A P O R A T IO N  RATE ( B U T Y i  ACETATE M I
APPEARANCE A N D ODOR
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IV FIRE AND EXPLOSION DATA
FLA SH POINT 
(TEST METHOD)
A U T O tG N lT IO N
TE M P E R A TU R E
F L A M M A B L E  L IM ITS  IN A IR ,  % BY VOL. LOWER UPPER





U N U S U A L FIRE 
AN D  EXPLOSION 
H A Z A R D
V HEALTH HAZARD INFORMATION
H E A L T H  H A Z A R D  D A T A
ROUTES OF EXPOSURE 





EFFECTS OF OVEREXPOSURE 
ACUTE OVEREXPOSURE
CHRONIC OVEREXPOSURE
EMERGENCY A N D  FIRST A ID  PROCEDURES 
EYES
SKIN





CONDITIONS CONTRIBUTING TO INSTABILITY
INCOMPA1 i BILITY
HAZARDOUS DECOMPOSITION PRODUCTS
CONDITIONS CONTRIBUTING TO HAZARDOUS POLYMERIZATION
VII SPILL OR LEAK PROCEDURES
STEPS TO BE TAKEN IF MATERIAL IS RELEASED OR SPILLED 
NEUTRALIZING CHEMICALS
WASTE DISPOSAL METHOD
_____________ VIII SPECIAL PROTECTION INFORMATION
VENTILATION REQUIREMENTS
SPECIFIC PERSONAL PROTECTIVE EQUIPMENT 
RESPIRATORY (SPECIFY IN DETAIL!
EYE
GLOVES











XII. TABLES AND FIGURE
TABLE XII-1
CHEMICAL AND PHYSICAL PROPERTIES OF ETHYLENE DIBROMIDE
Formula CH2BrCH2Br
Formula weight 187.88
Melting point (C) 9.6
Boiling point (C) 131.4
Vapor density (air=l) 6.5
Vapor pressure (mmHg at 25 C) 12.0
Firepoint None
Heat of vaporization 





(centipoise at 20 C)
1.65
Density (g/ml at 20 C) 2. 18
Density of saturated air (air=l) 1.08
Concentration of saturated air 








0.43 g/100 g water at 30 C
Conversion factors 
(760 mmHg at 25 C)
1 m<i/liter=l g/cu m=130 ppm 
1 ppm=7.68 mg/cu m=7.68 ng!lxte.r
Adapted from references 1,3,4,118
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TABLE XII-2
OCCUPATIONS WITH POTENTIAL EXPOSURES TO ETHYLENE DIBROMIDE
Antiknock compound makers Lead scavenger makers
Cabbage growers Motor fuel workers
Celluloid makers Nematode controllers
Corngrowers Oil processors
Drug makers Organic chemical synthesizers
Ethylene dibromide workers Resin makers
Fat processors Seed corn maggot controllers
Fire extinguisher makers Soil fumigators
Fruit fumigators Termite controllers
Fumigant workers Tetraethyl lead makers
Gasoline blenders Waterproofing makers
Grain elevator workers Waxmakers
Grain fumigators Wood insect controllers
Gum processors Wool reclaimers
Adapted from reference 21
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TABLE XII-3
CONCENTRATIONS* OF RADIOACTIVITY IN MOUSE TISSUES
AFTER INJECTION OF 40 MG/KG IP OF 14C-ETHYLENE DIBROMIDE
Tissue 1 hr 3 hr 24 hr
Bone (whole femur) 1.4 2.1 0.5
Brain 0.2 0.6 0.1
Tail of epididymis 3.1 4.4 0.7
Fat 4.9 2.4 0.3
Heart 1.1 1.1 0.2
Large intestine + contents 5.3 15.0 0.3
Small intestine + contents 34.0 5.8 0.4
Kidney 13.0 12.0 1.0
Liver 12.0 6.6 0.4
Lung 2.5 3.3 0.4
Muscle (gastrocnemius) 0.9 1.0 0.1
Skin 1.2 2.1 0.3
Spleen 4.1 4.7 0.6
Stomach + contents 1.7 4.6 1.0
Testis 1.1 1.5 0.2
Whole blood 7.2 7.4 6.2
Plasma 12 .0 12.0 2.6
Residue of animal 1.3 2.4 0.2
*Results expressed as % administered dose/g wet tissue. 
Adapted from reference 9
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TABLE XII-4
CONCENTRATIONS* OF RADIOACTIVITY IN MALE GUINEA PIG TISSUES
AFTER ADMINISTRATION OF 30 MG/KG IP OF 14C-ETHYLENE DIBROMIDE
Tissue Hours after Administration
4 8 12 24 48 72
Kidney 286.64 236.52 147.79 73.45 14.66 10.47
Liver 129.03 104.91 78.39 38.07 16.20 15.58
Adrenal 60. 73 60.82 26.56 28.63 13.24 10.43
Pancreas 35.04 36.81 28.85 18.68 7.52 6.01
Spleen 15.79 13.96 15.83 14.89 8.92 6.95
Heart 14.01 15.63 11.59 9.51 4.13 3.23
Lung 20.93 19.00 17.76 15.43 8.08 5.83
Testis 10.68 10.72 9.08 8.34 5.05 3.98
Brain 6.19 7.62 6.75 6.47 3.70 2.51
Fat** 21. 39 7.86 8.72 3.19 3.05 2.07
Muscle 5.53 4.97 4.58 4.15 2.91 2.16
Blood 9.97 3.40 5.78 4.59 3.36 2.77
*Values represent mean levels in jug/g of tissue or Mg/ml of fluid of 
duplicate determinations on three animals at each interval. 
**Suprarenal fat
Adapted from reference 10
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TABLE XII-5
RETENTION* OF RADIOACTIVITY IN MALE GUINEA PIG TISSUES
AFTER INJECTION OF 30 MG/KG IP OF 14C-ETHYLENE DIBROMIDE
Tissue Hours after Administration
4 8 12 24 48 72
Liver 16.29 13.65 10.50 4.72 2.12 2.16
Kidney 6.00 5.69 3.31 1.64 0.31 0.24
Stomach + contents 1. 14 0.52 0.62 0.38 0.18 0.18
Lung 0.35 0.38 0.37 0.24 0.12 0.10
Pancreas 0.31 0.36 0.33 0.20 0.07 0.06
Testis 0.16 0.17 0.12 0.12 0.07 0.06
Heart 0.13 0.16 0.12 0.10 0.04 0.03
Brain 0.12 0.16 0.14 0.13 0.07 0.05
Adrenal 0.09 0. 10 0.04 0.03 0.01 0.02
Spleen 0.07 0.06 0.07 0.08 0.03 0.02
*Values represent the mean % of the administered dose of duplicate deter­
minations on three animals at each interval.
Adapted from reference 10
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